EurekaMag PDF full texts Chapter 71,626

Chang, K.T.; Min, K-Tai. 2005: Drosophila melanogaster homolog of Down syndrome critical region 1 is critical for mitochondrial function. Nature Neuroscience 8(11): 1577-1585

de Bruijn, M.H. 1983: Drosophila melanogaster mitochondrial DNA, a novel organization and genetic code. Nature 304(5923): 234-241

Walker, J.A.; Bernards, Aé. 2007: Drosophila melanogaster neurofibromatosis-1: ROS, not Ras?. Nature Genetics 39(4): 443-445

Sakai, K.; Tsutsui, K.; Yamashita, T.; Iwabe, N.; Takahashi, K.; Wada, A.; Shichida, Y. 2017: Drosophila melanogaster rhodopsin Rh7 is a UV-to-visible light sensor with an extraordinarily broad absorption spectrum. Scientific Reports 7(1): 7349

Gonzalez, C. 2013: Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics. Nature Reviews. Cancer 13(3): 172-183

Hamilton, P.J.; Campbell, N.G.; Sharma, S.; Erreger, K.; Hansen, F.H.; Saunders, C.; Belovich, A.N.; Sahai, M.A.; Cook, E.H.; Gether, U.; McHaourab, H.S.; Matthies, H.J.G.; Sutcliffe, J.S.; Galli, A. 2013: Drosophila melanogaster: a novel animal model for the behavioral characterization of autism-associated mutations in the dopamine transporter gene. Molecular Psychiatry 18(12): 1235

Ghosh, S.; Ghosh, S.; Mandal, L. 2020: Drosophila metamorphosis involves hemocyte mediated macroendocytosis and efferocytosis. International Journal of Developmental Biology 64(4-5): 319-329

Kitatani, Y.; Tezuka, A.; Hasegawa, E.; Yanagi, S.; Togashi, K.; Tsuji, M.; Kondo, S.; Parrish, J.Z.; Emoto, K. 2020: Drosophila miR-87 promotes dendrite regeneration by targeting the transcriptional repressor Tramtrack69. Plos Genetics 16(8): E1008942

de Navascués, Jín.; Perdigoto, C.N.; Bian, Y.; Schneider, M.H.; Bardin, A.J.; Martínez-Arias, A.; Simons, B.D. 2012: Drosophila midgut homeostasis involves neutral competition between symmetrically dividing intestinal stem cells. EMBO Journal 31(11): 2473-2485

Chan, H.Y.; Bonini, N.M. 2000: Drosophila models of human neurodegenerative disease. Cell Death and Differentiation 7(11): 1075-1080

Yusuff, T.; Jensen, M.; Yennawar, S.; Pizzo, L.; Karthikeyan, S.; Gould, D.J.; Sarker, A.; Gedvilaite, E.; Matsui, Y.; Iyer, J.; Lai, Z.-C.; Girirajan, S. 2020: Drosophila models of pathogenic copy-number variant genes show global and non-neuronal defects during development. Plos Genetics 16(6): E1008792

Yamaguchi, M.; Lee, I.-S.; Jantrapirom, S.; Suda, K.; Yoshida, H. 2021: Drosophila models to study causative genes for human rare intractable neurological diseases. Experimental Cell Research 403(1): 112584

Lawal, H.O.; Terrell, A.; Lam, H.A.; Djapri, C.; Jang, J.; Hadi, R.; Roberts, L.; Shahi, V.; Chou, M-T.; Biedermann, T.; Huang, B.; Lawless, G.M.; Maidment, N.T.; Krantz, D.E. 2014: Drosophila modifier screens to identify novel neuropsychiatric drugs including aminergic agents for the possible treatment of Parkinson's disease and depression. Molecular Psychiatry 19(2): 235-242

Bernstein, S.I.; Mogami, K.; Donady, J.J.; Emerson, C.P. 1983: Drosophila muscle myosin heavy chain encoded by a single gene in a cluster of muscle mutations. Nature 302(5907): 393-397

Yang, H.; Hultmark, D. 2017: Drosophila muscles regulate the immune response against wasp infection via carbohydrate metabolism. Scientific Reports 7(1): 15713

Salkoff, L. 1983: Drosophila mutants reveal two components of fast outward current. Nature 302(5905): 249-251

Yanai, H.; Yoshioka, Y.; Yoshida, H.; Nakao, Y.; Plessis, A.; Yamaguchi, M. 2014: Drosophila myeloid leukemia factor acts with DREF to activate the JNK signaling pathway. Oncogenesis 3: E98

Guo, Y.; Kronert, W.A.; Hsu, K.H.; Huang, A.; Sarsoza, F.; Bell, K.M.; Suggs, J.A.; Swank, D.M.; Bernstein, S.I. 2020: Drosophila myosin mutants model the disparate severity of type 1 and type 2B distal arthrogryposis and indicate an enhanced actin affinity mechanism. Skeletal Muscle 10(1): 24

Januschke, J.; Llamazares, S.; Reina, J.; Gonzalez, C. 2011: Drosophila neuroblasts retain the daughter centrosome. Nature Communications 2: 243

Büschges, A. 2021: Drosophila neuroscience: Unravelling the circuits of sensory-motor control in the fly. Current Biology: Cb 31(8): R394-R396

Wicher, D.; Schäfer, R.; Bauernfeind, Ré.; Stensmyr, M.C.; Heller, R.; Heinemann, S.H.; Hansson, B.S. 2008: Drosophila odorant receptors are both ligand-gated and cyclic-nucleotide-activated cation channels. Nature 452(7190): 1007-1011

Keene, A.C.; Waddell, S. 2007: Drosophila olfactory memory: single genes to complex neural circuits. Nature Reviews. Neuroscience 8(5): 341-354

Godt, D.; Tepass, U. 1998: Drosophila oocyte localization is mediated by differential cadherin-based adhesion. Nature 395(6700): 387-391

McDonough-Goldstein, C.E.; Pitnick, S.; Dorus, S. 2021: Drosophila oocyte proteome composition covaries with female mating status. Scientific Reports 11(1): 3142

Ryan, S.M.; Almassey, M.; Burch, A.M.; Ngo, G.; Martin, J.M.; Myers, D.; Compton, D.; Archie, S.; Cross, M.; Naeger, L.; Salzman, A.; Virola-Iarussi, A.; Barbee, S.A.; Mortimer, N.T.; Sanyal, S.; Vrailas-Mortimer, A.D. 2021: Drosophila p38 MAPK interacts with BAG-3/starvin to regulate age-dependent protein homeostasis. Aging Cell 20(11): E13481

Dichtel-Danjoy, M-L.; Ma, D.; Dourlen, P.; Chatelain, G.; Napoletano, F.; Robin, M.; Corbet, M.; Levet, C.; Hafsi, H.; Hainaut, P.; Ryoo, H.D.; Bourdon, J-C.; Mollereau, B. 2013: Drosophila p53 isoforms differentially regulate apoptosis and apoptosis-induced proliferation. Cell Death and Differentiation 20(1): 108-116

Dare, S.S.; Merlo, E.; Rodriguez Curt, J.; Ekanem, P.E.; Hu, N.; Berni, J. 2020: Drosophila para bss Flies as a Screening Model for Traditional Medicine: Anticonvulsant Effects of Annona senegalensis. Frontiers in Neurology 11: 606919

Terriente-Felix, A.; Wilson, E.L.; Whitworth, A.J. 2020: Drosophila phosphatidylinositol-4 kinase fwd promotes mitochondrial fission and can suppress Pink1/parkin phenotypes. Plos Genetics 16(10): E1008844

Clark, I.E.; Dodson, M.W.; Jiang, C.; Cao, J.H.; Huh, J.R.; Seol, J.Hong.; Yoo, S.Ji.; Hay, B.A.; Guo, M. 2006: Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441(7097): 1162-1166

Montigny, A.; Tavormina, P.; Duboe, C.; San Clémente, H.él.èn.; Aguilar, M.; Valenti, P.; Lauressergues, D.; Combier, J.-P.; Plaza, S. 2021: Drosophila primary microRNA-8 encodes a microRNA-encoded peptide acting in parallel of miR-8. Genome Biology 22(1): 118

Kretova, O.V.; Fedoseeva, D.M.; Slovohotov, I.Y.; Klushevskaya, E.S.; Kravatsky, Y.V.; Tchurikov, N.A. 2020: Drosophila rDNA Genes Shape the Stable Contacts with the Tlk Gene at the Expression Area of Small RNAs and Affect on Looped Domains inside the Gene. Molekuliarnaia Biologiia 54(3): 445-449

Behbahani, A.H.; Palmer, E.H.; Corfas, R.án.A.; Dickinson, M.H. 2021: Drosophila re-zero their path integrator at the center of a fictive food patch. Current Biology: Cb 31(20): 4534-4546.E5

de Castro, I.P.; Costa, A.C.; Celardo, I.; Tufi, R.; Dinsdale, D.; Loh, S.H.Y.; Martins, L.M. 2013: Drosophila ref(2)P is required for the parkin-mediated suppression of mitochondrial dysfunction in pink1 mutants. Cell Death and Disease 4: E873

Botas, J. 2007: Drosophila researchers focus on human disease. Nature Genetics 39(5): 589-591

Boeynaems, S.; Bogaert, E.; Michiels, E.; Gijselinck, I.; Sieben, A.; Jovičić, A.; De Baets, G.; Scheveneels, W.; Steyaert, J.; Cuijt, I.; Verstrepen, K.J.; Callaerts, P.; Rousseau, F.; Schymkowitz, J.; Cruts, M.; Van Broeckhoven, C.; Van Damme, P.; Gitler, A.D.; Robberecht, W.; Van Den Bosch, L. 2016: Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Scientific Reports 6: 20877

Dickson, D. 1998: Drosophila set for fast-track sequencing. Nature 393(6683): 296

Ruel, L.; Bourouis, M.; Heitzler, P.; Pantesco, V.; Simpson, P. 1993: Drosophila shaggy kinase and rat glycogen synthase kinase-3 have conserved activities and act downstream of Notch. Nature 362(6420): 557-560

Lee, K-Sun.; Kwon, O-Yu.; Lee, J.H.; Kwon, K.; Min, K-Jin.; Jung, S-Ah.; Kim, A-Kyeong.; You, K-Hee.; Tatar, M.; Yu, K. 2008: Drosophila short neuropeptide F signalling regulates growth by ERK-mediated insulin signalling. Nature Cell Biology 10(4): 468-475

Falkenburg, P.E.; Haass, C.; Kloetzel, P.M.; Niedel, B.; Kopp, F.; Kuehn, L.; Dahlmann, B. 1988: Drosophila small cytoplasmic 19S ribonucleoprotein is homologous to the rat multicatalytic proteinase. Nature 331(6152): 190-192

Wang, X.; Shaw, W.Robert.; Tsang, H.T.H.; Reid, E.; O'Kane, C.J. 2007: Drosophila spichthyin inhibits BMP signaling and regulates synaptic growth and axonal microtubules. Nature Neuroscience 10(2): 177-185

Schulz, J.G.; Ceulemans, H.; Caussinus, E.; Baietti, M.F.; Affolter, M.; Hassan, B.A.; David, G. 2011: Drosophila syndecan regulates tracheal cell migration by stabilizing Robo levels. Embo Reports 12(10): 1039-1046

Grimes, L.; Griffiths, J.; Pasqualetto, G.; Brancale, A.; Kemp, P.J.; Young, M.T.; van der Goes van Naters, W. 2020: Drosophila taste neurons as an agonist-screening platform for P2X receptors. Scientific Reports 10(1): 8292

On, K.; Crevel, G.; Cotterill, S.; Itoh, M.; Kato, Y. 2021: Drosophila telomere capping protein HOAP interacts with DSB sensor proteins Mre11 and Nbs. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 26(4): 219-229

Xie, J.; Chen, S.; Bopassa, J.C.; Banerjee, S. 2021: Drosophila tubulin polymerization promoting protein mutants reveal pathological correlates relevant to human Parkinson's disease. Scientific Reports 11(1): 13614

Restrepo, S.; Basler, K. 2016: Drosophila wing imaginal discs respond to mechanical injury via slow InsP3R-mediated intercellular calcium waves. Nature Communications 7: 12450

Dougan, S.; DiNardo, S. 1992: Drosophila wingless generates cell type diversity among engrailed expressing cells. Nature 360(6402): 347-350

Van de Leemput, J.; Han, Z. 2021: Drosophila, a powerful model to study virus-host interactions and pathogenicity in the fight against SARS-CoV-2. Cell and Bioscience 11(1): 110

Noselli, Séphane. 2002: Drosophila, actin and videotape -- new insights in wound healing. Nature Cell Biology 4(11): E251-E253

Bier, E. 2005: Drosophila, the golden bug, emerges as a tool for human genetics. Nature Reviews. Genetics 6(1): 9-23

Tan, B.H.; Modlin, R.L. 2000: Drosophila, the savvy exterminator. Nature Immunology 1(5): 361

Luning, K.G. 1966: Drosophila-tests in pharmacology. Nature 209(5018): 84-86

Auerbach, C. 1966: Drosophila-tests in pharmacology. Nature 210(5031): 104

Knauf, F.; Preisig, P.A. 2011: Drosophila: a fruitful model for calcium oxalate nephrolithiasis?. Kidney International 80(4): 327-329

Sokolowski, M.B. 2001: Drosophila: genetics meets behaviour. Nature Reviews. Genetics 2(11): 879-890

Bryant, P.J.; Sang, J.H. 1968: Drosophila: lethal derangements of metamorphosis and modifications of gene expression caused by juvenile hormone mimics. Nature 220(5165): 393-394

Paton, D.M. 2020: Drospirenone: a novel progestogen used as an oral contraceptive without an estrogen component. Drugs of Today 56(5): 321-328

Wu, S.; Guo, C.; Zhao, H.; Sun, M.; Chen, J.; Han, C.; Peng, Q.; Qiao, H.; Peng, P.; Liu, Y.; Luo, S.D.; Pan, Y. 2019: Drosulfakinin signaling in fruitless circuitry antagonizes P1 neurons to regulate sexual arousal in Drosophila. Nature Communications 10(1): 4770

Kanbur, A.S.; Agarwal, A.; Rokade, M.L. 2021: Drotaverine-induced priapism. Indian Journal of Urology: Iju: Journal of the Urological Society of India 37(1): 90-91

LaRosa, S.P. 2006: Drotrecogin alfa (activated) in severe sepsis. New England Journal of Medicine 354(1): 94

Baillie, J.K.; Murray, G. 2006: Drotrecogin alfa (activated) in severe sepsis. New England Journal of Medicine 354(1): 94

Russo, G.; La Spina, M.; Disma, N.; Astuto, M. 2006: Drotrecogin alfa activated as a treatment for severe sepsis in pediatric cancer. Bone Marrow Transplantation 38(8): 575-576

Labbos, J.; Bradsher, J.; Kirkpatrick, P. 2003: Drotrecogin alpha (activated). Nature Reviews. Drug Discovery 2(1): 13-14

Kuswanto, H.; Puspa, A.W.; Ahmad, I.S.; Hibatullah, F. 2021: Drought Analysis in East Nusa Tenggara (Indonesia) Using Regional Frequency Analysis. Thescientificworldjournal 2021: 6626102

Prasad, J.K.; Pandey, P.; Anand, R.; Raghuwanshi, R. 2021: Drought Exposed Burkholderia seminalis JRBHU6 Exhibits Antimicrobial Potential Through Pyrazine-1,4-Dione Derivatives Targeting Multiple Bacterial and Fungal Proteins. Frontiers in Microbiology 12: 633036

Henderson, J.C.; Davies, F.T. 1990: Drought acclimation and the morphology of mycorrhizal Rosa hybrida L. cv. 'Ferdy' is independent of leaf elemental content. New Phytologist 115(3): 503-510

Vandegeer, R.; Miller, R.E.; Bain, M.; Gleadow, R.M.; Cavagnaro, T.R. 2013: Drought adversely affects tuber development and nutritional quality of the staple crop cassava (Manihot esculenta Crantz). Functional Plant Biology: Fpb 40(2): 195-200

Gómez-Gener, Lís.; Lupon, A.; Laudon, H.; Sponseller, R.A. 2020: Drought alters the biogeochemistry of boreal stream networks. Nature Communications 11(1): 1795

Dikici, M. 2020: Drought analysis with different indices for the Asi Basin (Turkey). Scientific Reports 10(1): 20739

Bellizzi, S.; Panu Napodano, C.M.; Fiamma, M.; Ali Maher, O. 2020: Drought and COVID-19 in the Eastern Mediterranean Region of the WHO. Public Health 183: 46-47

Xiang, L.-S.; Miao, L.-F.; Yang, F. 2021: Drought and Nitrogen Application Modulate the Morphological and Physiological Responses of Dalbergia odorifera to Different Niche Neighbors. Frontiers in Plant Science 12: 664122

Ma, Y.; Dias, M.C.; Freitas, H. 2020: Drought and Salinity Stress Responses and Microbe-Induced Tolerance in Plants. Frontiers in Plant Science 11: 591911

Delbiso, T.Darge.; Altare, C.; Rodriguez-Llanes, J.Manuel.; Doocy, S.; Guha-Sapir, D. 2017: Drought and child mortality: a meta-analysis of small-scale surveys from Ethiopia. Scientific Reports 7(1): 2212

Byers, E.A.; Coxon, G.; Freer, J.; Hall, J.W. 2020: Drought and climate change impacts on cooling water shortages and electricity prices in Great Britain. Nature Communications 11(1): 2239

Phillips, K.; Ludidi, N. 2017: Drought and exogenous abscisic acid alter hydrogen peroxide accumulation and differentially regulate the expression of two maize RD22-like genes. Scientific Reports 7(1): 8821

Di Francescantonio, D.éb.; Villagra, M.; Goldstein, G.; Campanello, P.I. 2020: Drought and frost resistance vary between evergreen and deciduous Atlantic Forest canopy trees. Functional Plant Biology: Fpb 47(9): 779-791

El-Madany, T.S.; Carrara, A.; Martín, M.P.; Moreno, G.; Kolle, O.; Pacheco-Labrador, J.; Weber, U.; Wutzler, T.; Reichstein, M.; Migliavacca, M. 2020: Drought and heatwave impacts on semi-arid ecosystems' carbon fluxes along a precipitation gradient. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 375(1810): 20190519

Feng, W.; Lu, H.; Yao, T.; Yu, Q. 2020: Drought characteristics and its elevation dependence in the Qinghai-Tibet plateau during the last half-century. Scientific Reports 10(1): 14323

Xie, T.; Shan, L.; Su, P. 2020: Drought conditions alter litter decomposition and nutrient release of litter types in an agroforestry system of China. Ecology and Evolution 10(15): 8018-8029

Dyosi, M.; Kalumba, A.M.; Magagula, H.B.; Zhou, L.; Orimoloye, I.R. 2021: Drought conditions appraisal using geoinformatics and multi-influencing factors. Environmental Monitoring and Assessment 193(6): 365

Orimoloye, I.R.; Belle, J.A.; Ololade, O.O. 2021: Drought disaster monitoring using MODIS derived index for drought years: A space-based information for ecosystems and environmental conservation. Journal of Environmental Management 284: 112028

Mahmud, T.; Sifa, S.F.; Islam, N.N.; Rafsan, M.A.; Kamal, A.S.M.M.; Hossain, M.S.; Rahman, M.Z.; Chakraborty, T.R. 2021: Drought dynamics of Northwestern Teesta Floodplain of Bangladesh: a remote sensing approach to ascertain the cause and effect. Environmental Monitoring and Assessment 193(4): 218

Svensk, M.; Coste, S.; Gérard, B.; Gril, E.; Julien, F.éd.ér.; Maillard, P.; Stahl, C.ém.; Leroy, C.él. 2020: Drought effects on resource partition and conservation among leaf ontogenetic stages in epiphytic tank bromeliads. Physiologia Plantarum 170(4): 488-507

Salvador, C.; Nieto, R.; Linares, C.; Díaz, J.; Alves, C.A.; Gimeno, L. 2021: Drought effects on specific-cause mortality in Lisbon from 1983 to 2016: Risks assessment by gender and age groups. Science of the Total Environment 751: 142332

Leybourne, D.J.; Preedy, K.F.; Valentine, T.A.; Bos, J.I.B.; Karley, A.J. 2021: Drought has negative consequences on aphid fitness and plant vigor: Insights from a meta-analysis. Ecology and Evolution 11(17): 11915-11929

Doughty, C.E.; Metcalfe, D.B.; Girardin, C.A.J.; Amézquita, F.Farfán.; Cabrera, D.Galiano.; Huasco, W.Huaraca.; Silva-Espejo, J.E.; Araujo-Murakami, A.; da Costa, M.C.; Rocha, W.; Feldpausch, T.R.; Mendoza, A.L.M.; da Costa, A.C.L.; Meir, P.; Phillips, O.L.; Malhi, Y. 2015: Drought impact on forest carbon dynamics and fluxes in Amazonia. Nature 519(7541): 78-82

Smith, L.T.; Aragão, L.E.O.C.; Sabel, C.E.; Nakaya, T. 2014: Drought impacts on children's respiratory health in the Brazilian Amazon. Scientific Reports 4: 3726

Mahlalela, P.T.; Blamey, R.C.; Hart, N.C.G.; Reason, C.J.C. 2020: Drought in the Eastern Cape region of South Africa and trends in rainfall characteristics. Climate Dynamics 55(9-10): 2743-2759

Malik, A.; Kumar, A.; Salih, S.Q.; Kim, S.; Kim, N.W.; Yaseen, Z.M.; Singh, V.P. 2020: Drought index prediction using advanced fuzzy logic model: Regional case study over Kumaon in India. Plos one 15(5): E0233280

Castillioni, K.; Wilcox, K.; Jiang, L.; Luo, Y.; Jung, C.G.; Souza, L. 2020: Drought mildly reduces plant dominance in a temperate prairie ecosystem across years. Ecology and Evolution 10(13): 6702-6713

Li, X.; Zuo, X.; Yue, P.; Zhao, X.; Hu, Y.; Guo, X.; Guo, A.; Xu, C.; Yu, Q. 2021: Drought of early time in growing season decreases community aboveground biomass, but increases belowground biomass in a desert steppe. Bmc Ecology and Evolution 21(1): 106

Gomes, L.E.d.O.; da Silva, E.C. 2020: Drought periods driving bioinvasion on hard substrates at a tropical estuary, Eastern Brazil. Marine Pollution Bulletin 160: 111563

Ma, X.; Huete, A.; Cleverly, J.; Eamus, D.; Chevallier, Fédéric.; Joiner, J.; Poulter, B.; Zhang, Y.; Guanter, L.; Meyer, W.; Xie, Z.; Ponce-Campos, G. 2016: Drought rapidly diminishes the large net CO 2 uptake in 2011 over semi-arid Australia. Scientific Reports 6: 37747

Aikens, E.O.; Monteith, K.L.; Merkle, J.A.; Dwinnell, S.P.H.; Fralick, G.L.; Kauffman, M.J. 2020: Drought reshuffles plant phenology and reduces the foraging benefit of green-wave surfing for a migratory ungulate. Global Change Biology 26(8): 4215-4225

Blum, A. 2011: Drought resistance - is it really a complex trait?. Functional Plant Biology: Fpb 38(10): 753-757

Dong, T.; Xi, L.; Xiong, B.; Qiu, X.; Huang, S.; Xu, W.; Wang, J.; Wang, B.; Yao, Y.; Duan, C.; Tang, X.; Sun, G.; Wang, X.; Deng, H.; Wang, Z. 2021: Drought resistance in Harumi tangor seedlings grafted onto different rootstocks. Functional Plant Biology: Fpb 48(5): 529-541

Liu, Y.; He, Z.; Xie, Y.; Su, L.; Zhang, R.; Wang, H.; Li, C.; Long, S. 2021: Drought resistance mechanisms of Phedimus aizoon L. Scientific Reports 11(1): 13600

Nardini, A.; Pitt, F. 1999: Drought resistance of Quercus pubescens as a function of root hydraulic conductance, xylem embolism and hydraulic architecture. New Phytologist 143(3): 485-493

Smeekens, S. 2017: Drought resistance: Spraying for yield. Nature Plants 3: 17023

De Souza, B.C.; Carvalho, E.C.D.; Oliveira, R.S.; de Araujo, F.S.; de Lima, A.é L.A.; Rodal, M.J.N. 2020: Drought response strategies of deciduous and evergreen woody species in a seasonally dry neotropical forest. Oecologia 194(1-2): 221-236

Meza, I.; Eyshi Rezaei, E.; Siebert, S.; Ghazaryan, G.; Nouri, H.; Dubovyk, O.; Gerdener, H.; Herbert, C.; Kusche, J.ür.; Popat, E.; Rhyner, J.; Jordaan, A.; Walz, Y.; Hagenlocher, M. 2021: Drought risk for agricultural systems in South Africa: Drivers, spatial patterns, and implications for drought risk management. Science of the Total Environment 799: 149505

Gatti, L.V.; Gloor, M.; Miller, J.B.; Doughty, C.E.; Malhi, Y.; Domingues, L.G.; Basso, L.S.; Martinewski, A.; Correia, C.S.C.; Borges, V.F.; Freitas, S.; Braz, R.; Anderson, L.O.; Rocha, H.; Grace, J.; Phillips, O.L.; Lloyd, J. 2014: Drought sensitivity of Amazonian carbon balance revealed by atmospheric measurements. Nature 506(7486): 76-80

Engelbrecht, B.M.J.; Comita, L.S.; Condit, R.; Kursar, T.A.; Tyree, M.T.; Turner, B.L.; Hubbell, S.P. 2007: Drought sensitivity shapes species distribution patterns in tropical forests. Nature 447(7140): 80-82

Bian, F.; Wang, Y.; Duan, B.; Wu, Z.; Zhang, Y.; Bi, Y.; Wang, A.; Zhong, H.; Du, X. 2021: Drought stress introduces growth, physiological traits and ecological stoichiometry changes in two contrasting Cunninghamia lanceolata cultivars planted in continuous-plantation soils. Bmc Plant Biology 21(1): 379

Zhuang, J.; Wang, Y.; Chi, Y.; Zhou, L.; Chen, J.; Zhou, W.; Song, J.; Zhao, N.; Ding, J. 2020: Drought stress strengthens the link between chlorophyll fluorescence parameters and photosynthetic traits. Peerj 8: E10046

Kaur, E.; Bhardwaj, R.D.; Kaur, S.; Grewal, S.K. 2021: Drought stress-induced changes in redox metabolism of barley (Hordeum vulgare L.). Biologia Futura 72(3): 347-358

Razi, K.; Muneer, S. 2021: Drought stress-induced physiological mechanisms, signaling pathways and molecular response of chloroplasts in common vegetable crops. Critical Reviews in Biotechnology 2021: 1-40

Vikram, P.; Swamy, B.P.Mallikarjuna.; Dixit, S.; Singh, R.; Singh, B.P.; Miro, B.; Kohli, A.; Henry, A.; Singh, N.K.; Kumar, A. 2015: Drought susceptibility of modern rice varieties: an effect of linkage of drought tolerance with undesirable traits. Scientific Reports 5: 14799

Melandri, G.; AbdElgawad, H.; Floková, K.ýn.; Jamar, D.C.; Asard, H.; Beemster, G.T.S.; Ruyter-Spira, C.; Bouwmeester, H.J. 2021: Drought tolerance in selected aerobic and upland rice varieties is driven by different metabolic and antioxidative responses. Planta 254(1): 13

Sahana, V.; Mondal, A.; Sreekumar, P. 2021: Drought vulnerability and risk assessment in India: Sensitivity analysis and comparison of aggregation techniques. Journal of Environmental Management 299: 113689

Tian, J.; Pang, Y.; Zhao, Z. 2021: Drought, Salinity, and Low Nitrogen Differentially Affect the Growth and Nitrogen Metabolism of Sophora japonica (L.) in a Semi-Hydroponic Phenotyping Platform. Frontiers in Plant Science 12: 715456

Gebre, B.; Ayenew, H.Y.; Biadgilign, S. 2021: Drought, hunger and coping mechanisms among rural household in Southeast Ethiopia. Heliyon 7(3): E06355

Geppert, C.; Contri, C.; De Boni, L.; Corcos, D.; Marini, L. 2021: Drought, nitrogen deposition and arthropod herbivory modify plant establishment dynamics after soil disturbance. Science of the Total Environment 796: 148956

Castorina, G.; Domergue, Fédéric.; Chiara, M.; Zilio, M.; Persico, M.; Ricciardi, V.; Horner, D.Stephen.; Consonni, G. 2020: Drought-Responsive ZmFDL1/MYB94 Regulates Cuticle Biosynthesis and Cuticle-Dependent Leaf Permeability. Plant Physiology 184(1): 266-282

Pontes-Lopes, A.; Silva, C.V.J.; Barlow, J.; Rincón, L.M.; Campanharo, W.A.; Nunes, C.ás.A.; de Almeida, C.T.; Silva Júnior, C.H.L.; Cassol, H.L.G.; Dalagnol, R.; Stark, S.C.; Graça, P.M.L.A.; Aragão, L.E.O.C. 2021: Drought-driven wildfire impacts on structure and dynamics in a wet Central Amazonian forest. PROCEEDINGS. Biological Sciences 288(1951): 20210094

Rolly, N.K.; Imran, Q.M.; Shahid, M.; Imran, M.; Khan, M.; Lee, S.-U.; Hussain, A.; Lee, I.-J.; Yun, B.-W. 2020: Drought-induced AtbZIP62 transcription factor regulates drought stress response in Arabidopsis. Plant Physiology and Biochemistry: Ppb 156: 384-395

Smith, C.F.; Schuett, G.W.; Reiserer, R.S.; Dana, C.E.; Collyer, M.L.; Davis, M.A. 2019: Drought-induced Suppression of Female Fecundity in a Capital Breeder. Scientific Reports 9(1): 15499

Ng, C.K.; Carr, K.; McAinsh, M.R.; Powell, B.; Hetherington, A.M. 2001: Drought-induced guard cell signal transduction involves sphingosine-1-phosphate. Nature 410(6828): 596-599

Here, A.-M.; Voltas, J.; L Pez, B.C.; Mart Nez-Vilalta, J. 2014: Drought-induced mortality selectively affects Scots pine trees that show limited intrinsic water-use efficiency responsiveness to raising atmospheric CO2. Functional Plant Biology: Fpb 41(3): 244-256

Maitra Majee, S.; Sharma, E.; Singh, B.; Khurana, J.P. 2020: Drought-induced protein (Di19-3) plays a role in auxin signaling by interacting with IAA14 in Arabidopsis. Plant Direct 4(6): E00234

Kuppler, J.; Wieland, J.; Junker, R.R.; Ayasse, M. 2021: Drought-induced reduction in flower size and abundance correlates with reduced flower visits by bumble bees. Aob Plants 13(1): Plab 001

Mikac, S.; Žmegač, A.; Trlin, D.; Paulić, V.; Oršanić, M.; Anić, I. 2018: Drought-induced shift in tree response to climate in floodplain forests of Southeastern Europe. Scientific Reports 8(1): 16495

Ryu, M.; Mishra, R.Chandra.; Jeon, J.; Lee, S.Keun.; Bae, H. 2018: Drought-induced susceptibility for Cenangium ferruginosum leads to progression of Cenangium-dieback disease in Pinus koraiensis. Scientific Reports 8(1): 16368

Dai, J.; Liu, H.; Wang, Y.; Guo, Q.; Hu, T.; Quine, T.; Green, S.; Hartmann, H.; Xu, C.; Liu, X.; Jiang, Z. 2020: Drought-modulated allometric patterns of trees in semi-arid forests. Communications Biology 3(1): 405

Charnley, G.E.C.; Kelman, I.; Murray, K.A. 2021: Drought-related cholera outbreaks in Africa and the implications for climate change: a narrative review. Pathogens and Global Health 2021: 1-10

Tollefson, J. 2011: Drought-tolerant maize gets US debut. Nature 469(7329): 144

Zhang, Q.; Shi, R.; Singh, V.P.; Xu, C.-Y.; Yu, H.; Fan, K.; Wu, Z. 2022: Droughts across China: Drought factors, prediction and impacts. Science of the Total Environment 803: 150018

Zhang, X.; Obringer, R.; Wei, C.; Chen, N.; Niyogi, D. 2017: Droughts in India from 1981 to 2013 and Implications to Wheat Production. Scientific Reports 7: 44552

Schiermeier, Q. 2018: Droughts, heatwaves and floods: How to tell when climate change is to blame. Nature 560(7716): 20-22

Guzman, A.; Weed, K.R. 2021: Drowning Outside the Insurance Pool. Ama Journal of Ethics 23(6): E499-E500

Szpilman, D.; Palacios Aguilar, J.; Barcala-Furelos, R.; Baker, S.; Dunne, C.; Peden, A.E.; Brander, R.; Claesson, A.; Avramidis, S.; Leavy, J.; Luckhaus, J.L.; Manino, L.A.; Marques, O.; Nyitrai, N.J.; Pascual-Gomez, L.-M.; Springer, L.; Stanley, T.J.; Venema, A.M.; Queiroga, A.C. 2021: Drowning and aquatic injuries dictionary. Resuscitation Plus 5: 100072

Gabrielli, A.; Layon, A.J. 1997: Drowning and near drowning. Journal of the Florida Medical Association 84(7): 452-457

Mathur, G.P.; Mathur, S. 1986: Drowning and near-drowning. Indian Pediatrics 23 Suppl: 189-194

Kot, P.A. 1974: Drowning and near-drowning. American Family Physician 10(1): 72-76

Ryan, C.A.; Dowling, G. 1993: Drowning deaths in people with epilepsy. Cmaj: Canadian Medical Association Journal 148(5): 781-784

Fessell, D.; Lexa, F.J. 2020: Drowning in E-Mail. Journal of the American College of Radiology: Jacr 2020

Clemens, T.; Oporia, F.; Parker, E.M.; Yellman, M.A.; Ballesteros, M.F.; Kobusingye, O. 2022: Drowning in Uganda: examining data from administrative sources. Injury Prevention: Journal of the International Society for Child and Adolescent Injury Prevention 28(1): 9-15

Ryan, K.M.; Dugas, J.; Pina, T.; Maksimenko, Y.; Liu, J. 2020: Drowning injuries in the United States: Patient characteristics, mortality risk, and associated primary diagnoses. Injury 51(11): 2560-2564

Lawson, B.; Duff, J.Paul.; Beckmann, K.M.; Chantrey, J.; Peck, K.M.; Irvine, R.M.; Robinson, R.A.; Cunningham, A.A. 2015: Drowning is an apparent and unexpected recurrent cause of mass mortality of Common starlings (Sturnus vulgaris). Scientific Reports 5: 17020

Martin, R.; Bruxner, G.; Ng, G.; Brewster, C.; Kothari, A. 2020: Drowning our sorrows: clinical and ethical considerations of termination in alcohol-affected pregnancy. Bmc Pregnancy and Childbirth 20(1): 356

Wheatley, D. 1972: Drowsiness and antidepressant drugs in mild depressive illness. British Journal of Psychiatry: the Journal of Mental Science 120(558): 507-509

Stawarczyk, D.; François, C.ém.; Wertz, J.ér.ôm.; D'Argembeau, A. 2020: Drowsiness or mind-wandering? Fluctuations in ocular parameters during attentional lapses. Biological Psychology 156: 107950

Dela Peña, I.; Shen, G.; Shi, W.-X. 2021: Droxidopa alters dopamine neuron and prefrontal cortex activity and improves attention-deficit/hyperactivity disorder-like behaviors in rats. European Journal of Pharmacology 892: 173826

Hauser, R.A.; Heritier, S.; Rowse, G.J.; Hewitt, L.Arthur.; Isaacson, S.H. 2016: Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic Hypotension. Clinical Neuropharmacology 39(5): 220-226

Luo, X.; Cai, S.; Li, Y.; Li, G.; Cao, Y.; Ai, C.; Gao, Y.; Li, T. 2020: Drp-1 as Potential Therapeutic Target for Lipopolysaccharide-Induced Vascular Hyperpermeability. Oxidative Medicine and Cellular Longevity 2020: 5820245

Adachi, Y.; Kato, T.; Yamada, T.; Murata, D.; Arai, K.; Stahelin, R.V.; Chan, D.C.; Iijima, M.; Sesaki, H. 2020: Drp1 Tubulates the ER in a GTPase-Independent Manner. Molecular Cell 80(4): 621-632.E6

Zhang, S.; Che, L.; He, C.; Huang, J.; Guo, N.; Shi, J.; Lin, Y.; Lin, Z. 2019: Drp1 and RB interaction to mediate mitochondria-dependent necroptosis induced by cadmium in hepatocytes. Cell Death and Disease 10(7): 523

Rappold, P.M.; Cui, M.; Grima, J.C.; Fan, R.Z.; de Mesy-Bentley, K.L.; Chen, L.; Zhuang, X.; Bowers, W.J.; Tieu, K. 2014: Drp1 inhibition attenuates neurotoxicity and dopamine release deficits in vivo. Nature Communications 5: 5244

Dulac, M.; Leduc-Gaudet, J.-P.; Reynaud, O.; Ayoub, M.-B.; Guérin, A.; Finkelchtein, M.; Hussain, S.N.; Gouspillou, G. 2020: Drp1 knockdown induces severe muscle atrophy and remodelling, mitochondrial dysfunction, autophagy impairment and denervation. Journal of Physiology 598(17): 3691-3710

Peña-Blanco, A.; Haschka, M.D.; Jenner, A.; Zuleger, T.; Proikas-Cezanne, T.; Villunger, A.; García-Sáez, A.J. 2020: Drp1 modulates mitochondrial stress responses to mitotic arrest. Cell Death and Differentiation 27(9): 2620-2634

Giovarelli, M.; Zecchini, S.; Martini, E.; Garrè, M.; Barozzi, S.; Ripolone, M.; Napoli, L.; Coazzoli, M.; Vantaggiato, C.; Roux-Biejat, P.; Cervia, D.; Moscheni, C.; Perrotta, C.; Parazzoli, D.; Clementi, E.; De Palma, C. 2020: Drp1 overexpression induces desmin disassembling and drives kinesin-1 activation promoting mitochondrial trafficking in skeletal muscle. Cell Death and Differentiation 27(8): 2383-2401

Chang, C-Rung.; Blackstone, C. 2007: Drp1 phosphorylation and mitochondrial regulation. Embo Reports 8(12): 1088-9; Author Reply 1089-90

Duan, C.; Kuang, L.; Xiang, X.; Zhang, J.; Zhu, Y.; Wu, Y.; Yan, Q.; Liu, L.; Li, T. 2020: Drp1 regulates mitochondrial dysfunction and dysregulated metabolism in ischemic injury via Clec16a-, BAX-, and GSH- pathways. Cell Death and Disease 11(4): 251

Ye, S.; Yang, P.; Cheng, K.; Zhou, T.; Wang, Y.; Hou, Z.; Jiang, Y.; Ren, L. 2016: Drp1-Dependent Mitochondrial Fission Mediates Toxicity of Positively Charged Graphene in Microglia. Acs Biomaterials Science and Engineering 2(5): 722-733

Johnson, J.; Mercado-Ayón, E.; Clark, E.; Lynch, D.; Lin, H. 2021: Drp1-dependent peptide reverse mitochondrial fragmentation, a homeostatic response in Friedreich ataxia. Pharmacology Research and Perspectives 9(3): E00755

Xie, L.; Shi, F.; Li, Y.; Li, W.; Yu, X.; Zhao, L.; Zhou, M.; Hu, J.; Luo, X.; Tang, M.; Fan, J.; Zhou, J.; Gao, Q.; Wu, W.; Zhang, X.; Liao, W.; Bode, A.M.; Cao, Y. 2020: Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance. Signal Transduction and Targeted Therapy 5(1): 56

Xie, L.; Shi, F.; Li, Y.; Li, W.; Yu, X.; Zhao, L.; Zhou, M.; Hu, J.; Luo, X.; Tang, M.; Fan, J.; Zhou, J.; Gao, Q.; Wu, W.; Zhang, X.; Liao, W.; Bode, A.M.; Cao, Y. 2020: Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance. Signal Transduction and Targeted Therapy 5: 56

Jin, C.; Zhong, Y.; Han, J.; Zhu, J.; Liu, Q.; Sun, D.; Xia, X.; Peng, X. 2020: Drp1-mediated mitochondrial fission induced autophagy attenuates cell apoptosis caused by 3-chlorpropane-1,2-diol in HEK293 cells. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 145: 111740

Wang, Y.; Lu, M.; Xiong, L.; Fan, J.; Zhou, Y.; Li, H.; Peng, X.; Zhong, Z.; Wang, Y.; Huang, F.; Chen, W.; Yu, X.; Mao, H. 2020: Drp1-mediated mitochondrial fission promotes renal fibroblast activation and fibrogenesis. Cell Death and Disease 11(1): 29

Seay, M.D.; Digre, K.B.; Rucker, J.C.; Leigh, R.J.; Zee, D. 2020: Drs. Richard John Leigh and David Zee. Journal of Neuro-Ophthalmology: the Official Journal of the North American Neuro-Ophthalmology Society 40(3): E17-E26

Yu, L.; Fan, G. 2021: DrsNet: Dual-resolution Semantic Segmentation with Rare Class-Oriented Superpixel Prior. Multimedia Tools and Applications 80(2): 1687-1706

Banach, M.; Penson, P.E. 2021: Drucebo effect - the challenge we should all definitely face!. Archives of Medical Science: Ams 17(2): 542-543

Srinivasan, C.S.; Zanello, G.; Nkegbe, P.; Cherukuri, R.; Picchioni, F.; Gowdru, N.; Webb, P. 2019: Drudgery reduction, physical activity and energy requirements in rural livelihoods. Economics and Human Biology 37: 100846

Zhai, Y.; Wang, J.; Qiu, L. 2021: Drug -driven self-assembly of pH-sensitive nano-vesicles with high loading capacity and anti-tumor efficacy. Biomaterials Science 9(9): 3348-3361

Khazaee-Pool, M.; Naghibi, S.A.; Pashaei, T.; Chaleshgar-Kordasiabi, M.; Daneshnia, M.; Ponnet, K. 2021: Drug Abstinence Self-Efficacy Scale (DASES): psychometric properties of the Farsi version. Substance Abuse Treatment Prevention and Policy 16(1): 1

Chopra, R.N. 1935: Drug Addiction in India and its Treatment. Indian Medical Gazette 70(3): 121-131

Wright, R.E. 1935: Drug Addiction in India and its Treatment. Indian Medical Gazette 70(8): 479

Wright, R.E. 1936: Drug Addiction in India and its Treatment. Indian Medical Gazette 71(7): 435

Koob, G.F. 2021: Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development. Pharmacological Reviews 73(1): 163-201

Huang, L.; Wang, D.; Zhang, C. 2021: Drug Affinity Responsive Target Stability (DARTS ) Assay to Detect Interaction Between a Purified Protein and a Small Molecule. Methods in Molecular Biology 2213: 175-182

Rodriguez-Furlan, C.; Zhang, C.; Raikhel, N.; Hicks, G.R. 2017: Drug Affinity Responsive Target Stability (DARTS) to Resolve Protein-Small Molecule Interaction in Arabidopsis. Current Protocols in Plant Biology 2(4): 370-378

Cravidi, C.; Caimmi, S.; De Filippo, M.; Martelli, A.; Caffarelli, C.; Miraglia Del Giudice, M.; Calvani, M.; Tosca, M.Angela.; Cardinale, F.; Marseglia, G.Luigi.; Manti, S.; Chiappini, E.; Caimmi, D. 2020: Drug Allergy in children: focus on beta-lactams and NSAIDs. Acta Bio-Medica: Atenei Parmensis 91(11-S): E2020008

Wouters, H.; Hilmer, S.N.; Twisk, J.; Teichert, M.; Van Der Meer, H.G.; Van Hout, H.P.J.; Taxis, K. 2020: Drug Burden Index and Cognitive and Physical Function in Aged Care Residents: A Longitudinal Study. Journal of the American Medical Directors Association 21(8): 1086-1092.E1

Black, S.; Lerman, J.; Banks, S.E.; Noghrehkar, D.; Curia, L.; Mai, C.L.; Schwengel, D.; Nelson, C.K.; Foster, J.M.T.; Breneman, S.; Arheart, K.L. 2019: Drug Calculation Errors in Anesthesiology Residents and Faculty: An Analysis of Contributing Factors. Anesthesia and Analgesia 128(6): 1292-1299

Conner, B. 2021: Drug Calculations in Veterinary Medical Education-Where Are We?. Journal of Veterinary Medical Education 48(3): 252-255

Betzler, F.; Helbig, J.; Viohl, L.; Ernst, F.; Roediger, L.; Gutwinski, S.; Ströhle, A.; Köhler, S. 2021: Drug Checking and its Potential Impact on Substance use. European Addiction Research 27(1): 25-32

Fregonese, M.; Albino, A.; Covino, C.; Gili, A.; Bacci, M.; Nicoletti, A.; Gambelunghe, C. 2021: Drug Checking as Strategy for Harm Reduction in Recreational Contests: Evaluation of two Different Drug Analysis Methodologies. Frontiers in Psychiatry 12: 596895

Fong, K.Y.; Zhao, J.J.; Tan, E.; Syn, N.L.; Sultana, R.; Zhuang, K.D.; Chua, J.M.E.; Patel, A.; Irani, F.G.; Tay, K.H.; Tan, B.S.; Too, C.W. 2021: Drug Coated Balloons for Dysfunctional Haemodialysis Venous Access: a Patient Level Meta-Analysis of Randomised Controlled Trials. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 62(4): 610-621

Uprety, D. 2017: Drug Combinations with Transplantation for Myeloma. New England Journal of Medicine 377(1): 92

Attal, M.; Richardson, P.G.; Moreau, P. 2017: Drug Combinations with Transplantation for Myeloma. New England Journal of Medicine 377(1): 93-94

Baer, D. 2017: Drug Combinations with Transplantation for Myeloma. New England Journal of Medicine 377(1): 92-93

Iglesias-Sancho, M.; Llambí Mateos, F.; Salleras-Redonnet, M. 2020: Drug Compounding for Diseases of the Oral Mucosa. Actas Dermo-Sifiliograficas 111(10): 822-828

Rauhut, A.S.; Warnick, J.A. 2020: Drug Conditioning and Sensitization in Mice: Importance of Early Voluntary Exercise. Neuroscience 442: 114-123

Docherty, M.; Mulvey, E.; Beardslee, J.; Sweeten, G.; Pardini, D. 2020: Drug Dealing and Gun Carrying go Hand in Hand: Examining how Juvenile Offenders' Gun Carrying Changes Before and After Drug Dealing Spells across 84 Months. Journal of Quantitative Criminology 36(4): 993-1015

Makvandi, P.; Josic, U.; Delfi, M.; Pinelli, F.; Jahed, V.; Kaya, E.; Ashrafizadeh, M.; Zarepour, A.; Rossi, F.; Zarrabi, A.; Agarwal, T.; Zare, E.N.; Ghomi, M.; Kumar Maiti, T.; Breschi, L.; Tay, F.R. 2021: Drug Delivery (Nano)Platforms for Oral and Dental Applications: Tissue Regeneration, Infection Control, and Cancer Management. Advanced Science 8(8): 2004014

Ebrahimi, S.; Vatani, P.; Amani, A.; Shamloo, A. 2021: Drug delivery performance of nanocarriers based on adhesion and interaction for abdominal aortic aneurysm treatment. International Journal of Pharmaceutics 594: 120153

Jaimalai, T.; Meeroekyai, S.; Suree, N.; Prangkio, P. 2020: Drug Delivery System Targeting CD4+ T Cells for HIV-1 Latency Reactivation Towards the Viral Eradication. Journal of Pharmaceutical Sciences 109(10): 3013-3020

Ishima, Y.; Maruyama, T.; Otagiri, M.; Ishida, T. 2020: Drug Delivery System for Refractory Cancer Therapy via an Endogenous Albumin Transport System. Chemical and Pharmaceutical Bulletin 68(7): 583-588

Zhao, R.; Lu, Z.; Yang, J.; Zhang, L.; Li, Y.; Zhang, X. 2020: Drug Delivery System in the Treatment of Diabetes Mellitus. Frontiers in Bioengineering and Biotechnology 8: 880

Metaxa, A.-F.; Vrontaki, E.; Efthimiadou, E.K.; Mavromoustakos, T. 2021: Drug Delivery Systems Based on Modified Polysaccharides: Synthesis and Characterization. Methods in Molecular Biology 2207: 151-161

Caimano, M.; Lospinoso Severini, L.; Loricchio, E.; Infante, P.; Di Marcotullio, L. 2021: Drug Delivery Systems for Hedgehog Inhibitors in the Treatment of SHH-Medulloblastoma. Frontiers in Chemistry 9: 688108

Aranda-Lara, L.; García, B.E.O.; Isaac-Olivé, K.; Ferro-Flores, G.; Meléndez-Alafort, L.; Morales-Avila, E. 2021: Drug Delivery Systems-Based Dendrimers and Polymer Micelles for Nuclear Diagnosis and Therapy. Macromolecular Bioscience 21(3): E2000362

Iatrou, H.; Fragouli, P.G.; Stavroulaki, D.; Athanasiou, B. 2021: Drug Delivery Through Multifunctional Polypeptidic Hydrogels. Methods in Molecular Biology 2207: 127-137

Samal, S.; Dash, P.; Dash, M. 2021: Drug Delivery to the Bone Microenvironment Mediated by Exosomes: An Axiom or Enigma. International Journal of Nanomedicine 16: 3509-3540

Chroni, A.; Chrysostomou, V.; Skandalis, A.; Pispas, S. 2021: Drug Delivery: Hydrophobic Drug Encapsulation into Amphiphilic Block Copolymer Micelles. Methods in Molecular Biology 2207: 71-83

Flemming, A. 2014: Drug Delivery: Non-invasive drug depot refill. Nature Reviews. Drug Discovery 13(11): 810-811

Blumenthal, K.G.; Castells, M.; Banerji, A. 2021: Drug desensitization in the coronavirus disease 2019 pandemic era: Local success to widespread potential. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 126(6): 739-741

Kowalczyk, M.; Golonko, A.; Świsłocka, R.; Kalinowska, M.; Parcheta, M.; Swiergiel, A.; Lewandowski, W.ło. 2021: Drug Design Strategies for the Treatment of Viral Disease. Plant Phenolic Compounds and their Derivatives. Frontiers in Pharmacology 12: 709104

McMillin, G.A. 2018: Drug Detection in Urine for Evaluating Exposure-No Limits!. Journal of Applied Laboratory Medicine 2(4): 648-652

Buckley, L.A.; Bebenek, I.; Cornwell, P.D.; Hodowanec, A.; Jensen, E.C.; Murphy, C.; Ghantous, H.N. 2020: Drug Development 101: a Primer. International Journal of Toxicology 39(5): 379-396

Bao, J.; Liu, B.; Wu, C. 2020: Drug Development and Treatment of Autophagy in other Diseases. Advances in Experimental Medicine and Biology 1207: 689-697

Cummings, J. 2021: Drug Development for Psychotropic, Cognitive-Enhancing, and Disease-Modifying Treatments for Alzheimer's Disease. Journal of Neuropsychiatry and Clinical Neurosciences 33(1): 3-13

Rathner, A.; Rathner, P.; Friedrich, A.; Wießner, M.; Kitzler, C.M.; Schernthaner, J.; Karl, T.; Krauß, J.; Lottspeich, F.; Mewes, W.; Hintner, H.; Bauer, J.W.; Breitenbach, M.; Müller, N.; Breitenbach-Koller, H.; von Hagen, J.ör. 2021: Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa. Skin Pharmacology and Physiology 34(4): 167-182

Garcia-Alvarez, A.; Hernando Cubero, J.; Capdevila, J. 2021: Drug Development in Neuroendocrine Tumors: what Is on the Horizon?. Current Treatment Options in Oncology 22(5): 43

Borys, N.; Dewhirst, M.W. 2021: Drug development of lyso-thermosensitive liposomal doxorubicin: Combining hyperthermia and thermosensitive drug delivery. Advanced Drug Delivery Reviews 178: 113985

Abualia, M.; Amarin, J.Z.; Zayed, A.A. 2019: Drug Effects on the Thyroid. New England Journal of Medicine 381(20): 1979-1980

Angus, L.; Peeters, R.P.; van der Veldt, A.A.M. 2019: Drug Effects on the Thyroid. New England Journal of Medicine 381(20

Converse, P.J.; Almeida, D.V.; Nuermberger, E.L. 2022: Drug Efficacy Testing in the Mouse Footpad Model of Buruli Ulcer. Methods in Molecular Biology 2387: 195-207

Lee, Y.-J.; Kook, H.; Ko, Y.-G.; Yu, C.W.; Joo, H.J.; Ahn, C.-M.; Choi, D. 2021: Drug Eluting Stent vs. Drug Coated Balloon for Native Femoropopliteal Artery Disease: a two Centre Experience. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 61(2): 287-295

Maning, J.; Blumer, V.; Chaparro, S. 2020: Drug Eluting Stents versus Bare Metal Stents for Cardiac Allograft Vasculopathy: A Systematic Review and Meta-Analysis. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 39(4s): S231

Stowers, J.H. 1911: Drug Eruptions: Their Nature and Varieties. Hospital 49(1277): 433-436

Burn, J.H. 1949: Drug Excretion in Milk. Monitor de la Farmacia y de la Terapeutica 55(1460): 127-130

Alrasheed, M.; Hincapie, A.L.; Guo, J.J. 2021: Drug Expenditure, Price, and Utilization in the U.S. Medicaid: a Trend Analysis for SSRi and SNRi Antidepressants from 1991 to 2018. Journal of Mental Health Policy and Economics 24(1): 3-11

Maddock, K.; Connor, K. 2020: Drug Fever: a Patient Case Scenario and Review of the Evidence. AACN Advanced Critical Care 31(3): 233-238

Fang, L.; Shi, G.H.; Richard, C.A.Èl.; Dong, X.; Thomas, J.C.; Victor, M.C.; Wang, T.; Shinkle, S.; Zhao, C. 2020: Drug Formulation Impact on Prefilled Syringe Functionality and Autoinjector Performance. Pda Journal of Pharmaceutical Science and Technology 74(6): 674-687

Schwartz, H.R.; Richards, R.; Fontana, R.E.; Joyce, A.J.; Honeywell, M.E.; Lee, M.J. 2020: Drug GRADE: An Integrated Analysis of Population Growth and Cell Death Reveals Drug-Specific and Cancer Subtype-Specific Response Profiles. Cell Reports 31(12): 107800

Prinz, H. 1912: Drug Idolatry in Dental Medicine. Dental Register 66(1): 30-39

Soumelidou, E.; Golič Grdadolnik, S.; Mavromoustakos, T. 2021: Drug Incorporation in the Drug Delivery System of Micelles. Methods in Molecular Biology 2207: 99-108

Norman, B.H. 2020: Drug Induced Liver Injury (DILI). Mechanisms and Medicinal Chemistry Avoidance/Mitigation Strategies. Journal of Medicinal Chemistry 63(20): 11397-11419

Gabora, K.; Piciu, A.; Piciu, D. 2021: Drug Induced Liver Injury to Immune Checkpoint Inhibitors Detected by F18-Fluorodeoxyglucose PET/CT. Journal of Gastrointestinal and Liver Diseases: Jgld 30(2): 191

Sekino, H. 2021: Drug Information Provided to Patients and Public-Present Regulatory Status and Future Prospects. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 141(3): 381-385

Patil, A.N.; Kumar, M.P.; Yadav, R.; Kosey, S.; Behl, T.; Kumaravel, J. 2021: Drug Information Services in Low-Resource Setting: a Responsibility of Pharmacists or Pharmacologists or Both the Professions Conjointly. Journal of Pharmacy and Bioallied Sciences 13(2): 283-290

Marberger, M. 2006: Drug Insight: 5alpha-reductase inhibitors for the treatment of benign prostatic hyperplasia. Nature Clinical Practice. Urology 3(9): 495-503

Folprecht, G.; Köhne, C-Henning. 2005: Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting. Nature Clinical Practice. Oncology 2(11): 578-587

Ruderman, E.M.; Pope, R.M. 2006: Drug Insight: abatacept for the treatment of rheumatoid arthritis. Nature Clinical Practice. Rheumatology 2(12): 654-660

van de Beek, D.; Weisfelt, M.; de Gans, J.; Tunkel, A.R.; Wijdicks, E.F.M. 2006: Drug Insight: adjunctive therapies in adults with bacterial meningitis. Nature Clinical Practice. Neurology 2(9): 504-516

Lévy, S. 2006: Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications. Nature Clinical Practice. Cardiovascular Medicine 3(4): 220-225

Pandolfo, M. 2008: Drug Insight: antioxidant therapy in inherited ataxias. Nature Clinical Practice. Neurology 4(2): 86-96

Bray, G.A. 2005: Drug Insight: appetite suppressants. Nature Clinical Practice. Gastroenterology and Hepatology 2(2): 89-95

Chancellor, M.B.; Fowler, C.J.; Apostolidis, A.; de Groat, W.C.; Smith, C.P.; Somogyi, G.T.; Aoki, K.Roger. 2008: Drug Insight: biological effects of botulinum toxin A in the lower urinary tract. Nature Clinical Practice. Urology 5(6): 319-328

Bernier, J. 2008: Drug Insight: cetuximab in the treatment of recurrent and metastatic squamous cell carcinoma of the head and neck. Nature Clinical Practice. Oncology 5(12): 705-713

Geusens, P.P.; Roux, C.H.; Reid, D.M.; Lems, W.F.; Adami, S.; Adachi, J.D.; Sambrook, P.N.; Saag, K.G.; Lane, N.E.; Hochberg, M.C. 2008: Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspective. Nature Clinical Practice. Rheumatology 4(5): 240-248

Engel, Jörg.B.; Schally, A.V. 2007: Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Nature Clinical Practice. Endocrinology and Metabolism 3(2): 157-167

Gillmore, J.D.; Hawkins, P.N. 2006: Drug Insight: emerging therapies for amyloidosis. Nature Clinical Practice. Nephrology 2(5): 263-270

Humbert, M.; Simonneau, Gérald. 2005: Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases. Nature Clinical Practice. Rheumatology 1(2): 93-101

McManus, F.; McInnes, G.T.; Connell, J.M.C. 2008: Drug Insight: eplerenone, a mineralocorticoid-receptor antagonist. Nature Clinical Practice. Endocrinology and Metabolism 4(1): 44-52

Sleijfer, S.; Wiemer, E.; Verweij, J. 2008: Drug Insight: gastrointestinal stromal tumors (GIST)--the solid tumor model for cancer-specific treatment. Nature Clinical Practice. Oncology 5(2): 102-111

Khan, O.; La Thangue, N.B. 2008: Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas. Nature Clinical Practice. Oncology 5(12): 714-726

Potenza, M.N.; Voon, V.; Weintraub, D. 2007: Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease. Nature Clinical Practice. Neurology 3(12): 664-672

Marrie, R.Ann.; Rudick, R.A. 2006: Drug Insight: interferon treatment in multiple sclerosis. Nature Clinical Practice. Neurology 2(1): 34-44

Cameron, D.A.; Stein, S. 2008: Drug Insight: intracellular inhibitors of HER2--clinical development of lapatinib in breast cancer. Nature Clinical Practice. Oncology 5(9): 512-520

Gervois, P.; Fruchart, J-Charles.; Staels, B. 2007: Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors. Nature Clinical Practice. Endocrinology and Metabolism 3(2): 145-156

Colosimo, C.; Fabbrini, G.; Berardelli, A. 2006: Drug Insight: new drugs in development for Parkinson's disease. Nature Clinical Practice. Neurology 2(11): 600-610

Briganti, A.; Salonia, A.; Gallina, A.; Saccà, A.; Montorsi, P.; Rigatti, P.; Montorsi, F. 2005: Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction. Nature Clinical Practice. Urology 2(5): 239-247

Mano, M.; Humblet, Y. 2008: Drug Insight: panitumumab, a human EGFR-targeted monoclonal antibody with promising clinical activity in colorectal cancer. Nature Clinical Practice. Oncology 5(7): 415-425

de Boer, N.K.H.; van Bodegraven, A.A.; Jharap, B.; de Graaf, P.; Mulder, C.J.J. 2007: Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD. Nature Clinical Practice. Gastroenterology and Hepatology 4(12): 686-694

Goffin, V.; Touraine, P.; Culler, M.D.; Kelly, P.A. 2006: Drug Insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia?. Nature Clinical Practice. Endocrinology and Metabolism 2(10): 571-581

Shahapuni, I.; Monge, M.; Oprisiu, R.; Mazouz, H.; Westeel, P-François.; Morinière, P.; Massy, Z.; Choukroun, G.; Fournier, A. 2006: Drug Insight: renal indications of calcimimetics. Nature Clinical Practice. Nephrology 2(6): 316-325

van der Heijden, J.W.; Dijkmans, B.A.C.; Scheper, R.J.; Jansen, G. 2007: Drug Insight: resistance to methotrexate and other disease-modifying antirheumatic drugs--from bench to bedside. Nature Clinical Practice. Rheumatology 3(1): 26-34

Sacco, R.L.; Liao, J.K. 2005: Drug Insight: statins and stroke. Nature Clinical Practice. Cardiovascular Medicine 2(11): 576-584

Fitch, M.T.; van de Beek, D. 2008: Drug Insight: steroids in CNS infectious diseases--new indications for an old therapy. Nature Clinical Practice. Neurology 4(2): 97-104

Mason, W.P.; Cairncross, J.Gregory. 2005: Drug Insight: temozolomide as a treatment for malignant glioma--impact of a recent trial. Nature Clinical Practice. Neurology 1(2): 88-95

Brennan, A.M.; Mantzoros, C.S. 2006: Drug Insight: the role of leptin in human physiology and pathophysiology--emerging clinical applications. Nature Clinical Practice. Endocrinology and Metabolism 2(6): 318-327

Gold, R.; Stangel, M.; Dalakas, M.C. 2007: Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues. Nature Clinical Practice. Neurology 3(1): 36-44

Pandi-Perumal, S.R.; Srinivasan, V.; Poeggeler, B.; Hardeland, Rüdiger.; Cardinali, D.P. 2007: Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon. Nature Clinical Practice. Neurology 3(4): 221-228

Weber, M.S.; Prod'homme, T.; Steinman, L.; Zamvil, S.S. 2005: Drug Insight: using statins to treat neuroinflammatory disease. Nature Clinical Practice. Neurology 1(2): 106-112

Sechi, A.; di Altobrando, A.; Cerciello, E.; Maietti, E.; Patrizi, A.; Savoia, F. 2021: Drug Intake and Actinic Keratosis: a Case-Control Study. Dermatology Practical and Conceptual 11(2): E2021031

Abubucker, S.; Reti, I.M.; Miller, C.; Schiavi, A. 2020: Drug Interaction with Remifentanil in a Transgender man Receiving Exogenous Testosterone and Electroconvulsive Therapy. Journal of Ect 36(4): E48-E49

Hofmann, T.; Hachenberg, T. 2020: Drug Interactions in Emergency Medicine. Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie: Ains 55(5): 314-322

Mohebbi, N.; Talebi, A.; Moghadamnia, M.; Nazari Taloki, Z.; Shakiba, A. 2020: Drug Interactions of Psychiatric and COVID-19 Medications. Basic and Clinical Neuroscience 11(2): 185-200

Fravel, M.A.; Ernst, M. 2021: Drug Interactions with Antihypertensives. Current Hypertension Reports 23(3): 14

Cirrincione, L.R.; Senneker, T.; Scarsi, K.; Tseng, A. 2020: Drug Interactions with Gender-Affirming Hormone Therapy: Focus on Antiretrovirals and Direct Acting Antivirals. Expert Opinion on Drug Metabolism and Toxicology 16(7): 565-582

Coccè, V.; Farronato, D.; Brini, A.Teresa.; Masia, C.; Giannì, A.Bruno.; Piovani, G.; Sisto, F.; Alessandri, G.; Angiero, F.; Pessina, A. 2017: Drug Loaded Gingival Mesenchymal Stromal Cells (GinPa-MSCs) Inhibit In Vitro Proliferation of Oral Squamous Cell Carcinoma. Scientific Reports 7(1): 9376

Liu, M.; Dasgupta, A.; Koczera, P.; Schipper, S.; Rommel, D.; Shi, Y.; Kiessling, F.; Lammers, T. 2020: Drug Loading in Poly(butyl cyanoacrylate)-Based Polymeric Microbubbles. Molecular Pharmaceutics 17(8): 2840-2848

Dvořák, Z.ěk.; Sokol, H.; Mani, S. 2020: Drug Mimicry: Promiscuous Receptors PXR and AhR, and Microbial Metabolite Interactions in the Intestine. Trends in Pharmacological Sciences 41(12): 900-908

Anand, A.; Hosanagar, A. 2021: Drug Misuse in the Veterinary Setting: an Under-recognized Avenue. Current Psychiatry Reports 23(2): 3

Xin, X.; Du, X.; Xiao, Q.; Azevedo, H.S.; He, W.; Yin, L. 2019: Drug Nanorod-Mediated Intracellular Delivery of microRNA-101 for Self-sensitization via Autophagy Inhibition. Nano-MicroLetters 11(1): 82

Appa, A.; Rodda, L.N.; Cawley, C.; Zevin, B.; Coffin, P.O.; Gandhi, M.; Imbert, E. 2021: Drug Overdose Deaths Before and After Shelter-in-Place Orders During the COVID-19 Pandemic in San Francisco. JAMA Network Open 4(5): E2110452

Zhang, Q.; Zhang, L.; Li, Y.; Ye, M. 2021: Drug Packaging Management Based on the Effect of Medical Images on the Intracellular Polysaccharide Synthesis and Antivertigo Activity of Phalaenopsis. Journal of Healthcare Engineering 2021: 3793610

Lynn, E.; Doyle, A.; Keane, M.; Bennett, K.; Cousins, G.ái. 2020: Drug Poisoning Deaths Among Women: a Scoping Review. Journal of Studies on Alcohol and Drugs 81(5): 543-555

Al-Rashdi, M.S.; Abdulaziz, B.; Al Balushi, K.A. 2020: Drug Prescribing Practices in Dental Care Patients at a Dental and Maxillofacial Surgery Clinic in Oman. Oman Medical Journal 35(6): E191

Gowers, S.; Claxton, M.; Rowlands, L.; Inbasagaran, A.; Wood, D.; Yi, I.; Hugo, P.; Clark-Stone, S.; Bryant-Waugh, R.; Nicholls, D.; Ayton, A. 2010: Drug Prescribing in Child and Adolescent Eating Disorder Services. Child and Adolescent Mental Health 15(1): 18-22

Russo, P.; Marcellusi, A.; Zanuzzi, M.; Carletto, A.; Fratto, M.E.; Favato, G.; Staniscia, T.; Romano, F. 2021: Drug Prices and Value of Oncology Drugs in Italy. Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 24(9): 1273-1278

Rome, B.N.; Feldman, W.B.; Kesselheim, A.S. 2020: Drug Prices, Rebates, and Discounts. JAMA 324(4): 399

Anderson-Cook, A.; Noda, A. 2020: Drug Prices, Rebates, and Discounts. JAMA 324(4): 398-399

Lexchin, J. 2021: Drug Promotion in India Since 2000: Problems Remain. International Journal of Health Services: Planning Administration Evaluation 51(3): 392-403

Bumbacea, R.S.; Ali, S.; Ogneva, D.O.; Motei, C.; Rusu, C.; Spiru, L. 2021: Drug Provocation Testing in the Diagnosis of Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Induced by Clarithromycin. Maedica 16(2): 297-301

García-Boyano, M.; Gómez-Traseira, C.; Umpiérrez, A.M.ía.; Quirce, S.; Boyano-Martínez, T. 2020: Drug Provocation Tests for Assessing Antibiotic Hypersensitivity: Is Shorter Also Better?. Pediatric Infectious Disease Journal 39(9): 835-839

Birmingham, K. 2002: Drug R&D costs queried. Nature Medicine 8(2): 93

Shalom, G.; Khoury, R.; Horev, A. 2020: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Associated with Mycoplasma pneumoniae Infection. Case Reports in Dermatology 12(3): 225-230

O'Malley, P.A. 2021: Drug Recalls and Significance for Safe Clinical Nurse Specialist Prescribing. Clinical Nurse Specialist Cns 35(6): 288-290

Meek, A.; Weaver, D.F. 2022: Drug-Receptor Interactions: it is a Numbers Game. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 49(4): 589-590

Qian, J.; Berkland, C. 2021: Drug Release Kinetics from Nondegradable Hydrophobic Polymers can be Modulated and Predicted by the Glass Transition Temperature. Advanced Healthcare Materials 10(12): E2100015

You, C.; Tseng, L.-F.; Pappas, A.; Concagh, D.; Kuang, Y. 2022: Drug Release and Pharmacokinetic Evaluation of Novel Implantable Mometasone Furoate Matrices in Rabbit Maxillary Sinuses. American Journal of Rhinology and Allergy 36(2): 198-206

Wang, X.; Burgess, D.J. 2021: Drug release from in situ forming implants and advances in release testing. Advanced Drug Delivery Reviews 178: 113912

Choi, H.; Schulte, A.; Müller, M.; Park, M.; Jo, S.; Schönherr, H. 2021: Drug Release from Thermo-Responsive Polymer Brush Coatings to Control Bacterial Colonization and Biofilm Growth on Titanium Implants. Advanced Healthcare Materials 10(11): E2100069

Partridge, M.A.; Karayusuf, E.K.; Shyu, G.; Georgaros, C.; Torri, A.; Sumner, G. 2020: Drug Removal Strategies in Competitive Ligand Binding Neutralizing Antibody (NAb) Assays: Highly Drug-Tolerant Methods and Interpreting Immunogenicity Data. Aaps Journal 22(5): 112

Senbabaoglu, F.; Aksu, A.C.; Cingoz, A.; Seker-Polat, F.; Borklu-Yucel, E.; Solaroglu, İh.; Bagci-Onder, T. 2020: Drug Repositioning Screen on a new Primary Cell Line Identifies Potent Therapeutics for Glioblastoma. Frontiers in Neuroscience 14: 578316

Yoon, S.; Kim, H.S. 2021: Drug Repositioning with an Anticancer Effect: Contributions to Reduced Cancer Incidence in Susceptible Individuals. In Vivo 35(6): 3039-3044

Benavides-Cordoba, V. 2020: Drug Repositioning for COVID-19. Colombia Medica 51(2): E4279

Beklen, H.; Gulfidan, G.; Arga, K.Y.; Mardinoglu, A.; Turanli, B. 2020: Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer. Frontiers in Oncology 10: 1273

Kifle, Z.D.; Ayele, A.G.; Enyew, E.F. 2021: Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment. Journal of Environmental and Public Health 2021: 6631721

Siswanto, S.; Yamamoto, H.; Furuta, H.; Kobayashi, M.; Nagashima, T.; Kayanuma, G.; Nagayasu, K.; Imai, Y.; Kaneko, S. 2021: Drug Repurposing Prediction and Validation from Clinical Big Data for the Effective Treatment of Interstitial Lung Disease. Frontiers in Pharmacology 12: 635293

Chen, C.Z.; Shinn, P.; Itkin, Z.; Eastman, R.T.; Bostwick, R.; Rasmussen, L.; Huang, R.; Shen, M.; Hu, X.; Wilson, K.M.; Brooks, B.; Guo, H.; Zhao, T.; Klump-Thomas, C.; Simeonov, A.; Michael, S.G.; Lo, D.C.; Hall, M.D.; Zheng, W. 2020: Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2. Biorxiv: the Preprint Server for Biology 2020

Chen, C.Z.; Shinn, P.; Itkin, Z.; Eastman, R.T.; Bostwick, R.; Rasmussen, L.; Huang, R.; Shen, M.; Hu, X.; Wilson, K.M.; Brooks, B.M.; Guo, H.; Zhao, T.; Klump-Thomas, C.; Simeonov, A.; Michael, S.G.; Lo, D.C.; Hall, M.D.; Zheng, W. 2020: Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2. Frontiers in Pharmacology 11: 592737

Sahoo, B.M.; Ravi Kumar, B.V.V.; Sruti, J.; Mahapatra, M.K.; Banik, B.K.; Borah, P. 2021: Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection. Frontiers in Molecular Biosciences 8: 628144

Abbasi, J. 2020: Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals. JAMA 324(10): 928

Pinzi, L.; Tinivella, A.; Caporuscio, F.; Rastelli, G. 2021: Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease. Frontiers in Pharmacology 12: 636989

Soleimani Zakeri, N.S.; Pashazadeh, S.; MotieGhader, H. 2021: Drug Repurposing for Alzheimer's Disease Based on Protein-Protein Interaction Network. Biomed Research International 2021: 1280237

Zhang, R.; Hristovski, D.; Schutte, D.; Kastrin, A.; Fiszman, M.; Kilicoglu, H. 2021: Drug repurposing for COVID-19 via knowledge graph completion. Journal of Biomedical Informatics 115: 103696

Ino, H.; Nakazawa, E.; Akabayashi, A. 2021: Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps. Cambridge Quarterly of Healthcare Ethics: Cq: the International Journal of Healthcare Ethics Committees 30(1): 51-58

Tsakaneli, A.; Williams, O. 2021: Drug Repurposing for Targeting Acute Leukemia with KMT2A (MLL)-Gene Rearrangements. Frontiers in Pharmacology 12: 741413

Yan, V.K.C.; Li, X.; Ye, X.; Ou, M.; Luo, R.; Zhang, Q.; Tang, B.; Cowling, B.J.; Hung, I.; Siu, C.W.; Wong, I.C.K.; Cheng, R.C.K.; Chan, E.W. 2021: Drug Repurposing for the Treatment of COVID-19: a Knowledge Graph Approach. Advanced Therapeutics 4(7): 2100055

Hammoud, H.; Saker, Z.; Harati, H.; Fares, Y.; Bahmad, H.F.; Nabha, S. 2020: Drug Repurposing in Medulloblastoma: Challenges and Recommendations. Current Treatment Options in Oncology 22(1): 6

Shakkour, Z.; Habashy, K.J.; Berro, M.; Takkoush, S.; Abdelhady, S.; Koleilat, N.; Eid, A.H.; Zibara, K.; Obeid, M.; Shear, D.; Mondello, S.; Wang, K.K.; Kobeissy, F. 2021: Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury. Neuroscientist: a Review Journal Bringing Neurobiology Neurology and Psychiatry 27(6): 620-649

Ghiam, M.K.; Patel, S.D.; Hoffer, A.; Selman, W.R.; Hoffer, B.J.; Hoffer, M.E. 2021: Drug Repurposing in the Treatment of Traumatic Brain Injury. Frontiers in Neuroscience 15: 635483

Li, Z.; He, P.; Long, Y.; Yuan, G.; Shen, W.; Chen, Z.; Zhang, B.; Wang, Y.; Yue, D.; Seidl, C.; Zhang, X. 2021: Drug Repurposing of Pantoprazole and Vitamin C Targeting Tumor Microenvironment Conditions Improves Anticancer Effect in Metastatic Castration-Resistant Prostate Cancer. Frontiers in Oncology 11: 660320

Shirley, D.-A.; Sharma, I.; Warren, C.A.; Moonah, S. 2021: Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent. Frontiers in Cellular and Infection Microbiology 11: 633194

De Felice, A.; Aureli, S.; Limongelli, V. 2021: Drug Repurposing on G Protein-Coupled Receptors Using a Computational Profiling Approach. Frontiers in Molecular Biosciences 8: 673053

Fiscon, G.; Conte, F.; Amadio, S.; Volonté, C.; Paci, P. 2021: Drug Repurposing: a Network-based Approach to Amyotrophic Lateral Sclerosis. Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics 18(3): 1678-1691

Kort, E.; Jovinge, S. 2021: Drug Repurposing: Claiming the Full Benefit from Drug Development. Current Cardiology Reports 23(6): 62

Ghosh, D.; Panja, A.; Saha, D.; Banerjee, U.; Datta, A.K.; Basu, A. 2021: Drug Repurposing: Hydroxyurea Therapy Improves the Transfusion-Free Interval in HbE/Beta-Thalassemia-Major Patients with the Xmni Polymorphism. Genetic Testing and Molecular Biomarkers 25(8): 563-570

She, P.; Wang, Y.; Li, Y.; Zhou, L.; Li, S.; Zeng, X.; Liu, Y.; Xu, L.; Wu, Y. 2021: Drug Repurposing: in vitro and in vivo Antimicrobial and Antibiofilm Effects of Bithionol Against Enterococcus faecalis and Enterococcus faecium. Frontiers in Microbiology 12: 579806

Ayalew, S.; Wegayehu, T.; Taye, H.; Wassie, L.; Girma, S.; Berg, S.; Mihret, A. 2021: Drug Resistance Conferring Mutation and Genetic Diversity of Mycobacterium tuberculosis Isolates in Tuberculosis Lymphadenitis Patients; Ethiopia. Infection and Drug Resistance 14: 575-584

Bedru, H.; Fikru, M.; Niguse, W.; Jemal, A.; Getinet, G.; Gobena, A.; Hailu, A.; Peter, S. 2021: Drug Resistance Pattern of M. tuberculosis Complex in Oromia Region of Ethiopia. Infection and Drug Resistance 14: 1679-1689

Löscher, W.; Potschka, H.; Sisodiya, S.M.; Vezzani, A. 2020: Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and new Innovative Treatment Options. Pharmacological Reviews 72(3): 606-638

Olivier, C.; Oliver, L.; Lalier, L.; Vallette, F.ço.M. 2020: Drug Resistance in Glioblastoma: the two Faces of Oxidative Stress. Frontiers in Molecular Biosciences 7: 620677

Almas, I.; Afzal, S.; Imtiaz, H.; Shaheen, M.A.; Daud, M.; Saghir, A.; Amin, I.; Shahid, M.; Idrees, M. 2020: Drug Resistance in Hepatitis C Virus: Future Prospects and Strategies to Combat it. Critical Reviews in Eukaryotic Gene Expression 30(4): 323-336

Lee, K.-C.; Yen, C.-K.; Chen, C.-N.; Chang, S.-F.; Lu, Y.-C.; Huang, W.-S. 2021: Drug Resistance of CPT-11 in Human DLD-1 Colorectal Cancer Cells through MutS Homolog 2 Upregulation. International Journal of Medical Sciences 18(5): 1269-1276

Yin, Y.Q.; Lu, J.; Zhou, Y.; Shi, L.E.; Yuan, D.F.; Chen, J.S.; Xuan, Y.; Hu, H.Y.; Zhang, Z.; Xu, X.Q.; Fu, G.F.; Wang, B. 2021: Drug Resistance to HIV-1 Integrase Inhibitors among Treatment-naive Patients in Jiangsu, China. Biomedical and Environmental Sciences: Bes 34(5): 400-403

Panda, P.K.; Agstam, S.; Mokta, J.; Sharma, A.; Sharma, Y.P. 2020: Drug Resistant Seizure Disorder in Young Patient. Journal of the Association of Physicians of India 68(12): 74

Zhang, J.; Shen, Z.; Song, Z.; Luan, J.; Li, Y.; Zhao, T. 2020: Drug Response Associated with and Prognostic lnc RNAs Mediated by DNA Methylation and Transcription Factors in Colon Cancer. Frontiers in Genetics 11: 554833

McInnes, G.; Altman, R.B. 2021: Drug Response Pharmacogenetics for 200,000 UK Biobank Participants. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 26: 184-195

Stanfield, Z.; Coşkun, M.; Koyutürk, M. 2017: Drug Response Prediction as a Link Prediction Problem. Scientific Reports 7: 40321

Zhou, J.; Li, M.; Wang, X.; He, Y.; Xia, Y.; Sweeney, J.A.; Kopp, R.F.; Liu, C.; Chen, C. 2021: Drug Response-Related DNA Methylation Changes in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder. Frontiers in Neuroscience 15: 674273

Furlan, G.; Caduff-Janosa, P.; Sottosanti, L.; Cappello, E.; Valdiserra, G.; Tuccori, M. 2020: Drug Safety in Geriatric Patients: Current Status and Proposed way Forward. Drug Safety 43(9): 853-866

Liao, Y.-H.; Chen, L.-Y.; Liao, K.-M.; Chen, C.-Y. 2020: Drug Safety of Benzodiazepines in Asian Patients with Chronic Obstructive Pulmonary Disease. Frontiers in Pharmacology 11: 592910

Menduti, G.; Rasà, D.M.; Stanga, S.; Boido, M. 2020: Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment. Frontiers in Pharmacology 11: 592234

Akay, M.; Hite, J.; Avci, N.Gul.; Fan, Y.; Akay, Y.; Lu, G.; Zhu, J-Jiguang. 2018: Drug Screening of Human GBM Spheroids in Brain Cancer Chip. Scientific Reports 8(1): 15423

Dai, Y.-H.; Chen, G.-Y.; Tang, C.-H.; Huang, W.-C.; Yang, J.-C.; Wu, Y.-C. 2021: Drug Screening of Potential Multiple Target Inhibitors for Estrogen Receptor-α-positive Breast Cancer. In Vivo 35(2): 761-777

Duan, X.; Chen, H.; Fan, L.; Kong, J. 2016: Drug Self-Assembled Delivery System with Dual Responsiveness for Cancer Chemotherapy. Acs Biomaterials Science and Engineering 2(12): 2347-2354

Mason, A.B.; Dartois, V.ér. 2021: Drug Sensitivity Testing of Mycobacterium tuberculosis Growing in a Hollow Fiber Bioreactor. Methods in Molecular Biology 2314: 715-731

Moss, J.D.; Schwenk, H.T.; Chen, M.; Gaskari, S. 2021: Drug Shortage and Critical Medication Inventory Management at a Children's Hospital During the COVID-19 Pandemic. Journal of Pediatric Pharmacology and Therapeutics: Jppt: the Official Journal of Ppag 26(1): 21-25

Shukar, S.; Zahoor, F.; Hayat, K.; Saeed, A.; Gillani, A.H.; Omer, S.; Hu, S.; Babar, Z.-U.-D.; Fang, Y.; Yang, C. 2021: Drug Shortage: Causes, Impact, and Mitigation Strategies. Frontiers in Pharmacology 12: 693426

Calleja, K. 2020: Drug Shortages and Group Purchasing Organizations. JAMA 324(8): 808-809

Shin, E.; Lee, Y.Chul.; Kim, S.Ri.; Kim, S.Ha.; Park, J. 2015: Drug Signature-based Finding of Additional Clinical Use of LC28-0126 for Neutrophilic Bronchial Asthma. Scientific Reports 5: 17784

van den Reek, J.M.P.A.; Kievit, W.; Gniadecki, R.; Goeman, J.J.; Zweegers, J.; van de Kerkhof, P.C.M.; Seyger, M.M.B.; de Jong, E.M.G.J. 2015: Drug Survival Studies in Dermatology:Principles, Purposes, and Pitfalls. Journal of Investigative Dermatology 135(7): 1-5

Yu, C.-L.; Yang, C.-H.; Chi, C.-C. 2020: Drug Survival of Biologics in Treating Ankylosing Spondylitis: a Systematic Review and Meta-analysis of Real-World Evidence. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 34(5): 669-679

Lockshin, B.; Cronin, A.; Harrison, R.W.; McLean, R.R.; Anatale-Tardiff, L.; Burge, R.; Zhu, B.; Malatestinic, W.N.; Atiya, B.; Murage, M.J.; Gallo, G.; Strober, B.; Van Voorhees, A. 2021: Drug survival of ixekizumab, TNF inhibitors, and other IL-17 inhibitors in real-world patients with psoriasis: the Corrona Psoriasis Registry. Dermatologic Therapy 34(2): E14808

Gibson, S.E.R.; Harrison, J.; Cox, J.A.G. 2021: Drug Susceptibility Screening Using in Vitro Models of Hypoxic Non-Replicating Persistent Mycobacteria. Methods in Molecular Biology 2314: 247-260

Ettari, R.; Previti, S.; Di Chio, C.; Maiorana, S.; Allegra, A.; Schirmeister, T.; Zappalà, M. 2020: Drug Synergism: Studies of Combination of RK-52 and Curcumin against Rhodesain of Trypanosoma brucei rhodesiense. Acs Medicinal Chemistry Letters 11(5): 806-810

Chiurillo, M.A.; Jensen, B.C.; Docampo, R. 2021: Drug Target Validation of the Protein Kinase AEK1, Essential for Proliferation, Host Cell Invasion, and Intracellular Replication of the Human Pathogen Trypanosoma cruzi. Microbiology Spectrum 9(2): E0073821

Shafer, W.M. 2020: Drug Targeting a Gonococcal Virulence Factor Exploits Host Antimicrobial Peptides in Clearance of Infection. Journal of Infectious Diseases 222(10): 1585-1586

Ferraro, F.; Cabrera, M.A.; Álvarez, G.án.I.; Corvo, I. 2020: Drug Targets: Screening for Small Molecules that Inhibit Fasciola hepatica Enzymes. Methods in Molecular Biology 2137: 221-231

Motrapu, M.; Świderska, M.K.; Mesas, I.; Marschner, J.A.; Lei, Y.; Martinez Valenzuela, L.; Fu, J.; Lee, K.; Angelotti, M.L.; Antonelli, G.; Romagnani, P.; Anders, H.-J.; Anguiano, L. 2020: Drug Testing for Residual Progression of Diabetic Kidney Disease in Mice Beyond Therapy with Metformin, Ramipril, and Empagliflozin. Journal of the American Society of Nephrology: Jasn 31(8): 1729-1745

Tefera, G.M.; Zeleke, A.Z.; Jima, Y.M.; Kebede, T.M. 2020: Drug Therapy Problems and the Role of Clinical Pharmacist in Surgery Ward: Prospective Observational and Interventional Study. Drug Healthcare and Patient Safety 12: 71-83

Ruedy, J. 1965: Drug Therapy for Acute Pyelonephritis. Canadian Medical Association Journal 92(24): 1278

Lewin, P.K. 1964: Drug Therapy in Dysmenorrhea. Canadian Medical Association Journal 91(10): 569

Boucher, R.C. 1992: Drug Therapy in the 1990s : what can we Expect for Cystic Fibrosis?. Drugs 43(4): 431-439

Anderson, P.O. 2020: Drug Therapy of Genetic Diseases During Breastfeeding. Breastfeeding Medicine: the Official Journal of the Academy of Breastfeeding Medicine 15(7): 426-428

Olsen, T.W.; Dyer, R.B.; Mano, F.; Boatright, J.H.; Chrenek, M.A.; Paley, D.; Wabner, K.; Schmit, J.; Chae, J.B.; Sellers, J.T.; Singh, R.J.; Wiedmann, T.S. 2020: Drug Tissue Distribution of TUDCA from a Biodegradable Suprachoroidal Implant versus Intravitreal or Systemic Delivery in the Pig Model. Translational Vision Science and Technology 9(6): 11

Kharlamova, N.; Hermanrud, C.; Dunn, N.; Ryner, M.; Hambardzumyan, K.; Vivar Pomiano, N.; Marits, P.; Gjertsson, I.; Saevarsdottir, S.; Pullerits, R.; Fogdell-Hahn, A. 2020: Drug Tolerant Anti-drug Antibody Assay for Infliximab Treatment in Clinical Practice Identifies Positive Cases Earlier. Frontiers in Immunology 11: 1365

Nakazono, Y.; Arakawa, H.; Nishino, M.; Yamaki, I.; Oba, T.; Tomotoshi, K.; Kakinuma, C.; Ogihara, T.; Tamai, I. 2021: Drug Transcellular Transport Assay Using a High Porosity Honeycomb Film. Biological and Pharmaceutical Bulletin 44(5): 635-641

Seelinger, G.ün.; Mannel, M. 2007: Drug Treatment in Juvenile Depression - Is St. John's Wort a Safe and Effective Alternative?. Child and Adolescent Mental Health 12(3): 143-149

Held, F.; Klein, A.-K.; Berthele, A. 2021: Drug Treatment of Neuromyelitis Optica Spectrum Disorders: out with the Old, in with the New?. Immunotargets and Therapy 10: 87-101

Alghoul, M.S.; Vaca, E.E.; Mioton, L.M.; Zins, J.E. 2020: Letter to the Editor: The Functional Anatomy of the Deep Facial Fat Compartments: A Detailed Imaging-Based Investigation. Plastic and Reconstructive Surgery 2020

Anderson, P.O. 2020: Drug Treatment of Raynaud's Phenomenon of the Nipple. Breastfeeding Medicine: the Official Journal of the Academy of Breastfeeding Medicine 15(11): 686-688

Mandge, V.; Husain, A.M. 2020: Drug Trials in Status Epilepticus: Current Evidence and Future Concepts. Journal of Clinical Neurophysiology: Official Publication of the American Electroencephalographic Society 37(5): 434-445

Fekadu, G.; Bekele, F.; Bekele, K.; Hanbisa, S.; Belay, G.; Maqbool, M. 2020: Drug use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia. Cardiovascular Therapeutics 2020: 2509875

Obeid, W.M.N.; Abdoon, I.H.; Osman, B.; Osman, W.J.A.; Suliman, H.M.; Mohamed, E.M.; Mothana, R.A.A. 2021: Drug use evaluation of cefepime at Khartoum North Teaching Hospital in Sudan. International Journal of Clinical Practice 75(4): E13882

Adinolfi, A.C.; Bezerra, A.éi.G.; Curado, D.F.án.; de Souza, A.A.L.; Galduróz, J.é C.F. 2022: Drug use Frequency Variation and Mental Health During the COVID-19 Pandemic: an Online Survey. International Journal of Mental Health and Addiction 20(5): 2755-2769

Kalichman, S.C.; Kalichman, M.O.; Banas, E.; Hill, M.; Katner, H. 2021: Drug Use and Life Chaos as Potential Factors Contributing to HIV Viral Load among People with Lower Health Literacy. Substance use and Misuse 2021: 1-9

Patel, R.; Redmond, N.M.; Kesten, J.M.; Linton, M.-J.; Horwood, J.; Wilcox, D.; Munafo, J.; Coast, J.; Macleod, J.; Jeal, N. 2020: Drug use in Street Sex wor Kers (DUSSK) study: results of a mixed methods feasibility study of a complex intervention to reduce illicit drug use in drug dependent female sex workers. Bmj Open 10(12): E036491

Zin, C.S.; Taufek, N.H.; Bux, S.H. 2020: Drug Utilization and Drug Pricing in the Private Primary Healthcare System in Malaysia: An Employer Price Control Mechanism. Frontiers in Public Health 8: 551328

Cabezón, E.; Arechaga, I. 2020: Drug Weaponry to Fight Against SARS-CoV-2. Frontiers in Molecular Biosciences 7: 204

Sica, D.A. 1999: Drug absorption in congestive heart failure: impact on management. Progress in Cardiovascular Nursing 14(2): 72-74

Budha, N.R.; Frymoyer, A.; Smelick, G.S.; Jin, J.Y.; Yago, M.R.; Dresser, M.J.; Holden, S.N.; Benet, L.Z.; Ware, J.A. 2012: Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the Achilles heel of targeted therapy?. Clinical Pharmacology and Therapeutics 92(2): 203-213

Amble, F.R. 1990: Drug abuse by adolescents. Texas Medicine 86(11): 58-63

Matsumura, Y. 1998: Drug abuse in Japan. Nihon Arukoru Yakubutsu Igakkai Zasshi 33(5): 597-602

Allen, V.R. 1969: Drug abuse in adolescence. Pediatrics 44(6): 1038-1039

Reyes, B.V. 1983: Drug abuse in the Philippines. Seishin Shinkeigaku Zasshi 85(8): 473-477

Cahal, D.A. 1970: Drug abuse in the United Kingdom. Applied Therapeutics 12(9): 16; 21-23

Rigatelli, G.; De Santis, G.; Zuin, M. 2021: Drug abuse, hypothermia, or acute myocardial infarction?. European Heart Journal. Case Reports 5(10): Ytab 309

Bousquet, J. 1995: Drug accidents of immunological origin. Physiopathology. La Revue du Praticien 45(9): 1145-1148

Webster, D.J.; Flook, D.; Jenkins, J.; Hutchings, A.; Routledge, P.A. 1989: Drug acetylation in breast cancer. British Journal of Cancer 60(2): 236-237

Bueding, E. 1949: Drug action and enzymes. Alumni Bulletin. Western Reserve University. School of Medicine 13(5): 83-86

Benzi, G.; Arrigoni, E.; Pastoris, O.; Villa, R.F.; Dossena, M.; Agnoli, A.; Giuffrida, A.M. 1982: Drug action on the metabolic changes induced by acute hypoxia on synaptosomes from the cerebral cortex. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 2(2): 229-239

Yang, H.; Li, J.; Zheng, Y.; Zhou, L.; Tong, S.; Zhao, B.; Cai, W. 2016: Drug activity screening based on microsomes-hydrogel system in predicting metabolism induced antitumor effect of oroxylin A. Scientific Reports 6: 21604

Llorca, P.M.; Scotto, J.C. 1995: Drug addiction and AIDS. La Revue du Praticien 45(11): 1371-1374

Gentilini, M.; Duneton, P. 1993: Drug addiction and AIDS. Bulletin de l'Academie Nationale de Medecine 177(8): 1353-1369

Carratala, R.E. 1946: Drug addiction and crime. Criminalia 12: 2-12

Faucett, R.L. 1957: Drug addiction and other considerations in the management of pain with narcotic drugs. American Practitioner and Digest of Treatment 8(8): 1230-1231

Bongain, A.; Huss, M.; Gillet, J.Y. 1992: Drug addiction and pregnancy. La Revue du Praticien 42(8): 1004-1009

Fauchère, P.A. 1983: Drug addiction and the general hospital. KRANKENPFLEGE. Soins Infirmiers 76(9): 27-28

Swetlow, G.I. 1948: Drug addiction and the law. BULLETIN. Medical Society of the County of Kings 27(3): 86-92

Kalivas, P.W.; O'Brien, C. 2008: Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 33(1): 166-180

McGinn, M.A.; Pantazis, C.B.; Tunstall, B.J.; Marchette, R.C.N.; Carlson, E.R.; Said, N.; Koob, G.F.; Vendruscolo, L.F. 2021: Drug addiction co-morbidity with alcohol: Neurobiological insights. International Review of Neurobiology 157: 409-472

Palenzona, C. 1984: Drug addiction in Europe. Minerva Medica 75(7): 338-342

Zimmering, P.; Toolan, J. 1952: Drug addiction in adolescents. Journal of Nervous and Mental Disease 116(3): 262-265

Zimmering, P.; Toolan, J.M. 1952: Drug addiction in adolescents. A.M.A. Archives of Neurology and Psychiatry 67(4): 556-558

Ewald, K. 1948: Drug addiction in applicable criminal law; a forensic-psychiatric contribution. Der Nervenarzt 19(6): 265-267

Yang, Z.; Ye, J.; Li, C.; Zhou, D.; Shen, Q.; Wu, J.; Cao, L.; Wang, T.; Cui, D.; He, S.; Qi, G.; He, L.; Liu, Y. 2013: Drug addiction is associated with leukocyte telomere length. Scientific Reports 3: 1542

Self, D.W. 1995: Drug addiction. Cocaine abuse takes a shot. Nature 378(6558): 666-667

Harrison, C. 2010: Drug addiction: Blocking cocaine-seeking behaviour. Nature Reviews. Drug Discovery 9(10): 764-765

Tyndale, R. 2008: Drug addiction: a critical problem calling for novel solutions. Clinical Pharmacology and Therapeutics 83(4): 503-506

Liu, J-Feng.; Li, J-Xu. 2018: Drug addiction: a curable mental disorder?. Acta Pharmacologica Sinica 39(12): 1823-1829

Robbins, T.W.; Everitt, B.J. 1999: Drug addiction: bad habits add up. Nature 398(6728): 567-570

Cheron, J.; Kerchove d'Exaerde, A.de. 2021: Drug addiction: from bench to bedside. Translational Psychiatry 11(1): 424

Volkow, N.D.; Li, T-Kai. 2004: Drug addiction: the neurobiology of behaviour gone awry. Nature Reviews. Neuroscience 5(12): 963-970

Pouletty, P. 2002: Drug addictions: towards socially accepted and medically treatable diseases. Nature Reviews. Drug Discovery 1(9): 731-736

Reh, T. 1945: Drug addicts and their surveillance. Gesundheit 25: 4-13

Ciura, K.; Ulenberg, S.; Kapica, H.; Kawczak, P.; Belka, M.; Bączek, T. 2020: Drug affinity to human serum albumin prediction by retention of cetyltrimethylammonium bromide pseudostationary phase in micellar electrokinetic chromatography and chemically advanced template search descriptors. Journal of Pharmaceutical and Biomedical Analysis 188: 113423

Wadman, M. 2005: Drug agency accused of political bias. Nature 437(7056): 179

Castells, M.C. 2020: Drug allergy labeling and delabeling in the coronavirus disease 2019 era: what is important and what do we need to know. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 124(6): 523-525

Chan, B.; Freeman, M.; Ayers, C.; Korthuis, P.; Paynter, R.; Kondo, K.; Kansagara, D. 2021: Drug and Alcohol Dependence response to KK-21-1460 "Considering rationales for use in defining subgroups for the treatment of stimulant use disorder". Drug and Alcohol Dependence 221: 108571

Bechara, R.; Feray, A.; Pallardy, M. 2021: Drug and Chemical Allergy: a Role for a Specific Naive T-Cell Repertoire?. Frontiers in Immunology 12: 653102

Proschmann, U.; Haase, R.; Inojosa, H.; Akgün, K.; Ziemssen, T. 2021: Drug and Neurofilament Levels in Serum and Breastmilk of Women with Multiple Sclerosis Exposed to Natalizumab During Pregnancy and Lactation. Frontiers in Immunology 12: 715195

Mynott, R.L.; Wallington-Beddoe, C.T. 2021: Drug and Solute Transporters in Mediating Resistance to Novel Therapeutics in Multiple Myeloma. Acs Pharmacology and Translational Science 4(3): 1050-1065

Peraza, N.; Bello, M.S.; Schiff, S.J.; Cho, J.; Zhang, Y.; Callahan, C.; Tackett, A.; Leventhal, A.M. 2021: Drug and alcohol dependence acute effects of pod-style e-cigarettes in vaping-naïve smokers. Drug and Alcohol Dependence 228: 109083

Young, K.N.; Yeates, E.O.; Grigorian, A.; Schellenberg, M.; Owattanapanich, N.; Barmparas, G.; Margulies, D.; Juillard, C.; Garber, K.; Cryer, H.; Tillou, A.; Burruss, S.; Penaloza-Villalobos, L.; Lin, A.; Figueras, R.Arthur.; Brenner, M.; Firek, C.; Costantini, T.; Santorelli, J.; Curry, T.; Wintz, D.; Biffl, W.L.; Schaffer, K.B.; Duncan, T.K.; Barbaro, C.; Diaz, G.; Johnson, A.; Chinn, J.; Naaseh, A.; Leung, A.; Grabar, C.; Nahmias, J. 2021: Drug and alcohol positivity of traumatically injured patients related to COVID-19 stay-at-home orders. American Journal of Drug and Alcohol Abuse 2021: 1-7

Kmietowicz, Z. 2021: Drug and alcohol services for young people cut by £26m in six years. Bmj 372: N817

Crane, H.M.; Nance, R.M.; Whitney, B.M.; Ruderman, S.; Tsui, J.I.; Chander, G.; McCaul, M.E.; Lau, B.; Mayer, K.H.; Batey, D.Scott.; Safren, S.A.; Moore, R.D.; Eron, J.J.; Napravnik, S.; Mathews, W.Chris.; Fredericksen, R.J.; Hahn, A.W.; Mugavero, M.J.; Lober, W.B.; Saag, M.S.; Kitahata, M.M.; Delaney, J.A.C. 2021: Drug and alcohol use among people living with HIV in care in the United States by geographic region. Aids Care 2021: 1-8

Dozois, A.; Nkondora, P.; Noste, E.; Mfinanga, J.A.; Sawe, H.R.; Runyon, M.S. 2021: Drug and alcohol use in Tanzanian road traffic collision drivers. African Journal of Emergency Medicine: Revue Africaine de la Medecine d'Urgence 11(4): 390-395

Wadman, M. 1996: Drug and cigarette company donations favour Republicans. Nature 383(6595): 5

Harnisch, L.; Matthews, I.; Chard, J.; Karlsson, M.O. 2013: Drug and disease model resources: a consortium to create standards and tools to enhance model-based drug development. Cpt: Pharmacometrics and Systems Pharmacology 2: E34

Stathias, V.; Jermakowicz, A.M.; Maloof, M.E.; Forlin, M.; Walters, W.; Suter, R.K.; Durante, M.A.; Williams, S.L.; Harbour, J.William.; Volmar, C-Henry.; Lyons, N.J.; Wahlestedt, C.; Graham, R.M.; Ivan, M.E.; Komotar, R.J.; Sarkaria, J.N.; Subramanian, A.; Golub, T.R.; Schürer, S.C.; Ayad, N.G. 2018: Drug and disease signature integration identifies synergistic combinations in glioblastoma. Nature Communications 9(1): 5315

Pardridge, W.M. 2002: Drug and gene targeting to the brain with molecular Trojan horses. Nature Reviews. Drug Discovery 1(2): 131-139

Livingston, A.N.; Mattingly, T.J. 2021: Drug and medical device product failures and the stability of the pharmaceutical supply chain. Journal of the American Pharmacists Association: Japha 61(1): E119-E122

Staniszewska, M.; Iking, J.; Lückerath, K.; Hadaschik, B.; Herrmann, K.; Ferdinandus, J.; Fendler, W.P. 2021: Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer. Nuclear Medicine and Biology 96-97: 101-111

Ludwig, A.; Monico, L.B.; Gryczynski, J.; Lertch, E.; Schwartz, R.P.; Fishman, M.; Dionne, R.; Mitchell, S.G. 2021: Drug and sexual HIV-risk behaviors among adolescents and young adults with opioid use disorder. Journal of Substance Abuse Treatment 130: 108477

McCLUSKEY, C.M. 1959: Drug and solution control. Hospital Management 87(4): 100 Passim

Nigam, S.K.; Bush, K.T.; Bhatnagar, V. 2007: Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues. Nature Clinical Practice. Nephrology 3(8): 443-448

Matheny, J.; Smith, B.; Courtney, B.; Mair, M. 2009: Drug and vaccine development for infectious diseases: the value of priority review vouchers. Clinical Pharmacology and Therapeutics 85(6): 571-572

Richards, R.; Schwartz, H.R.; Honeywell, M.E.; Stewart, M.S.; Cruz-Gordillo, P.; Joyce, A.J.; Landry, B.D.; Lee, M.J. 2020: Drug antagonism and single-agent dominance result from differences in death kinetics. Nature Chemical Biology 16(7): 791-800

Delaye, M.; Rodrigues, M. 2020: Drug approval : entrectinib and larotrectinib - cancers with NTRK fusion. Bulletin du Cancer 107(11): 1085-1086

Frantz, S. 2006: Drug approval triggers debate on future direction for cancer treatments. Nature Reviews. Drug Discovery 5(2): 91

Buderi, R. 1990: Drug approval: product licensing by phone. Nature 343(6255): 196

Vlatakis, G.; Andersson, L.I.; Müller, R.; Mosbach, K. 1993: Drug assay using antibody mimics made by molecular imprinting. Nature 361(6413): 645-647

Ledford, H. 2012: Drug bests cystic-fibrosis mutation. Nature 482(7384): 145

Saegusa, A. 1998: Drug bill cuts force firms overseas. Nature Biotechnology 16(6): 506-507

Komatsu, T.S.; Okimoto, N.; Koyama, Y.M.; Hirano, Y.; Morimoto, G.; Ohno, Y.; Taiji, M. 2020: Drug binding dynamics of the dimeric SARS-CoV-2 main protease, determined by molecular dynamics simulation. Scientific Reports 10(1): 16986

Mitcheson, J.S. 2003: Drug binding to HERG channels: evidence for a 'non-aromatic' binding site for fluvoxamine. British Journal of Pharmacology 139(5): 883-884

Catta-Preta, C.M.C.; Mottram, J.C. 2018: Drug candidate and target for leishmaniasis. Nature 560(7717): 171-172

Ledford, H. 2012: Drug candidates derailed in case of mistaken identity. Nature 483(7391): 519

Gever, L.N. 1982: Drug challenge: drug combinations. Nursing 12(2): 106

Tobias, S.; Shapiro, A.M.; Grant, C.J.; Patel, P.; Lysyshyn, M.; Ti, L. 2021: Drug checking identifies counterfeit alprazolam tablets. Drug and Alcohol Dependence 218: 108300

Oliveira, M.A.; Lino-Alvarado, A.E.; Moriya, H.T.; Vitorasso, R.L. 2021: Drug class effects on respiratory mechanics in animal models: access and applications. Experimental Biology and Medicine 246(9): 1094-1103

Weinberger, M.M. 1992: Drug clearance in patients with cystic fibrosis. Clinical Pharmacology and Therapeutics 52(1): 106-107

Rathore, S.; Tehrani, S.; Prvulovic, D.; Araya, M.; Lefèvre, T.; Banning, A.P.; Burzotta, F.; Rigatelli, G.; Gutierrez-Chico, J.Luis.; Bonaventura, K.; Chevalier, B.; Kinoshita, Y.; Sikic, J.; Alfonso, F.; Louvard, Y.; Stankovic, G. 2020: Drug coated balloons and their role in bifurcation coronary angioplasty: appraisal of the current evidence and future directions. Expert Review of Medical Devices 17(10): 1021-1033

Corballis, N.H.; Paddock, S.; Gunawardena, T.; Merinopoulos, I.; Vassiliou, V.S.; Eccleshall, S.C. 2021: Drug coated balloons for coronary artery bifurcation lesions: a systematic review and focused meta-analysis. Plos one 16(7): E0251986

Correia, A.S.é; Gärtner, F.át.; Vale, N. 2021: Drug combination and repurposing for cancer therapy: the example of breast cancer. Heliyon 7(1): E05948

Di Chio, C.; Previti, S.; De Luca, F.; Allegra, A.; Zappalà, M.; Ettari, R. 2021: Drug combination studies of PS-1 and quercetin against rhodesain of Trypanosoma brucei rhodesiense. Natural Product Research 2021: 1-5

Ahmed, H.; Curtis, C.R.; Tur-Gracia, S.; Olatunji, T.O.; Carter, K.C.; Williams, R.A.M. 2020: Drug combinations as effective anti-leishmanials against drug resistant Leishmania mexicana. Rsc Medicinal Chemistry 11(8): 905-912

Tyers, M.; Wright, G.D. 2019: Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nature Reviews. Microbiology 17(3): 141-155

Sinha, G. 2006: Drug companies accused of stalling tailored therapies. Nature Medicine 12(9): 983

Rimmer, A. 2021: Drug companies are fined more than £260m for overcharging NHS for hydrocortisone pills. Bmj 374: N1809

May, M. 2011: Drug companies hope to breathe life into asthma pipeline. Nature Medicine 17(6): 642-643

Dolgin, E. 2012: Drug companies look to biomarkers to salvage cancer target. Nature Medicine 18(9): 1312-1313

Clarke, T. 2003: Drug companies snub antibiotics as pipeline threatens to run dry. Nature 425(6955): 225

Casassus, B. 2021: Drug company Servier is found guilty of manslaughter and aggravated deceit over Mediator diabetes drug. Bmj 372: N873

Wadman, M. 1999: Drug company backs Africa's war on AIDS. Nature 399(6732): 96

Munafo, A.; Christen, Y.; Nussberger, J.; Shum, L.Y.; Borland, R.M.; Lee, R.J.; Waeber, B.; Biollaz, J.; Brunner, H.R. 1992: Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist. Clinical Pharmacology and Therapeutics 51(5): 513-521

Johnson, L.R.; Weaver, P.G.; Forsythe, L.E.; Thomasy, S.M.; Knych, H.K. 2021: Drug content on receipt and over time for compounded formulations of famciclovir. Journal of Feline Medicine and Surgery 23(6): 519-525

Borkowski, B. 1970: Drug control in Poland. Pharmazeutische Praxis 8: 187-191

Cimons, M. 2003: Drug costs threaten patent protection. Nature Medicine 9(1): 9

Guillot, B. 2020: Drug course: from evaluation to price. Annales de Dermatologie et de Venereologie 147(12s): A29-A30

Kapourani, A.; Tzakri, T.; Valkanioti, V.; Kontogiannopoulos, K.N.; Barmpalexis, P. 2021: Drug crystal growth in ternary amorphous solid dispersions: Effect of surfactants and polymeric matrix-carriers. International Journal of Pharmaceutics: X 3: 100086

Mahase, E. 2020: Drug deaths: England and Wales see highest number since records began. Bmj 371: M3988

Shio, M.Temi.; Paquet, M.; Martel, C.; Bosschaerts, T.; Stienstra, S.; Olivier, M.; Fortin, A. 2014: Drug delivery by tattooing to treat cutaneous leishmaniasis. Scientific Reports 4: 4156

Cai, S.S.; Li, T.; Akinade, T.; Zhu, Y.; Leong, K.W. 2021: Drug delivery carriers with therapeutic functions. Advanced Drug Delivery Reviews 176: 113884

Corbett, J.M.; Hawthorne, I.; Coulter, I.S.; English, K. 2021: Drug delivery formulation impacts cyclosporine efficacy in a humanised mouse model of acute graft versus host disease. Transplant Immunology 65: 101373

Arruebo, M.; Vilaboa, N.; Santamaria, J. 2010: Drug delivery from internally implanted biomedical devices used in traumatology and in orthopedic surgery. Expert Opinion on Drug Delivery 7(5): 589-603

Dhanasingh, A.; Hochmair, I. 2021: Drug delivery in cochlear implantation. Acta Oto-Laryngologica 141(Sup1): 135-156

Colella, F.; Garcia, J.ão.P.; Sorbona, M.; Lolli, A.; Antunes, B.; D'Atri, D.; Barré, F.P.Y.; Oieni, J.; Vainieri, M.L.; Zerrillo, L.; Capar, S.; Häckel, S.; Cai, Y.; Creemers, L.B. 2020: Drug delivery in intervertebral disc degeneration and osteoarthritis: Selecting the optimal platform for the delivery of disease-modifying agents. Journal of Controlled Release: Official Journal of the Controlled Release Society 328: 985-999

Smith, B.; Uhl, K. 2009: Drug delivery in the twenty-first century: a new paradigm. Clinical Pharmacology and Therapeutics 85(5): 451-455

Edelman, E.R.; Lovich, M. 1998: Drug delivery models transported to a new level. Nature Biotechnology 16(2): 136-137

Alazzawi, H.F.; Salih, I.K.; Albayati, T.M. 2021: Drug delivery of amoxicillin molecule as a suggested treatment for covid-19 implementing functionalized mesoporous SBA-15 with aminopropyl groups. Drug Delivery 28(1): 856-864

Grice, P.T.; Liu, J.; Gabrielson, A.T.; Pearce, I.; Bivalacqua, T.J.; Modgil, V. 2020: Drug delivery options and therapeutic advances in the management of erectile dysfunction. Expert Opinion on Drug Delivery 17(9): 1259-1268

Narayanamurthy, R.; Yang, J.-L.J.; Yager, J.Y.; Unsworth, L.D. 2021: Drug delivery platforms for neonatal brain injury. Journal of Controlled Release: Official Journal of the Controlled Release Society 330: 765-787

Prow, T.W.; Mandinova, A. 2020: Drug delivery progress in benign and malignant lesions of aging skin. Advanced Drug Delivery Reviews 153: 1

Patel, S.K.; Valicherla, G.R.; Micklo, A.C.; Rohan, L.C. 2021: Drug delivery strategies for management of women's health issues in the upper genital tract. Advanced Drug Delivery Reviews 177: 113955

Lai, V.; Neshat, S.Y.; Rakoski, A.; Pitingolo, J.; Doloff, J.C. 2021: Drug delivery strategies in maximizing anti-angiogenesis and anti-tumor immunity. Advanced Drug Delivery Reviews 179: 113920

Brain, D.; Plant-Hately, A.; Heaton, B.; Arshad, U.; David, C.; Hedrich, C.; Owen, A.; Liptrott, N.J. 2021: Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19. Advanced Drug Delivery Reviews 178: 113848

Malacarne, M.C.; Banfi, S.; Rugiero, M.; Caruso, E. 2021: Drug delivery systems for the photodynamic application of two photosensitizers belonging to the porphyrin family. Photochemical and Photobiological Sciences: Official Journal of the European Photochemistry Association and the European Society for Photobiology 20(8): 1011-1025

Mukhtar, M.; Ali, H.; Ahmed, N.; Munir, R.; Talib, S.; Khan, A.S.; Ambrus, R. 2020: Drug delivery to macrophages: a review of nano-therapeutics targeted approach for inflammatory disorders and cancer. Expert Opinion on Drug Delivery 17(9): 1239-1257

Kumar, A.S.; Kamalasanan, K. 2021: Drug delivery to optimize angiogenesis imbalance in keloid: a review. Journal of Controlled Release: Official Journal of the Controlled Release Society 329: 1066-1076

Moradi Kashkooli, F.; Soltani, M.; Hamedi, M.-H. 2020: Drug delivery to solid tumors with heterogeneous microvascular networks: Novel insights from image-based numerical modeling. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 151: 105399

Mofidfar, M.; Abdi, B.; Ahadian, S.; Mostafavi, E.; Desai, T.A.; Abbasi, F.; Sun, Y.; Manche, E.E.; Ta, C.N.; Flowers, C.W. 2021: Drug delivery to the anterior segment of the eye: a review of current and future treatment strategies. International Journal of Pharmaceutics 607: 120924

Hartwig, O.; Shetab Boushehri, M.A.; Shalaby, K.S.; Loretz, B.; Lamprecht, A.; Lehr, C.-M. 2021: Drug delivery to the inflamed intestinal mucosa - targeting technologies and human cell culture models for better therapies of IBD. Advanced Drug Delivery Reviews 175: 113828

Edwards, R.H. 2001: Drug delivery via the blood-brain barrier. Nature Neuroscience 4(3): 221-222

Nguyen, D.N.; Chen, S.C-Y.; Lu, J.; Goldberg, M.; Kim, P.; Sprague, A.; Novobrantseva, T.; Sherman, J.; Shulga-Morskaya, S.; de Fougerolles, A.; Chen, J.; Langer, R.; Anderson, D.G. 2009: Drug delivery-mediated control of RNA immunostimulation. Molecular Therapy: the Journal of the American Society of Gene Therapy 17(9): 1555-1562

Ashford, M. 2020: Drug delivery-the increasing momentum. Drug Delivery and Translational Research 10(6): 1888-1894

Siegel, R.A. 1998: Drug delivery. A lesson from secretory granules. Nature 394(6692): 427-428

Bradley, C.A. 2018: Drug delivery: DNA nanorobots - seek and destroy. Nature Reviews. Cancer 18(4): 208

Bradley, C.A. 2018: Drug delivery: DNA nanorobots - seek and destroy. Nature Reviews. Drug Discovery 17(4): 242

Flight, M.Hoyos. 2012: Drug delivery: Encapsulation improves therapeutic stem cell action. Nature Reviews. Drug Discovery 11(2): 106

Boso, D.P.; Di Mascolo, D.; Santagiuliana, R.; Decuzzi, P.; Schrefler, B.A. 2020: Drug delivery: Experiments, mathematical modelling and machine learning. Computers in Biology and Medicine 123: 103820

Villanueva, M.Teresa. 2015: Drug delivery: Get in there!. Nature Reviews. Cancer 15(6): 317

Dawson, K.A.; Yan, Y. 2016: Drug delivery: Leukocyte-like carriers. Nature Materials 15(9): 935-936

Cully, M. 2015: Drug delivery: Long live the peptides. Nature Reviews. Drug Discovery 14(11): 750

Flemming, A. 2010: Drug delivery: Nanobioconjugate shrinks brain tumours. Nature Reviews. Drug Discovery 9(12): 917

Kingwell, K. 2016: Drug delivery: New targets for drug delivery across the BBB. Nature Reviews. Drug Discovery 15(2): 84-85

Campolongo, M.J.; Luo, D. 2009: Drug delivery: Old polymer learns new tracts. Nature Materials 8(6): 447-448

Prausnitz, M.R. 2015: Drug delivery: Puncturing cells en masse. Nature Materials 14(5): 470-471

Curry, F-Roy.E. 2016: Drug delivery: Redefining tumour vascular barriers. Nature Nanotechnology 11(6): 494-496

Crunkhorn, S. 2016: Drug delivery: Star-shaped pill sustains drug release. Nature Reviews. Drug Discovery 16(1): 16-17

Butcher, N.J.; Mortimer, G.M.; Minchin, R.F. 2016: Drug delivery: Unravelling the stealth effect. Nature Nanotechnology 11(4): 310-311

Hoag, H. 2014: Drug delivery: brain food. Nature 510(7506): S6-S7

de la Zerda, A.; Gambhir, S.S. 2007: Drug delivery: keeping tabs on nanocarriers. Nature Nanotechnology 2(12): 745-746

West, J.L. 2003: Drug delivery: pulsed polymers. Nature Materials 2(11): 709-710

Couvreur, P. 2014: Drug delivery: replenishing reservoirs in vivo. Nature Nanotechnology 9(11): 874-875

Putnam, D. 2008: Drug delivery: the heart of the matter. Nature Materials 7(11): 836-837

Quesnel, L.B.; York, P.; Skinner, V.M. 1971: Drug dependence and phenotypic masking in E. coli. Nature 233(5315): 121-122

Ozaki, S. 2012: Drug dependence syndrome as a side effect of medical drug use. Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 6): 597-600

Acuda, S.W. 1988: Drug dependence: health and socio-economic consequences. Kenya Nursing Journal 16(2): 11-23

Eddy, N.B.; Halbach, H.; Isbell, H.; Seevers, M.H. 1966: Drug dependence: its significance and characteristics. Psychopharmacology Bulletin 3(3): 1-12

Guedes, I.A.; Costa, L.S.C.; Dos Santos, K.B.; Karl, A.L.M.; Rocha, Gório.K.; Teixeira, I.M.; Galheigo, M.M.; Medeiros, V.; Krempser, E.; Custódio, Fábio.L.; Barbosa, H.J.C.; Nicolás, M.F.; Dardenne, L.E. 2021: Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants. Scientific Reports 11(1): 5543

Tou, W.Ieong.; Chang, S-Sen.; Lee, C-Chun.; Chen, C.Yu-Chian. 2013: Drug design for neuropathic pain regulation from traditional Chinese medicine. Scientific Reports 3: 844

Lee, C-Jin.; Liang, X.; Wu, Q.; Najeeb, J.; Zhao, J.; Gopalaswamy, R.; Titecat, M.; Sebbane, F.; Lemaitre, N.; Toone, E.J.; Zhou, P. 2016: Drug design from the cryptic inhibitor envelope. Nature Communications 7: 10638

Da Silva, A.P.; Chiari, L.P.A.; Guimaraes, A.R.; Honorio, K.M.; da Silva, A.ér.B.F. 2021: Drug design of new 5-HT6R antagonists aided by artificial neural networks. Journal of Molecular Graphics and Modelling 104: 107844

Taylor, G. 1993: Drug design. A rational attack on influenza. Nature 363(6428): 401-402

Brady, L.; Dodson, G. 1994: Drug design. Reflections on a peptide. Nature 368(6473): 692-693

Mann, J. 1995: Drug design. Rules for the manipulation of polyketides. Nature 375(6532): 533-534

Crunkhorn, S. 2016: Drug design: Cannabinoid receptor structure revealed. Nature Reviews. Drug Discovery 15(12): 822

Eisenstein, M. 2018: Drug designers embrace cryo-EM. Nature Biotechnology 36(7): 557-558

Rutter, D.V. 1998: Drug designers in anaesthesia. Anaesthesia 53(4): 405

Batool, A.; Bibi, N.; Amin, F.; Kamal, M.A. 2021: Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach. European Journal of Pharmacology 892: 173779

Coumbis, R.J.; Albano, E.H.; Lyons, M. 1970: Drug detection in urines of commercial blood bank donors. JAMA 214(3): 596

Belsey, M.J. 2007: Drug developer strategies to boost competitiveness. Nature Reviews. Drug Discovery 6(4): 265-266

Chi, K.Rae. 2016: Drug developers delve into the cell's trash-disposal machinery. Nature Reviews. Drug Discovery 15(5): 295-297

Willyard, C. 2011: Drug developers explore vitamin D benefits without the vitamin. Nature Medicine 17(1): 9

Sheridan, C. 2016: Drug developers refocus efforts on RAS. Nature Biotechnology 34(3): 217-218

Sheridan, C. 2019: Drug developers switch gears to inhibit STING. Nature Biotechnology 37(3): 199-201

Hohl, R.J. 2014: Drug development (and academic medicine): charting the course forward. Clinical Pharmacology and Therapeutics 96(5): 519-522

Rubin, E.H.; Gilliland, D.Gary. 2012: Drug development and clinical trials--the path to an approved cancer drug. Nature Reviews. Clinical Oncology 9(4): 215-222

Woosley, R.L.; Cossman, J. 2007: Drug development and the FDA's Critical Path Initiative. Clinical Pharmacology and Therapeutics 81(1): 129-133

Bertsch, T.G.; Denton, T.T.; Perea, N.M.; Ahmed, A.; McKeirnan, K.C. 2021: Drug development and the process of transitioning to team-based learning in a qualitative way. Currents in Pharmacy Teaching and Learning 13(6): 723-728

McCracken, J.T.; Anagnostou, E.; Arango, C.; Dawson, G.; Farchione, T.; Mantua, V.; McPartland, J.; Murphy, D.; Pandina, G.; Veenstra-VanderWeele, J. 2021: Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 48: 3-31

Pangalos, M.N.; Schechter, L.E.; Hurko, O. 2007: Drug development for CNS disorders: strategies for balancing risk and reducing attrition. Nature Reviews. Drug Discovery 6(7): 521-532

Reynolds, K.S. 2009: Drug development for emerging infections. Clinical Pharmacology and Therapeutics 86(3): 225-229

Berry-Kravis, E.M.; Lindemann, L.; Jønch, A.E.; Apostol, G.; Bear, M.F.; Carpenter, R.L.; Crawley, J.N.; Curie, A.; Des Portes, V.; Hossain, F.; Gasparini, F.; Gomez-Mancilla, B.; Hessl, D.; Loth, E.; Scharf, S.H.; Wang, P.P.; Von Raison, F.; Hagerman, R.; Spooren, W.; Jacquemont, Sébastien. 2018: Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nature Reviews. Drug Discovery 17(4): 280-299

Varela-Nieto, I.; Murillo-Cuesta, S.; Calvino, M.; Cediel, R.; Lassaletta, L. 2020: Drug development for noise-induced hearing loss. Expert Opinion on Drug Discovery 15(12): 1457-1471

Teo, M.Yuen.; O'Shaughnessy, M.J.; McBride, S.M.; Vargas, H.A.; Scher, H.I. 2018: Drug development for noncastrate prostate cancer in a changed therapeutic landscape. Nature Reviews. Clinical Oncology 15(3): 168-182

Teo, M.Yuen.; O'Shaughnessy, M.J.; McBride, S.M.; Vargas, H.A.; Scher, H.I. 2018: Drug development for noncastrate prostate cancer in a changed therapeutic landscape. Nature Reviews. Clinical Oncology 15(3): 150

Jiang, K. 2013: Drug development for progeria yields insights into normal aging. Nature Medicine 19(5): 515

Molinski, T.F.; Dalisay, D.S.; Lievens, S.L.; Saludes, J.P. 2009: Drug development from marine natural products. Nature Reviews. Drug Discovery 8(1): 69-85

Arango, C. 2021: Drug development in ASD, an ISCTM-ECNP joint adventure. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 48: 1-2

Woodcock, J. 2014: Drug development in serious diseases: the new "breakthrough therapy" designation. Clinical Pharmacology and Therapeutics 95(5): 483-485

Luo, Z-Wei.; Ovcjak, A.; Wong, R.; Yang, B-Xue.; Feng, Z-Ping.; Sun, H-Shuo. 2020: Drug development in targeting ion channels for brain edema. Acta Pharmacologica Sinica 41(10): 1272-1288

Dugger, S.A.; Platt, A.; Goldstein, D.B. 2018: Drug development in the era of precision medicine. Nature Reviews. Drug Discovery 17(3): 183-196

Fitzgerald, G. 2010: Drug development needs a new brand of science. Nature 468(7326): 869

Comoglio, P.M.; Giordano, S.; Trusolino, L. 2008: Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nature Reviews. Drug Discovery 7(6): 504-516

Do, A.; Ilagan-Ying, Y.C.; Mehal, W.Z.; Lim, J.K. 2020: Drug development of nonalcoholic fatty liver disease: challenges in research, regulatory pathways, and study endpoints. Expert Opinion on Drug Discovery 2020: 1-10

Lalonde, R.L.; Wagner, J.A. 2009: Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment. Clinical Pharmacology and Therapeutics 86(5): 557-561

Baras, A.I.; Baras, A.S.; Schulman, K.A. 2012: Drug development risk and the cost of capital. Nature Reviews. Drug Discovery 11(5): 347-348

Holt, P.G.; Sly, P.D.; Martinez, F.D.; Weiss, S.T.; Björkstén, B.; von Mutius, E.; Wahn, U. 2004: Drug development strategies for asthma: in search of a new paradigm. Nature Immunology 5(7): 695-698

Ito, T.; May, W.S. 1996: Drug development train gathering steam. Nature Medicine 2(4): 403-404

Gershon, D. 1992: Drug development. Orphan drug windfalls?. Nature 355(6359): 381

Maxmen, A. 2013: Drug development: A combined effort. Nature 502(7470): S4-S6

Morgan, B. 2016: Drug development: A healthy pipeline. Nature 533(7603): S116-S117

Zhang, W.; Sidhu, S.S. 2018: Drug development: Allosteric inhibitors hit USP7 hard. Nature Chemical Biology 14(2): 110-111

Cully, M. 2013: Drug development: Chemical brace. Nature 503(7475): S10-S12

Chakma, J. 2013: Drug development: Educate physicians about investor types. Nature 494(7437): 314

Eisenstein, M. 2012: Drug development: Holding out for reinforcements. Nature 484(7395): S16-S18

Cully, M. 2014: Drug development: Illuminated targets. Nature 511(7508): S12-S13

Bishai, W.R. 2017: Drug development: Locking down metabolism. Nature Chemical Biology 13(9): 925-926

Hubbell, J.A. 2010: Drug development: Longer-lived proteins. Nature 467(7319): 1051-1052

Scudellari, M. 2015: Drug development: Mix and match. Nature 521(7551): S12-S14

Begley, C.Glenn.; Ellis, L.M. 2012: Drug development: Raise standards for preclinical cancer research. Nature 483(7391): 531-533

Weintraub, K. 2013: Drug development: Releasing the brakes. Nature 504(7480): S6-S8

Paulson, T. 2014: Drug development: Searching for patterns. Nature 507(7490): S10-S11

Katsnelson, A. 2014: Drug development: The modelling challenge. Nature 508(7494): S8-S9

Owens, B. 2015: Drug development: The treasure chest. Nature 525(7570): S6-S8

DeWeerdt, S. 2016: Drug development: Through the barrier. Nature 537(7621): S154-S157

May, M. 2014: Drug development: Time for teamwork. Nature 509(7498): S4-S5

Hoag, H. 2014: Drug development: a chance of survival. Nature 515(7527): S118-S120

Humphries, C. 2014: Drug development: a complicated path. Nature 515(7526): S4-S5

Katsnelson, A. 2013: Drug development: target practice. Nature 498(7455): S8-S9

Scudellari, M. 2014: Drug development: try and try again. Nature 516(7529): S4-S6

Zini, J.; Kekkonen, J.; Kaikkonen, V.A.; Laaksonen, T.; Keränen, P.; Talala, T.; Mäkynen, A.J.; Yliperttula, M.; Nissinen, I. 2021: Drug diffusivities in nanofibrillar cellulose hydrogel by combined time-resolved Raman and fluorescence spectroscopy. Journal of Controlled Release: Official Journal of the Controlled Release Society 334: 367-375

Belleudi, V.; Poggi, F.R.; Perna, S.; Naldi, L.; Bortolus, R.; Rosa, A.C.; Kirchmayer, U.; Davoli, M.; Addis, A. 2020: Drug discontinuation in pregnant women with psoriasis: the PSO-MOTHER cohort study. Pharmacoepidemiology and Drug Safety 29(8): 904-912

Bakke, O.M.; Wardell, W.M.; Lasagna, L. 1984: Drug discontinuations in the United Kingdom and the United States, 1964 to 1983: issues of safety. Clinical Pharmacology and Therapeutics 35(5): 559-567

Clearfield, H.R. 1982: Drug dissolution of gallstones. Medical Trial Technique Quarterly 29(2): 209-213

Flaherty, S.M.; Russell, I.J.; Lukashkin, A.N. 2021: Drug distribution along the cochlea is strongly enhanced by low-frequency round window micro vibrations. Drug Delivery 28(1): 1312-1320

Khare, A.K. 1998: Drug donations to developing countries. Africa Health 21(1): 8-9

Smith, N.A. 2021: Drug dosage in patients with obesity: Investigation of lean body mass. Anaesthesia and Intensive Care 49(6): 486-488

Ochs, H.R. 1981: Drug dosage in the aged. Die Medizinische Welt 32(7): 225-228

Abduljalil, K.; Badhan, R.K.S. 2020: Drug dosing during pregnancy-opportunities for physiologically based pharmacokinetic models. Journal of Pharmacokinetics and Pharmacodynamics 47(4): 319-340

Wells, M.; Goldstein, L. 2020: Drug dosing errors in simulated paediatric emergencies - Comprehensive dosing guides outperform length-based tapes with precalculated drug doses. African Journal of Emergency Medicine: Revue Africaine de la Medecine d'Urgence 10(2): 74-80

Coats, A.J.S. 2019: Drug dosing for heart failure: does sex or size matter?. Nature Reviews. Cardiology 16(12): 705-706

Sprangers, B.; Sandhu, G.; Rosner, M.H.; Tesarova, P.; Stadler, W.M.; Malyszko, J. 2021: Drug dosing in cancer patients with decreased kidney function: a practical approach. Cancer Treatment Reviews 93: 102139

Brater, D.C. 2009: Drug dosing in patients with impaired renal function. Clinical Pharmacology and Therapeutics 86(5): 483-489

Erstad, B.L.; Barletta, J.F. 2020: Drug dosing in the critically ill obese patient-a focus on sedation, analgesia, and delirium. Critical Care 24(1): 315

Erstad, B.L.; Barletta, J.F. 2021: Drug dosing in the critically ill obese patient: a focus on medications for hemodynamic support and prophylaxis. Critical Care 25(1): 77

Duke, E.J.; Glassman, E. 1968: Drug effects in Drosophila: streptomycin sensitive strains and fluorouracil resistant strains. Nature 220(5167): 588-589

Guidi, A.; Petrella, G.; Fustaino, V.; Saccoccia, F.; Lentini, S.; Gimmelli, R.; Di Pietro, G.; Bresciani, A.; Cicero, D.O.; Ruberti, G. 2020: Drug effects on metabolic profiles of Schistosoma mansoni adult male parasites detected by 1H-NMR spectroscopy. Plos Neglected Tropical Diseases 14(10): E0008767

Xia, X. 2020: Drug efficacy and toxicity prediction: an innovative application of transcriptomic data. Cell Biology and Toxicology 36(6): 591-602

Changal, K.H.; Mir, T.; Khan, S.; Nazir, S.; Elzanatey, A.; Meenakshisundaram, C.; Mubbasher, S.; Sheikh, M.A. 2021: Drug-Eluting Stents Versus Bare-Metal Stents in Large Coronary Artery Revascularization: Systematic Review and Meta-Analysis. Cardiovascular Revascularization Medicine: Including Molecular Interventions 23: 42-49

Ludwig, C.; Goh, V.; Rajkumar, J.; Au, J.; Tsoukas, M. 2020: Drug eruptions associated with tumor therapy: Great imitators. Clinics in Dermatology 38(2): 208-215

Shin, H.T.; Chang, M.W. 2001: Drug eruptions in children. Current Problems in Pediatrics 31(7): 207-234

Chu, C.-Y. 2020: Drug eruptions: Great imitators. Clinics in Dermatology 38(2): 193-207

O'connor Donelan, T.D. 1954: Drug eruptions: old and new. Journal of the Irish Medical Association 35(206): 229-230

Drummond, M. 1954: Drug eruptions: old and new. Journal of the Irish Medical Association 35(206): 230-231

Li, X.; Li, Y.; Guo, S.; Liu, W. 2020: Drug evaluation and pharmaceutical care in a critically ill COVID-19 patient. International Journal of Clinical Pharmacology and Therapeutics 58(10): 568-574

López-Briz, E.; Fraga-Fuentes, M.ª D.; Clopés-Estela, A.; Ortega-Eslava, A.; Alegre-Del Rey, E.J.ús. 2020: Drug evaluation is also a clinical activity. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 45(1): 45-47

Gründemann, D.; Gorboulev, V.; Gambaryan, S.; Veyhl, M.; Koepsell, H. 1994: Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372(6506): 549-552

More, B. 2018: Drug executives should take a Hippocratic oath. Nature 555(7698): 561

More, B. 2018: Drug executives should take a Hippocratic oath. Nature 555(7698): 561

Yao, X-Qiu.; Kenzaki, H.; Murakami, S.; Takada, S. 2010: Drug export and allosteric coupling in a multidrug transporter revealed by molecular simulations. Nature Communications 1: 117

Such-Díaz, A.; Díaz-Marín, C.; Sánchez-Pérez, R.; Iglesias-Peinado, I. 2020: Drug exposure associated with exacerbation of symptoms in patients with myasthenia gravis. Revista de Neurologia 71(4): 143-150

Iacobelli, S.; Lorrain, S.; Gouyon, B.éa.; Gambacorta, S.; Laforgia, N.; Gouyon, J.-B.; Bonsante, F. 2020: Drug exposure for PDA closure in France: a prospective, cohort-based, analysis. European Journal of Clinical Pharmacology 76(12): 1765-1772

Gerber, D.E.; Putnam, W.C. 2021: Drug exposure: still relevant after all these years. Oncotarget 12(8): 721-722

Zhang, X.; Zhao, M.; Zheng, C. 2021: Drug fever induced by carboplatin-based regimens: Higher incidence in a women's hospital. Taiwanese Journal of Obstetrics and Gynecology 60(5): 882-887

Butler, D. 2012: Drug firm to share raw trial data. Nature 490(7420): 322

Towie, N. 2005: Drug firms donate compounds for anti-HIV gel. Nature 438(7064): 6-7

Wang, P.-H. 2020: Drug for heart is applicable to liver: Is it possible?. Journal of the Chinese Medical Association: Jcma 83(12): 1057-1058

Wadman, M. 2005: Drug giants fail to name compounds in trial database. Nature 435(7042): 548

Firestone, R.A. 2006: Drug giants hamstrung by timid middle management. Nature 441(7091): 282

Ledford, H. 2010: Drug giants turn their backs on RNA interference. Nature 468(7323): 487

Kiiski, I.; Ollikainen, E.; Artes, S.; Järvinen, P.äi.; Jokinen, V.; Sikanen, T. 2021: Drug glucuronidation assays on human liver microsomes immobilized on microfluidic flow-through reactors. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 158: 105677

Villani, A.; Costa, C.; Fabbrocini, G.; Scalvenzi, M. 2020: Drug holiday regimen for vismodegib treatment in patients with multiple primary basal cell carcinomas. Dermatologic Therapy 33(4): E13707

Eisenstein, M. 2021: Drug hunters uncloak the non-coding 'hidden' genome. Nature Biotechnology 39(10): 1169-1171

Scheckel, C.J.; Vincent Rajkumar, S. 2021: Drug importation: limitations of current proposals and opportunities for improvement. Blood Cancer Journal 11(7): 132

Bayer, R. 1953: Drug induced acceleration of the opening of the isthmic cervical segment in labor. Zentralblatt für Gynakologie 75(37): 1444-1456

Black, M. 1983: Drug induced liver disease. Postgraduate Medical Journal 59(Suppl 4): 116-122

Zuberi, S.J. 1981: Drug induced liver disease. JPMA. Journal of the Pakistan Medical Association 31(2): 32-33

Pannier, R. 1983: Drug induced lung disease. European Journal of Respiratory Diseases. Suppl 126: 151-156

Abu-El-Haija, M.; Hornung, L.; Lin, T.K.; Nathan, J.D.; Thompson, T.; Vitale, D.S.; Nasr, A.; Husain, S.Z.; Denson, L. 2020: Drug induced pancreatitis is the leading known cause of first attack acute pancreatitis in children. Pancreatology: Official Journal of the International Association of Pancreatology . 20(6): 1103-1108

Takimoto, R.; Takamori, K. 2004: Drug induced toxic epidermal necrolysis. Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 5): 515-518

Schweiger, J.; Phillips, K.; Patel, A.; Echols, C. 2022: Drug induced very severe hypertriglyceridemia in a pediatric stem cell transplant recipient. Pediatric Blood and Cancer 69(2): E29379

Oligino, T.; Poliani, P.L.; Wang, Y.; Tsai, S.Y.; O'Malley, B.W.; Fink, D.J.; Glorioso, J.C. 1998: Drug inducible transgene expression in brain using a herpes simplex virus vector. Gene Therapy 5(4): 491-496

Rogers, P.G. 1987: Drug information for patients. Lancet 1(8536): 810-811

Giovanazzi, A.; Miselli, M.; Poggiolini, D. 1988: Drug information for patients. Lancet 1(8581): 362

Hill, J. 1980: Drug information for patients. Canadian Medical Association Journal 122(4): 395 399

Macleod, S.M. 1980: Drug information for patients. Canadian Medical Association Journal 122(4): 399

Maywald, U.; Schindler, C.; Bux, Y.; Kirch, W. 2005: Drug information for patients -- unmet needs, evaluation and influence on the compliance. Deutsche Medizinische Wochenschrift 130(24): 1485-1490

Lumholtz, I.B. 1979: Drug information: agents for the treatment of gynecologic diseases. Hormone substitution in the climacteric. Sygeplejersken 79(36): 17

Lumholtz, I.B. 1979: Drug information: agents for the treatment of gynecologic diseases. Hormone substitution in the climacteric. Sygeplejersken 79(38): 10

Karimi, S.E.; Zanjari, N.; SoleimanvandiAzar, N.; Ahounbar, E.; Mohammadi Gharehghani, M.A.; Ahmadi, S. 2021: Drug injection and associated factors among the elderly living with HIV/AIDS in Tehran, Iran. Medical Journal of the Islamic Republic of Iran 35: 55

Skomsvoll, J.F.; Wallenius, M.; Koksvik, H.S.; Rødevand, E.; Salvesen, K.A.; Spigset, O.; Kvien, T.K. 2007: Drug insight: Anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation. Nature Clinical Practice. Rheumatology 3(3): 156-164

Chapurlat, R.D.; Delmas, P.D. 2006: Drug insight: Bisphosphonates for postmenopausal osteoporosis. Nature Clinical Practice. Endocrinology and Metabolism 2(4): 211-9; Quiz Following 238

Colao, A.; Di Sarno, A.; Guerra, E.; De Leo, M.; Mentone, A.; Lombardi, G. 2006: Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women. Nature Clinical Practice. Endocrinology and Metabolism 2(4): 200-210

Keith, W.Nicol.; Bilsland, A.; Hardie, M.; Evans, T.R.Jeffry. 2004: Drug insight: Cancer cell immortality-telomerase as a target for novel cancer gene therapies. Nature Clinical Practice. Oncology 1(2): 88-96

Gurbel, P.A.; Tantry, U.S. 2006: Drug insight: Clopidogrel nonresponsiveness. Nature Clinical Practice. Cardiovascular Medicine 3(7): 387-395

Olanow, C.Warren.; Obeso, Jé.A.; Stocchi, F. 2006: Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease. Nature Clinical Practice. Neurology 2(7): 382-392

Mulder, J.E.; Kolatkar, N.S.; LeBoff, M.S. 2006: Drug insight: Existing and emerging therapies for osteoporosis. Nature Clinical Practice. Endocrinology and Metabolism 2(12): 670-680

Kelly, W.Kevin.; Marks, P.A. 2005: Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid. Nature Clinical Practice. Oncology 2(3): 150-157

Borer, J.S. 2004: Drug insight: If inhibitors as specific heart-rate-reducing agents. Nature Clinical Practice. Cardiovascular Medicine 1(2): 103-109

Steffens, S.; Mach, Fçois. 2006: Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients?. Nature Clinical Practice. Nephrology 2(7): 378-387

Beuers, U. 2006: Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nature Clinical Practice. Gastroenterology and Hepatology 3(6): 318-328

Oo, T.H.; Hesketh, P.J. 2005: Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting. Nature Clinical Practice. Oncology 2(4): 196-201

Cernea, S.; Herold, K.C. 2006: Drug insight: New immunomodulatory therapies in type 1 diabetes. Nature Clinical Practice. Endocrinology and Metabolism 2(2): 89-98

Fung, S.K.; Lok, A.S.F. 2004: Drug insight: Nucleoside and nucleotide analog inhibitors for hepatitis B. Nature Clinical Practice. Gastroenterology and Hepatology 1(2): 90-97

Katznelson, L. 2006: Drug insight: Primary medical therapy of acromegaly. Nature Clinical Practice. Endocrinology and Metabolism 2(2): 109-17; Quiz Following 117

Amory, J.K.; Page, S.T.; Bremner, W.J. 2006: Drug insight: Recent advances in male hormonal contraception. Nature Clinical Practice. Endocrinology and Metabolism 2(1): 32-41

Santoro, M.; Carlomagno, F. 2006: Drug insight: Small-molecule inhibitors of protein kinases in the treatment of thyroid cancer. Nature Clinical Practice. Endocrinology and Metabolism 2(1): 42-52

Raffel, O.Christopher.; White, H.D. 2006: Drug insight: Statin use in the elderly. Nature Clinical Practice. Cardiovascular Medicine 3(6): 318-328

Bhasin, S.; Calof, O.M.; Storer, T.W.; Lee, M.L.; Mazer, N.A.; Jasuja, R.; Montori, V.M.; Gao, W.; Dalton, J.T. 2006: Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nature Clinical Practice. Endocrinology and Metabolism 2(3): 146-159

Kojima, M.; Kangawa, K. 2006: Drug insight: The functions of ghrelin and its potential as a multitherapeutic hormone. Nature Clinical Practice. Endocrinology and Metabolism 2(2): 80-88

Mackler, N.J.; Pienta, K.J. 2005: Drug insight: Use of docetaxel in prostate and urothelial cancers. Nature Clinical Practice. Urology 2(2): 92

Schneider, B.P.; Sledge, G.W. 2007: Drug insight: VEGF as a therapeutic target for breast cancer. Nature Clinical Practice. Oncology 4(3): 181-189

Larkin, J.M.G.; Chowdhury, S.; Gore, M.E. 2007: Drug insight: advances in renal cell carcinoma and the role of targeted therapies. Nature Clinical Practice. Oncology 4(8): 470-479

Fosang, A.J.; Little, C.B. 2008: Drug insight: aggrecanases as therapeutic targets for osteoarthritis. Nature Clinical Practice. Rheumatology 4(8): 420-427

Kalidindi, S.R.; Tang, W.H.Wilson.; Francis, G.S. 2007: Drug insight: aldosterone-receptor antagonists in heart failure--the journey continues. Nature Clinical Practice. Cardiovascular Medicine 4(7): 368-378

Nielsen, O.H.; Munck, L.K. 2007: Drug insight: aminosalicylates for the treatment of IBD. Nature Clinical Practice. Gastroenterology and Hepatology 4(3): 160-170

Hering, D.; Piper, C.; Horstkotte, D. 2005: Drug insight: an overview of current anticoagulation therapy after heart valve replacement. Nature Clinical Practice. Cardiovascular Medicine 2(8): 415-422

Chang, J.T.; Lichtenstein, G.R. 2006: Drug insight: antagonists of tumor-necrosis factor-alpha in the treatment of inflammatory bowel disease. Nature Clinical Practice. Gastroenterology and Hepatology 3(4): 220-228

Langford, C.A. 2008: Drug insight: anti-tumor necrosis factor therapies for the vasculitic diseases. Nature Clinical Practice. Rheumatology 4(7): 364-370

Henderson, C.; Davis, J.C. 2006: Drug insight: anti-tumor-necrosis-factor therapy for ankylosing spondylitis. Nature Clinical Practice. Rheumatology 2(4): 211-218

Reinacher-Schick, A.; Pohl, M.; Schmiegel, W. 2008: Drug insight: antiangiogenic therapies for gastrointestinal cancers--focus on monoclonal antibodies. Nature Clinical Practice. Gastroenterology and Hepatology 5(5): 250-267

Helft, Gérard.; Gilard, M.; Le Feuvre, C.; Zaman, A.G. 2006: Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation. Nature Clinical Practice. Cardiovascular Medicine 3(12): 673-680

Patrono, C.; Rocca, B. 2007: Drug insight: aspirin resistance--fact or fashion?. Nature Clinical Practice. Cardiovascular Medicine 4(1): 42-50

Maree, A.O.; Cox, D.; Fitzgerald, D.J. 2007: Drug insight: aspirin resistance-fact or fashion?. Nature Clinical Practice. Cardiovascular Medicine 4(3): E1; Author Reply E2

Rothman, M.T. 2005: Drug insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options. Nature Clinical Practice. Cardiovascular Medicine 2(9): 465-474

Reed, J.C. 2006: Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms. Nature Clinical Practice. Oncology 3(7): 388-398

Spektor, G.; Fuster, V. 2005: Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now?. Nature Clinical Practice. Cardiovascular Medicine 2(6): 290-300

Hinz, B.; Renner, B.; Brune, K. 2007: Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal. Nature Clinical Practice. Rheumatology 3(10): 552-60; Quiz 1 P Following 589

Rigby, W.F.C. 2007: Drug insight: different mechanisms of action of tumor necrosis factor antagonists-passive-aggressive behavior?. Nature Clinical Practice. Rheumatology 3(4): 227-233

Heneka, M.T.; Landreth, G.E.; Hüll, M. 2007: Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders. Nature Clinical Practice. Neurology 3(9): 496-504

Faderl, S.; Kantarjian, H.M. 2005: Drug insight: emerging new drugs in the treatment of myelodysplastic syndromes. Nature Clinical Practice. Oncology 2(7): 348-355

Loriot, Y.; Perlemuter, G.; Malka, D.; Penault-Llorca, Fédérique.; Penault-Lorca, Fédérique.; Boige, Vérie.; Deutsch, E.; Massard, C.; Armand, J.Pierre.; Soria, J-Charles. 2008: Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy. Nature Clinical Practice. Oncology 5(5): 268-278

Dunaif, A. 2008: Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome--a reappraisal. Nature Clinical Practice. Endocrinology and Metabolism 4(5): 272-283

Samaniego, M.; Becker, B.N.; Djamali, A. 2006: Drug insight: maintenance immunosuppression in kidney transplant recipients. Nature Clinical Practice. Nephrology 2(12): 688-699

Fantini, M.C.; Becker, C.; Kiesslich, R.; Neurath, M.F. 2006: Drug insight: novel small molecules and drugs for immunosuppression. Nature Clinical Practice. Gastroenterology and Hepatology 3(11): 633-644

Salama, A.D.; Pusey, C.D. 2006: Drug insight: rituximab in renal disease and transplantation. Nature Clinical Practice. Nephrology 2(4): 221-230

Taplin, M-Ellen. 2007: Drug insight: role of the androgen receptor in the development and progression of prostate cancer. Nature Clinical Practice. Oncology 4(4): 236-244

McMaster, A.; Ray, D.W. 2008: Drug insight: selective agonists and antagonists of the glucocorticoid receptor. Nature Clinical Practice. Endocrinology and Metabolism 4(2): 91-101

Bhuket, T.P.; Higgins, P.D.R. 2006: Drug insight: statins and gastrointestinal cancer. Nature Clinical Practice. Gastroenterology and Hepatology 3(10): 552-562

Lipinski, M.J.; Abbate, A.; Fuster, V.; Vetrovec, G.W. 2007: Drug insight: statins for nonischemic heart failure--evidence and potential mechanisms. Nature Clinical Practice. Cardiovascular Medicine 4(4): 196-205

Srinivas-Shankar, U.; Wu, F.C.W. 2006: Drug insight: testosterone preparations. Nature Clinical Practice. Urology 3(12): 653-665

Kumar, S.; Anderson, K.C. 2005: Drug insight: thalidomide as a treatment for multiple myeloma. Nature Clinical Practice. Oncology 2(5): 262-270

Taylor, R.P.; Lindorfer, M.A. 2007: Drug insight: the mechanism of action of rituximab in autoimmune disease--the immune complex decoy hypothesis. Nature Clinical Practice. Rheumatology 3(2): 86-95

Wong, F. 2007: Drug insight: the role of albumin in the management of chronic liver disease. Nature Clinical Practice. Gastroenterology and Hepatology 4(1): 43-51

Gotto, A.M.; Farmer, J.A. 2006: Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol. Nature Clinical Practice. Cardiovascular Medicine 3(12): 664-672

Panchapakesan, U.; Chen, X-Ming.; Pollock, C.A. 2005: Drug insight: thiazolidinediones and diabetic nephropathy--relevance to renoprotection. Nature Clinical Practice. Nephrology 1(1): 33-43

Sanossian, N.; Ovbiagele, B. 2008: Drug insight: translating evidence on statin therapy into clinical benefits. Nature Clinical Practice. Neurology 4(1): 43-49

Moss, M.L.; Sklair-Tavron, L.; Nudelman, R. 2008: Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis. Nature Clinical Practice. Rheumatology 4(6): 300-309

Hohlfeld, R.; Wekerle, H. 2005: Drug insight: using monoclonal antibodies to treat multiple sclerosis. Nature Clinical Practice. Neurology 1(1): 34-44

Cooney, M.M.; van Heeckeren, W.; Bhakta, S.; Ortiz, J.; Remick, S.C. 2006: Drug insight: vascular disrupting agents and angiogenesis--novel approaches for drug delivery. Nature Clinical Practice. Oncology 3(12): 682-692

Brown, A.J.; Slatopolsky, E. 2007: Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. Nature Clinical Practice. Endocrinology and Metabolism 3(2): 134-144

Sanzenbacher, G.T.; Wettstein, G. 2020: Drug insurance and the strategic behavior of drug manufacturers: Evergreening and generic entry after Medicare Part D. Journal of Health Economics 72: 102332

Jonkman, S.; Pelloux, Y.; Everitt, B.J. 2012: Drug intake is sufficient, but conditioning is not necessary for the emergence of compulsive cocaine seeking after extended self-administration. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 37(7): 1612-1619

Mori, T.; Aisa, Y.; Kato, J.; Nakamura, Y.; Ikeda, Y.; Okamoto, S. 2009: Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplantation 44(6): 371-374

Mori, T.; Kato, J.; Yamane, A.; Ono, Y.; Shimizu, T.; Okamoto, S. 2011: Drug interaction between voriconazole and tacrolimus in allogeneic hematopoietic SCT recipients. Bone Marrow Transplantation 46(3): 450-451

Bilek, O.; Holanek, M.; Jurica, J.; Stepankova, S.; Vasina, J.; Selingerova, I.; Poprach, A.; Borilova, S.; Kazda, T.; Kiss, I.; Zdrazilova-Dubska, L. 2021: Drug interaction profile of TKi alectinib allows effective and safe treatment of ALK+ lung cancer in the kidney transplant recipient. International Immunopharmacology 99: 108012

Huang, S-M.; Temple, R.; Throckmorton, D.C.; Lesko, L.J. 2007: Drug interaction studies: study design, data analysis, and implications for dosing and labeling. Clinical Pharmacology and Therapeutics 81(2): 298-304

Yuk, J.H.; Williams, T.W. 1991: Drug interaction with quinolone antibiotics in intensive care unit patients. Archives of Internal Medicine 151(3): 619

Yeh, P.J.; Hegreness, M.J.; Aiden, A.Presser.; Kishony, R. 2009: Drug interactions and the evolution of antibiotic resistance. Nature Reviews. Microbiology 7(6): 460-466

Orme, M.L.; Back, D.J. 1986: Drug interactions between oral contraceptive steroids and antibiotics. British Dental Journal 160(5): 169-170

Oswald, S.; Nassif, A.; Modess, C.; Keiser, M.; Ulrich, A.; Runge, D.; Hanke, U.; Lütjohann, D.; Engel, A.; Weitschies, W.; Siegmund, W. 2011: Drug interactions between the immunosuppressant tacrolimus and the cholesterol absorption inhibitor ezetimibe in healthy volunteers. Clinical Pharmacology and Therapeutics 89(4): 524-528

Djuricich, P.; Vázquez, E. 2009: Drug interactions chart. An abbreviated, at-a-glance guide to HIV drug interactions. Positively Aware: the Monthly Journal of the Test Positive Aware Network 20(2): 56-58

Rogero-Blanco, Eísa.; Del-Cura-González, I.; Aza-Pascual-Salcedo, M.; García de Blas González, F.; Terrón-Rodas, C.; Chimeno-Sánchez, S.; García-Domingo, E.; López-Rodríguez, J.A. 2021: Drug interactions detected by a computer-assisted prescription system in primary care patients in Spain: MULTIPAP study. European Journal of General Practice 27(1): 90-96

Forgerini, M.; Schiavo, G.; Lucchetta, R.C.; Mastroianni, P.íc.d.C. 2021: Drug interactions for elderly people with mental and behavioral disorders: a systematic scoping review. Archives of Gerontology and Geriatrics 93: 104283

Castro-Moraga, M.ía.E.; Campos L, A.; Figueroa V, C.; Yizmeyián M, A.í; Piñera M, C. 2021: Drug interactions in HIV-infected children undergoing treatment with antiretrovirals. Andes Pediatrica: Revista Chilena de Pediatria 92(3): 446-454

Ghoneim, M.M. 1971: Drug interactions in anesthesia. Journal of the Iowa Medical Society 61(5): 294 Passim

Chadha, M. 2005: Drug interactions in anesthesia. Middle East Journal of Anaesthesiology 18(3): 457-475

Wulf, H. 1991: Drug interactions in bupivacaine-induced cardiotoxicity. Regional Anesthesia 16(2): 116-117

Scripture, C.D.; Figg, W.D. 2006: Drug interactions in cancer therapy. Nature Reviews. Cancer 6(7): 546-558

Torres, J.H.; Bons, P.; Bayssière, J.; Blayac, J.P.; Boucard, R. 1990: Drug interactions in dentistry. Actualites Odonto-Stomatologiques 44(171): 407-413

Caldarone, C.V. 1974: Drug interactions in dentistry. Journal of the Rhode Island State Dental Society 7(1): 3-4

Dawoud, B.E.S.; Roberts, A.; Yates, J.M. 2014: Drug interactions in general dental practice--considerations for the dental practitioner. British Dental Journal 216(1): 15-23

Callahan, A.M.; Fava, M.; Rosenbaum, J.F. 1993: Drug interactions in psychopharmacology. Psychiatric Clinics of North America 16(3): 647-671

Kuprash, L.P.; Zaika, M.U. 1985: Drug interactions in the elderly. Meditsinskaia Sestra 44(10): 26-29

Fabre, J.; Dayer, P.; Leemann, T. 1985: Drug interactions in the elderly. Therapeutische Umschau. Revue Therapeutique 42(12): 831-836

Leather, H.L. 2004: Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know. Bone Marrow Transplantation 33(2): 137-152

Mullin, J.M.; Schrogie, J.J. 2013: Drug interactions produced by proton pump inhibitors: not simply a pH effect. Clinical Pharmacology and Therapeutics 93(2): 150

Fletcher, C.V. 2010: Drug interactions should be evaluated in patients. Clinical Pharmacology and Therapeutics 88(5): 585-587

Fancher, K.M.; Pappacena, J.J. 2020: Drug interactions with Bruton's tyrosine kinase inhibitors: clinical implications and management. Cancer ChemoTherapy and Pharmacology 86(4): 507-515

Cromdos, S. 1981: Drug interactions with cimetidine. Australian Nurses' Journal. Royal Australian Nursing Federation 11(2): 34; 40

Schwinghammer, T.L. 1981: Drug interactions with cimetidine. American Journal of Hospital Pharmacy 38(12): 1976-1978

Hall, D.; Kraus, F.; Rudolph, W. 1993: Drug interactions with digitalis glycosides. Herz 18(2): 124-134

Kowalsky, S.F. 1990: Drug interactions with fluconazole. PharmacoTherapy 10(6): 170s-173s

Jobski, K.; Hoffmann, F.; Herget-Rosenthal, S.; Dörks, M. 2020: Drug interactions with oral anticoagulants in German nursing home residents: comparison between vitamin K antagonists and non-vitamin K antagonist oral anticoagulants based on two nested case-control studies. Clinical Research in Cardiology: Official Journal of the German Cardiac Society 109(4): 465-475

Back, D.J.; Breckenridge, A.M.; Orme, M.L. 1983: Drug interactions with oral contraceptive steroids. Ippf Medical Bulletin 17(1): 1-2

Ho, V.; Tee, C.; See, K.C. 2020: Drug interactions with potential antivirals used for COVID-19 in older persons. Geriatrics and Gerontology International 20(7): 737-739

Hunninghake, D.B.; Azarnoff, D.L. 1968: Drug interactions with warfarin. Archives of Internal Medicine 121(4): 349-352

Kwan, D.; Bartle, W.R. 1993: Drug interactions with warfarin. Medical Journal of Australia 158(8): 574-575

Neuman, M. 1970: Drug interactions. i. La Presse Medicale 78(44): 1938-1940

Wilson, V. 2017: Drug interactions: Time to put our pens down. British Dental Journal 222(4): 226

Hodge, C.; Marra, F.; Marzolini, C.; Boyle, A.; Gibbons, S.; Siccardi, M.; Burger, D.; Back, D.; Khoo, S. 2020: Drug interactions: a review of the unseen danger of experimental COVID-19 therapies. Journal of Antimicrobial ChemoTherapy 75(12): 3417-3424

Shah, S.; Singh, A. 2020: Drug labeling: the study of compliance of regulatory requirements for prescription drugs in India. Perspectives in Clinical Research 11(4): 164-167

Kesselheim, A.S.; Avorn, J. 2012: Drug labels: a flawed source of data for studying orphan drug approvals. Clinical Pharmacology and Therapeutics 92(6): 694; Author Reply 695

Robey, S.; David, F.S. 2017: Drug launch curves in the modern era. Nature Reviews. Drug Discovery 16(1): 13-14

Fleming, E.; Ma, P. 2002: Drug life-cycle technologies. Nature Reviews. Drug Discovery 1(10): 751-752

Kastens, W. 1960: Drug list for pharmacies. Pharmazeutische Praxis 10: 230-231

Chen, H.; Chi, X.; Li, B.; Zhang, M.; Ma, Y.; Achilefu, S.; Gu, Y. 2014: Drug loaded multilayered gold nanorods for combined photothermal and chemotherapy. Biomaterials Science 2(7): 996-1006

Xi, X.-M.; Xia, S.-J.; Lu, R. 2021: Drug loading techniques for exosome-based drug delivery systems. Die Pharmazie 76(2): 61-67

Šoltys, M.; Zůza, D.; Boleslavská, T.; Machač Akhlasová, S.; Balouch, M.; Kovačík, P.; Beránek, J.; Škalko-Basnet, N.ša.; Flaten, G.ør.E.; Štěpánek, F.še. 2021: Drug loading to mesoporous silica carriers by solvent evaporation: a comparative study of amorphization capacity and release kinetics. International Journal of Pharmaceutics 607: 120982

Francke, N.M.; Bunjes, H. 2021: Drug localization and its effect on the physical stability of poloxamer 188-stabilized colloidal lipid emulsions. International Journal of Pharmaceutics 599: 120394

Mullard, A. 2014: Drug makers and NIH team up to find and validate targets. Nature Reviews. Drug Discovery 13(4): 241-243

Hodgson, J. 2019: Drug makers chase anti-flu pill. Nature Biotechnology 37(6): 576-578

Schmidt, C. 2008: Drug makers chase cancer stem cells. Nature Biotechnology 26(4): 366-367

Sheridan, C. 2015: Drug makers target ubiquitin proteasome pathway anew. Nature Biotechnology 33(11): 1115-1117

Aubin, P.-A.; Rigumye, L.O.ée.; Kosel, M.; Besson, M.; Favrod-Coune, T. 2020: Drug management of behavioral disorders in people with developmental and intellectual disability. Revue Medicale Suisse 16(708): 1786-1789

Tuttle, C.B. 1985: Drug management of pain in cancer patients. Canadian Medical Association Journal 132(2): 121-134

Appel, W.C. 1985: Drug management of pain in cancer patients. Canadian Medical Association Journal 132(8): 899-900

Webb, S. 2010: Drug marketing and the new media. Nature Biotechnology 28(5): 396-398

Cheney, C.A. 2008: Drug menus in protocol applications. A la carte is OK. Lab Animal 37(9): 398-399

Thulin, J.D. 2008: Drug menus in protocol applications. Allow flexibility, with limits. Lab Animal 37(9): 397-398

Strait, K.R. 2008: Drug menus in protocol applications. Formalize SOPs. Lab Animal 37(9): 398

Charo, L.M.; Homer, M.V.; Natarajan, L.; Haunschild, C.; Chung, K.; Mao, J.J.; DeMichele, A.M.; Su, H.Irene. 2020: Drug metabolising enzyme polymorphisms and chemotherapy-related ovarian failure in young breast cancer survivors. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 2020: 1-6

Zdesenko, G.; Mutapi, F. 2020: Drug metabolism and pharmacokinetics of praziquantel: a review of variable drug exposure during schistosomiasis treatment in human hosts and experimental models. Plos Neglected Tropical Diseases 14(9): E0008649

von Bahr, C.; Groth, C.G.; Jansson, H.; Lundgren, G.; Lind, M.; Glaumann, H. 1980: Drug metabolism in human liver in vitro: establishment of a human liver bank. Clinical Pharmacology and Therapeutics 27(6): 711-725

Richter, E.; Epping, J.; Fuchshofen-Röckel, M.; Heusler, H.; Zilly, W. 1980: Drug metabolism in patients with liver disease. Leber Magen Darm 10(5): 234-240

Khokhar, J.Y.; Tyndale, R.F. 2011: Drug metabolism within the brain changes drug response: selective manipulation of brain CYP2B alters propofol effects. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 36(3): 692-700

Nebert, D.W. 1990: Drug metabolism. Growth signal pathways. Nature 347(6295): 709-710

Krynetski, E.; Evans, W.E. 2003: Drug methylation in cancer therapy: lessons from the TPMT polymorphism. Oncogene 22(47): 7403-7413

Nguipdop-Djomo, P.; Rodrigues, L.C.; Smith, P.G.; Abubakar, I.; Mangtani, P. 2020: Drug misuse, tobacco smoking, alcohol and other social determinants of tuberculosis in UK-born adults in England: a community-based case-control study. Scientific Reports 10(1): 5639

Viny, A.D.; Levine, R.L. 2020: Drug modulation by nuclear condensates. Science 368(6497): 1314-1315

Rüther, E.; Benkert, O.; Eckmann, F.; Eckmann, I.; Grohmann, R.; Helmchen, H.; Hippius, H.; Müller-Oerlinghausen, B.; Poser, W.; Schmidt, L.; Stille, G.; Strauss, A.; Uberla, K. 1980: Drug monitoring in psychiatry. Arzneimittel-Forschung 30(8): 1181-1183

Ge, L.; Yu, J. 2014: Drug monitoring: bright lights yield drug readout. Nature Chemical Biology 10(7): 490-491

Zintchenko, A.; Susha, A.S.; Concia, M.; Feldmann, J.; Wagner, E.; Rogach, A.L.; Ogris, M. 2009: Drug nanocarriers labeled with near-infrared-emitting quantum dots (quantoplexes): imaging fast dynamics of distribution in living animals. Molecular Therapy: the Journal of the American Society of Gene Therapy 17(11): 1849-1856

Rehman, A.; Jafari, S.M.; Tong, Q.; Riaz, T.; Assadpour, E.; Aadil, R.M.; Niazi, S.; Khan, I.M.; Shehzad, Q.; Ali, A.; Khan, S. 2020: Drug nanodelivery systems based on natural polysaccharides against different diseases. Advances in Colloid and Interface Science 284: 102251

Tevaarwerk, J.M. 1993: Drug nomenclature: suggestions for change. Cmaj: Canadian Medical Association Journal 148(5): 714-715

Essayagh, T.; Essayagh, M.; Essayagh, S. 2021: Drug non-adherence in hypertensive patients in Morocco, and its associated risk factors. European Journal of Cardiovascular Nursing 20(4): 324-330

Tideiksaar, R. 1984: Drug noncompliance in the elderly. Hospital Physician 20(3): 92

Iida, K. 1999: Drug of nitrate and nitrite. Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 394-396

Gallagher, M.J.; Clearkin, L.G. 2000: Drug or drusen? Central retinal vein occlusion in a young healthy woman with disc drusen. Eye 14: 401-402

Verlinde, C.L.; Dijkstra, B.W. 1995: Drug or tool, design or serendipity?. Nature Structural Biology 2(6): 429-432

Gan, W.Q.; Buxton, J.A.; Palis, H.; Janjua, N.Z.; Scheuermeyer, F.X.; Xavier, C.é G.; Zhao, B.; Desai, R.; Slaunwhite, A.K. 2021: Drug overdose and the risk of cardiovascular diseases: a nested case-control study. Clinical Research in Cardiology: Official Journal of the German Cardiac Society 2021

Cano, M.; Gelpí-Acosta, C. 2021: Drug overdose mortality among stateside Puerto Ricans: Evidence of a health disparity. International Journal on Drug Policy 90: 103079

Storflor, J.Guldteig.; Pettersen, L.Carina.; Slørdal, L.; Spigset, O. 2013: Drug package inserts--varying information for the same medicines. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 133(9): 955-959

Butler, D. 2009: Drug patent plan gets mixed reviews. Nature 457(7233): 1064

Patel, J.P.; Spiller, S.E.; Barker, E.D. 2021: Drug penetration in pediatric brain tumors: Challenges and opportunities. Pediatric Blood and Cancer 68(6): E28983

Minchinton, A.I.; Tannock, I.F. 2006: Drug penetration in solid tumours. Nature Reviews. Cancer 6(8): 583-592

Fang, M.; Richardson, B.; Cameron, C.M.; Dazard, J.-E.; Cameron, M.J. 2021: Drug perturbation gene set enrichment analysis (dpGSEA): a new transcriptomic drug screening approach. Bmc Bioinformatics 22(1): 22

DeFrancesco, L. 2019: Drug pipeline 1Q19. Nature Biotechnology 37(6): 579-580

DeFrancesco, L. 2020: Drug pipeline 1Q20. Nature Biotechnology 38(5): 519-520

DeFrancesco, L. 2021: Drug pipeline 1Q21-the old and the new. Nature Biotechnology 39(5): 536-537

DeFrancesco, L. 2017: Drug pipeline 2Q17. Nature Biotechnology 35(8): 703

DeFrancesco, L. 2020: Drug pipeline 2Q20. Nature Biotechnology 38(8): 913-914

DeFrancesco, L. 2021: Drug pipeline 2Q21-accelerated approvals to the fore. Nature Biotechnology 39(8): 904-905

DeFrancesco, L. 2017: Drug pipeline 3Q17. Nature Biotechnology 35(12): 1125

DeFrancesco, L. 2018: Drug pipeline 3Q18. Nature Biotechnology 36(12): 1132

DeFrancesco, L. 2019: Drug pipeline 3Q19. Nature Biotechnology 37(12): 1392-1393

DeFrancesco, L. 2020: Drug pipeline 3Q20. Nature Biotechnology 38(11): 1230-1231

DeFrancesco, L. 2014: Drug pipeline 4Q13. Nature Biotechnology 32(2): 125

DeFrancesco, L. 2020: Drug pipeline 4Q19. Nature Biotechnology 38(2): 124-125

DeFrancesco, L. 2016: Drug pipeline Q4 2015. Nature Biotechnology 34(2): 128

Dolgin, E. 2012: Drug pipeline is flush with new options for chronic constipation. Nature Medicine 18(9): 1308-1309

Mak, C. 2012: Drug pipeline: 1Q12. Nature Biotechnology 30(5): 383

DeFrancesco, L. 2013: Drug pipeline: 1Q13. Nature Biotechnology 31(6): 482

DeFrancesco, L. 2015: Drug pipeline: 1Q15. Nature Biotechnology 33(6): 580

DeFrancesco, L. 2016: Drug pipeline: 1Q16. Nature Biotechnology 34(5): 457

DeFrancesco, L. 2017: Drug pipeline: 1Q17. Nature Biotechnology 35(5): 400

DeFrancesco, L. 2018: Drug pipeline: 1Q18. Nature Biotechnology 36(5): 386

DeFrancesco, L. 2014: Drug pipeline: 2Q14. Nature Biotechnology 32(8): 710

DeFrancesco, L. 2015: Drug pipeline: 2Q15. Nature Biotechnology 33(8): 795

DeFrancesco, L. 2016: Drug pipeline: 2Q16. Nature Biotechnology 34(8): 799

DeFrancesco, L. 2018: Drug pipeline: 2Q18. Nature Biotechnology 36(8): 677

DeFrancesco, L. 2019: Drug pipeline: 2Q19. Nature Biotechnology 37(8): 840-841

DeFrancesco, L. 2015: Drug pipeline: 3Q15. Nature Biotechnology 33(11): 1126

DeFrancesco, L. 2016: Drug pipeline: 3Q16. Nature Biotechnology 34(11): 1089

DeFrancesco, L. 2015: Drug pipeline: 4Q14. Nature Biotechnology 33(2): 124

DeFrancesco, L. 2017: Drug pipeline: 4Q16. Nature Biotechnology 35(2): 107

DeFrancesco, L. 2018: Drug pipeline: 4Q17. Nature Biotechnology 36(2): 130

DeFrancesco, L. 2019: Drug pipeline: 4Q18. Nature Biotechnology 37(3): 206-208

Peng, W. 2011: Drug pipeline: Q111. Nature Biotechnology 29(5): 383

Peng, W. 2010: Drug pipeline: Q210. Nature Biotechnology 28(7): 640

DeFrancesco, L. 2012: Drug pipeline: Q212. Nature Biotechnology 30(9): 817

Peng, W. 2010: Drug pipeline: Q310. Nature Biotechnology 28(10): 998

Peng, W. 2011: Drug pipeline: Q311. Nature Biotechnology 29(10): 859

DeFrancesco, L. 2012: Drug pipeline: Q312. Nature Biotechnology 30(12): 1164

Peng, W. 2011: Drug pipeline: Q410. Nature Biotechnology 29(2): 101

Mak, H.Craig. 2012: Drug pipeline: Q411. Nature Biotechnology 30(1): 15

Todrick, A. 1971: Drug plasma levels and clinical effect. Proceedings of the Royal Society of Medicine 64(3): 290

Shotar, A.M. 2005: Drug poisoning in childhood. Saudi Medical Journal 26(12): 1948-1950

Domingo-Echaburu, S.; Dávalos, L.M.; Orive, G.; Lertxundi, U. 2021: Drug pollution and Sustainable Development Goals. Science of the Total Environment 800: 149412

Sloane, P.; Lekan-Rutledge, D. 1988: Drug prescribing by telephone: a potential cause of polypharmacy in nursing homes. Journal of the American Geriatrics Society 36(6): 574-575

Lamy, P.P. 1981: Drug prescribing for the elderly. Bulletin of the new York Academy of Medicine 57(8): 718-730

Ouslander, J.G. 1981: Drug prescribing for the elderly. Western Journal of Medicine 135(6): 455-462

Cayley, A.C. 1985: Drug prescribing in the elderly. British Journal of Hospital Medicine 34(6): 355-357

Liabeuf, S.; Laville, M. 2021: Drug prescription in patients with chronic kidney disease: a true challenge. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 36(3): 385-386

Emeriau, J.P.; Fourrier, A.; Dartigues, J.F.; Begaud, B. 1998: Drug prescriptions for the elderly. Bulletin de l'Academie Nationale de Medecine 182(7): 1419-1428; Discussion: 1428-1429

Hügel, A.; Hügel, I. 1989: Drug prescriptions in general practice. Zeitschrift für Arztliche Fortbildung 83(22): 1111-1113

Pasina, L.; Novella, A.; Cortesi, L.; Nobili, A.; Tettamanti, M.; Ianes, A. 2020: Drug prescriptions in nursing home residents: an Italian multicenter observational study. European Journal of Clinical Pharmacology 76(7): 1011-1019

Ehsani, J.P.; Michael, J.P.; Duren, M.; Shields, W.C.; Compton, R.P.; Fowler, D.; Smith, G. 2021: Drug presence in driving deaths in Maryland: Comparing trends and prevalence in medical examiner and FARS data. Accident; Analysis and Prevention 154: 106066

Bosch, X. 2001: Drug price deal spells windfall for researchers. Nature 414(6860): 138

Leite, S.N.; Ribeiro, A.A.; Pontes, M.A.; Vargas de Moraes, R. 2020: Drug price transparency initiative: the need for a broader view. Research in Social and Administrative Pharmacy: Rsap 16(9): 1324-1325

Ramsey, S. 2017: Drug pricing should depend on shared values. Nature 552(7685): S78

Ramsey, S. 2017: Drug pricing should depend on shared values. Nature 552(7685): S78

Malas, T.B.; Vlietstra, W.J.; Kudrin, R.; Starikov, S.; Charrout, M.; Roos, M.; Peters, D.J.M.; Kors, J.A.; Vos, R.; 't Hoen, P.A.C.; van Mulligen, E.M.; Hettne, K.M. 2019: Drug prioritization using the semantic properties of a knowledge graph. Scientific Reports 9(1): 6281

Tosh, S. 2021: Drug prohibition and the criminalization of immigrants: the compounding of drug war disparities in the United States deportation regime. International Journal on Drug Policy 87: 102846

Blue, B.A. 1992: Drug promotion and scientific exchange. New England Journal of Medicine 326(2): 133; Author Reply 134

Vogel, R.M. 1992: Drug promotion and scientific exchange. New England Journal of Medicine 326(2): 134

Budiansky, S. 1982: Drug promotion. FDA steps in. Nature 298(5877): 784-785

Vanholder, R.; Van Landschoot, N.; De Smet, R.; Schoots, A.; Ringoir, S. 1988: Drug protein binding in chronic renal failure: evaluation of nine drugs. Kidney International 33(5): 996-1004

Abreu, S.; Castelblanco-Arango, I.Y.; Gómez-Pineda, P.A.; Cardona, R. 2020: Drug provocation tests to identify analgesic alternatives for an infant with Stevens-Johnson syndrome caused by ibuprofen-acetaminophen. Revista Alergia Mexico 67(2): 189-195

Cortes, A.; Park, M.; McCarthy, B.C. 2021: Drug purchase price volatility in an academic medical center. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 78(Suppl_2): S33-S37

MacSweeney, D.; Parr, D. 1970: Drug pushers in the United Kingdom. Nature 228(5270): 422-424

Gerdes, H.; Casado, P.; Dokal, A.; Hijazi, M.; Akhtar, N.; Osuntola, R.; Rajeeve, V.; Fitzgibbon, J.; Travers, J.; Britton, D.; Khorsandi, S.; Cutillas, P.R. 2021: Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs. Nature Communications 12(1): 1850

Lobo, I.ês.; Ferreira, M.ár.; Velho, G.ór.; Sanches, M.; Selores, M. 2008: Drug rash with eosinophilia and systemic symptoms (DRESS syndrome). Acta Medica Portuguesa 21(4): 367-372

Gordon, J.S.; Neyman, K.M.; Wells, R.D.; Chen, S.C. 2012: Drug rash with eosinophilia and systemic symptoms (DRESS syndrome). Cutis 89(4): 180-182

López-Anglada, L.; Vázquez, L.; Pérez-Simón, J.A.; Dávila, I.; Santos-Briz, A.; García, L.; Caballero, D. 2011: Drug rash with eosinophilia and systemic symptoms (DRESS) after an unrelated donor BM transplant. Bone Marrow Transplantation 46(11): 1487-1488

Trivedi, A.; Sharma, S.; Govindan, R. 2022: Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in a paediatric patient taking zonisamide. European Journal of Hospital Pharmacy: Science and Practice 29(4): 231-234

Kerkemeyer, K.L.S.; Lee, S.; Lai, F.Y.X.; Mar, A. 2020: Drug rash with eosinophilia and systemic symptoms syndrome without eosinophilia managed with intravenous immunoglobulin. Internal Medicine Journal 50(9): 1156-1157

Ramirez, G.A.; Della-Torre, E.; Tresoldi, M.; Scarpellini, P.; Ciceri, F.; Dagna, L.; Yacoub, M.-R. 2021: Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 27(8): 1190-1192

Cardones, A.R. 2020: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. Clinics in Dermatology 38(6): 702-711

Guerrero Gómez, D.A.; París Zorro, S.; Aponte Barrios, W.; Carrillo Bayona, J.A. 2020: Drug reaction with eosinophilia and systemic symptoms (DRESS) with severe and atypical lung involvement. Radiology Case Reports 15(11): 2178-2182

Sandhu, S.; Neema, S.; Vashisht, D.; Venugopal, R.; Sengupta, P.; Radhakrishnan, S. 2021: Drug reaction with eosinophilia and systemic symptoms: a single center descriptive observational study. Dermatologic Therapy 34(1): E14670

Herman, A.; Matthews, M.; Mairlot, M.; Nobile, L.; Fameree, L.; Jacquet, L.-M.; Baeck, M. 2020: Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19. Journal of the European Academy of Dermatology and Venereology: Jeadv 34(12): E768

Menteşoğlu, D.; Doğan Günaydın, S.; Ersoy-Evans, S. 2020: Drug reaction with eosinophilia and systemic symptoms syndrome induced by apixaban. Dermatologic Therapy 33(4): E13719

Wollina, U.; Abdel-Naser, M.B. 2020: Drug reactions affecting hair and nails. Clinics in Dermatology 38(6): 693-701

D'Arcy, P.F. 1987: Drug reactions and interactions. Journal de Pharmacie de Belgique 42(3): 221-224

D'Arcy, P.F. 1987: Drug reactions and interactions. Journal de Pharmacie de Belgique 42(6): 404-408

D'Arcy, P.F. 1988: Drug reactions and interactions. Journal de Pharmacie de Belgique 43(3): 233-236

D'Arcy, P.F. 1987: Drug reactions and interactions. Journal de Pharmacie de Belgique 42(2): 152-159

Renoz, L. 1984: Drug reactions and interactions. Journal de Pharmacie de Belgique 39(1): 63-65

Scrace, B.; Fityan, A.; Bigham, C. 2020: Drug reactions with eosinophilia and systemic symptoms. Bja Education 20(2): 65-71

Byron, J.W. 1973: Drug receptors and the haemopoietic stem cell. Nature: new Biology 241(109): 152-154

Bennett, J. 1980: Drug receptors and their effectors. Nature 285(5762): 192-193

Rang, H.P. 1971: Drug receptors and their function. Nature 231(5298): 91-96

Black, J.W.; Shankley, N.P. 1995: Drug receptors. Inverse agonists exposed. Nature 374(6519): 214-215

Flower, R. 2002: Drug receptors: a long engagement. Nature 415(6872): 587

Kuczynski, E.A.; Sargent, D.J.; Grothey, A.; Kerbel, R.S. 2013: Drug rechallenge and treatment beyond progression--implications for drug resistance. Nature Reviews. Clinical Oncology 10(10): 571-587

Lemprière, S. 2019: Drug reduces excess iron in ultra-rare neurodegenerative disease. Nature Reviews. Neurology 15(9): 492-493

Sanderson, L.; da Silva, M.; Sekhar, G.N.; Brown, R.C.; Burrell-Saward, H.; Fidanboylu, M.; Liu, B.; Dailey, L.A.; Dreiss, C.éc.A.; Lorenz, C.; Christie, M.; Persaud, S.J.; Yardley, V.; Croft, S.L.; Valero, M.; Thomas, S.A. 2021: Drug reformulation for a neglected disease. the NANOHAT project to develop a safer more effective sleeping sickness drug. Plos Neglected Tropical Diseases 15(4): E0009276

Lee, B-Yu.; Clemens, D.L.; Silva, A.; Dillon, B.Jane.; Masleša-Galić, Sša.; Nava, S.; Ding, X.; Ho, C-Ming.; Horwitz, M.A. 2017: Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time. Nature Communications 8: 14183

Dickson, D. 1980: Drug regulations: signs change. Nature 285(5765): 430-431

Saiz, L.Carlos.; Alvarez, Jús.; Martínez, H. 2011: Drug regulatory agencies' role in the interaction between clopidogrel and proton pump inhibitors. American Journal of Gastroenterology 106(7): 1369-1370

Aldhous, P. 2005: Drug rehabilitation: cold turkey, Vietnamese style. Nature 433(7026): 568-569

Ruangritchankul, S.; Peel, N.M.; Hanjani, L.S.; Gray, L.C. 2020: Drug related problems in older adults living with dementia. Plos one 15(7): E0236830

Bi, H.; Chen, Z.; Qiu, J. 2021: Drug release and magneto-calorific analysis of magnetic lipid microcapsules for potential cancer therapeutics. Designed Monomers and Polymers 24(1): 156-161

Asare-Addo, K.; Totea, A.-M.; Nokhodchi, A. 2020: Drug release from magnesium aluminium silicate-polyethylene oxide (PEO) nanocomposite matrices: An investigation using the USP IIi apparatus. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 153: 105474

Sagan, J.ří 2020: Drug repositioning - antibiotics as cytostatics. Klinicka Mikrobiologie a Infekcni Lekarstvi 26(4): 138-139

Bibi, N.; Farid, A.; Gul, S.; Ali, J.; Amin, F.; Kalthiya, U.; Hupp, T. 2021: Drug repositioning against COVID-19: a first line treatment. Journal of Biomolecular Structure and Dynamics 2021: 1-15

Ballard, C.; Aarsland, D.; Cummings, J.; O'Brien, J.; Mills, R.; Molinuevo, J.Luis.; Fladby, T.; Williams, G.; Doherty, P.; Corbett, A.; Sultana, J. 2020: Drug repositioning and repurposing for Alzheimer disease. Nature Reviews. Neurology 16(12): 661-673

Khanjani, F.; Jafari, L.; Azadiyan, S.; Roozbehi, S.; Moradian, C.; Zahiri, J.; Hasannia, S.; Sajedi, R.H. 2021: Drug repositioning based on gene expression data for human HER2-positive breast cancer. Archives of Biochemistry and Biophysics 712: 109043

Gao, H.; Ni, Y.; Mo, X.; Li, D.; Teng, S.; Huang, Q.; Huang, S.; Liu, G.; Zhang, S.; Tang, Y.; Lu, L.; Liang, H. 2021: Drug repositioning based on network-specific core genes identifies potential drugs for the treatment of autism spectrum disorder in children. Computational and Structural Biotechnology Journal 19: 3908-3921

Meng, Y.; Jin, M.; Tang, X.; Xu, J. 2021: Drug repositioning based on similarity constrained probabilistic matrix factorization: COVID-19 as a case study. Applied Soft Computing 103: 107135

Deepthi, K.; Jereesh, A.S. 2020: Drug repositioning based on the target micro RNAs using bilateral-inductive matrix completion. Molecular Genetics and Genomics: Mgg 295(5): 1305-1314

Lucchetta, M.; Pellegrini, M. 2021: Drug repositioning by merging active subnetworks validated in cancer and COVID-19. Scientific Reports 11(1): 19839

Alamgir, J.; Yajima, M.; Ergas, R.; Chen, X.; Hill, N.; Munir, N.; Saeed, M.; Gersing, K.; Haendel, M.; Chute, C.G.; Abid, M.R. 2021: Drug repositioning candidates identified using in-silico quasi-quantum molecular simulation demonstrate reduced COVID-19 mortality in 1.5M patient records. Medrxiv: the Preprint Server for Health Sciences 2021

Corbett, A.; Pickett, J.; Burns, A.; Corcoran, J.; Dunnett, S.B.; Edison, P.; Hagan, J.J.; Holmes, C.; Jones, E.; Katona, C.; Kearns, I.; Kehoe, P.; Mudher, A.; Passmore, A.; Shepherd, N.; Walsh, F.; Ballard, C. 2012: Drug repositioning for Alzheimer's disease. Nature Reviews. Drug Discovery 11(11): 833-846

Amemiya, T.; Gromiha, M.Michael.; Horimoto, K.; Fukui, K. 2019: Drug repositioning for dengue haemorrhagic fever by integrating multiple omics analyses. Scientific Reports 9(1): 523

Lüscher Dias, T.; Schuch, V.; Beltrão-Braga, Pícia.Cristina.Baleeiro.; Martins-de-Souza, D.; Brentani, H.Paula.; Franco, Gória.Regina.; Nakaya, H.Imoto. 2020: Drug repositioning for psychiatric and neurological disorders through a network medicine approach. Translational Psychiatry 10(1): 141

Fabbri, C.; Kasper, S.; Zohar, J.; Souery, D.; Montgomery, S.; Albani, D.; Forloni, G.; Ferentinos, P.; Rujescu, D.; Mendlewicz, J.; De Ronchi, D.; Riva, M.Andrea.; Lewis, C.M.; Serretti, A. 2021: Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study. ProgressinNeuro-PsychopharmacologyandBiologicalPsychiatry 104: 110050

Nilbert, M.; Mellemkjær, L. 2020: Drug repositioning in cancer: a role for antihistamines in breast cancer?. Acta Oncologica 59(9): 1007-1008

Bouscary, A.; Quessada, C.; René, F.éd.ér.; Spedding, M.; Henriques, A.; Ngo, S.; Loeffler, J.-P. 2020: Drug repositioning in neurodegeneration: An overview of the use of ambroxol in neurodegenerative diseases. European Journal of Pharmacology 884: 173446

Sekiguchi, M.; Sagano, N.; Kawazoe, H.; Hiraga, Y.; Jibiki, A.; Yokoyama, Y.; Suzuki, S.; Nakamura, T. 2021: Drug repositioning of antipsychotic drugs for cisplatin-induced pica behavior in mice. Die Pharmazie 76(10): 484-487

Rauschenbach, L.èl.; Wieland, A.; Reinartz, R.; Kebir, S.; Till, A.; Darkwah Oppong, M.; Dobersalske, C.; Ullrich, V.; Ahmad, A.; Jabbarli, R.; Pierscianek, D.; Fröhlich, H.; Simon, M.; Brüstle, O.; Sure, U.; Glas, M.; Scheffler, B.ör. 2020: Drug repositioning of antiretroviral ritonavir for combinatorial therapy in glioblastoma. European Journal of Cancer 140: 130-139

Parisi, D.; Adasme, M.F.; Sveshnikova, A.; Bolz, S.N.; Moreau, Y.; Schroeder, M. 2020: Drug repositioning or target repositioning: a structural perspective of drug-target-indication relationship for available repurposed drugs. Computational and Structural Biotechnology Journal 18: 1043-1055

Metin, R.; Akten, E.Demet. 2021: Drug repositioning to propose alternative modulators for glucocorticoid receptor through structure-based virtual screening. Journal of Biomolecular Structure and Dynamics 2021: 1-16

Ashburn, T.T.; Thor, K.B. 2004: Drug repositioning: identifying and developing new uses for existing drugs. Nature Reviews. Drug Discovery 3(8): 673-683

Ciliberto, G.; Mancini, R.; Paggi, M.G. 2020: Drug repurposing against COVID-19: focus on anticancer agents. Journal of Experimental and Clinical Cancer Research: Cr 39(1): 86

Kumar, V.; Liu, H.; Wu, C. 2021: Drug repurposing against SARS-CoV-2 receptor binding domain using ensemble-based virtual screening and molecular dynamics simulations. Computers in Biology and Medicine 135: 104634

Arun, K.G.; Sharanya, C.S.; Abhithaj, J.; Francis, D.; Sadasivan, C. 2020: Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target. Journal of Biomolecular Structure and Dynamics 2020: 1-12

Heimfarth, L.; Serafini, M.R.; Martins-Filho, P.R.; Quintans, J.d.S.S.; Quintans-Júnior, L.J.é 2020: Drug repurposing and cytokine management in response to COVID-19: a review. International Immunopharmacology 88: 106947

Nath, J.; Paul, R.; Ghosh, S.K.; Paul, J.; Singha, B.; Debnath, N. 2020: Drug repurposing and relabeling for cancer therapy: Emerging benzimidazole antihelminthics with potent anticancer effects. Life Sciences 258: 118189

Lundström-Stadelmann, B.; Rufener, R.; Hemphill, A. 2020: Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis. International Journal for Parasitology. Drugs and Drug Resistance 13: 121-129

Singh, T.U.; Parida, S.; Lingaraju, M.C.; Kesavan, M.; Kumar, D.; Singh, R.K. 2020: Drug repurposing approach to fight COVID-19. Pharmacological Reports: Pr 72(6): 1479-1508

Thirunavukkarasu, M.Kumar.; Karuppasamy, R. 2021: Drug repurposing combined with MM/PBSA based validation strategies towards MEK inhibitors screening. Journal of Biomolecular Structure and Dynamics 2021: 1-12

Williams, G.; Gatt, A.; Clarke, E.; Corcoran, J.; Doherty, P.; Chambers, D.; Ballard, C. 2019: Drug repurposing for Alzheimer's disease based on transcriptional profiling of human iPSC-derived cortical neurons. Translational Psychiatry 9(1): 220

Kumar, N.; Gahlawat, A.; Kumar, R.Naresh.; Singh, Y.Pal.; Modi, G.; Garg, P. 2020: Drug repurposing for Alzheimer's disease: in silico and in vitro investigation of FDA-approved drugs as acetylcholinesterase inhibitors. Journal of Biomolecular Structure and Dynamics 2020: 1-15

Gupta, R.K.; Nwachuku, E.L.; Zusman, B.E.; Jha, R.M.; Puccio, A.M. 2021: Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium. Plos one 16(9): E0257784

Loucera, C.; Esteban-Medina, M.; Rian, K.; Falco, Mías.M.; Dopazo, Jín.; Peña-Chilet, Mía. 2020: Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection. Signal Transduction and Targeted Therapy 5(1): 290

Ng, Y.L.; Salim, C.K.; Chu, J.J.H. 2021: Drug repurposing for COVID-19: Approaches, challenges and promising candidates. Pharmacology and Therapeutics 228: 107930

Trindade, J.D.'A.S.; Freire-de-Lima, C.él.G.; Côrte-Real, S.; Decote-Ricardo, D.; Freire de Lima, M.E. 2021: Drug repurposing for Chagas disease: in vitro assessment of nimesulide against Trypanosoma cruzi and insights on its mechanisms of action. Plos one 16(10): E0258292

Rampioni, G.; Visca, P.; Leoni, L.; Imperi, F. 2017: Drug repurposing for antivirulence therapy against opportunistic bacterial pathogens. Emerging Topics in Life Sciences 1(1): 13-22

Tran, A.A.; Prasad, V. 2020: Drug repurposing for cancer treatments: a well-intentioned, but misguided strategy. LANCET. Oncology 21(9): 1134-1136

Rai, S.; Bhatia, V.; Bhatnagar, S. 2021: Drug repurposing for hyperlipidemia associated disorders: An integrative network biology and machine learning approach. Computational Biology and Chemistry 92: 107505

Behera, S.K.; Mahapatra, N.; Tripathy, C.S.; Pati, S. 2021: Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An in silico approach. Indian Journal of Medical Research 153(1; 2: 132-143

Bharadwaj, S.; Dubey, A.; Kamboj, N.Kumar.; Sahoo, A.Kumar.; Kang, S.Gu.; Yadava, U. 2021: Drug repurposing for ligand-induced rearrangement of Sirt2 active site-based inhibitors via molecular modeling and quantum mechanics calculations. Scientific Reports 11(1): 10169

Liu, Y.; Tong, Z.; Shi, J.; Li, R.; Upton, M.; Wang, Z. 2021: Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria. Theranostics 11(10): 4910-4928

Ezebuo, F.C.; Uzochukwu, I.C. 2020: Drug repurposing for schistosomiasis: molecular docking and dynamics investigations. Journal of Biomolecular Structure and Dynamics 2020: 1-15

Batalha, P.N.; Forezi, L.S.M.; Lima, C.G.S.; Pauli, F.P.; Boechat, F.C.S.; de Souza, M.C.íl.B.V.; Cunha, A.C.; Ferreira, V.F.; da Silva, F.d.C. 2021: Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches. Bioorganic Chemistry 106: 104488

Rivero-García, Iés.; Castresana-Aguirre, M.; Guglielmo, L.; Guala, D.; Sonnhammer, E.L.L. 2021: Drug repurposing improves disease targeting 11-fold and can be augmented by network module targeting, applied to COVID-19. Scientific Reports 11(1): 20687

Srivastava, K.; Singh, M.K. 2021: Drug repurposing in COVID-19: a review with past, present and future. Metabolism Open 12: 100121

Mao, Z.; Valluru, M.K.; Ong, A.C.M. 2021: Drug repurposing in autosomal dominant polycystic kidney disease: back to the future with pioglitazone. Clinical Kidney Journal 14(7): 1715-1718

van Driel, B.O.; van der Velden, J. 2020: Drug repurposing in cardiology. Netherlands Heart Journal: Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2020: 1-2

Karatzas, E.; Bourdakou, M.M.; Kolios, G.; Spyrou, G.M. 2017: Drug repurposing in idiopathic pulmonary fibrosis filtered by a bioinformatics-derived composite score. Scientific Reports 7(1): 12569

Bouche, G.; Gedye, C.; Meheus, L.; Pantziarka, P. 2020: Drug repurposing in oncology. LANCET. Oncology 21(12): E542

Frantzi, M.; Latosinska, A.; Mokou, M.; Mischak, H.; Vlahou, A. 2020: Drug repurposing in oncology. LANCET. Oncology 21(12): E543

Bertolini, F.; Sukhatme, V.P.; Bouche, G. 2015: Drug repurposing in oncology--patient and health systems opportunities. Nature Reviews. Clinical Oncology 12(12): 732-742

Vassileva, S.; Mateeva, V.; Drenovska, K. 2021: Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction?. Clinics in Dermatology 39(3): 430-445

Mahmoud, D.B.; Shitu, Z.; Mostafa, A. 2020: Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?. Journal Genetic Engineering and Biotechnology 18(1): 35

Sun, J.; Yogarajah, T.; Lee, R.Ching.Hua.; Kaur, P.; Inoue, M.; Tan, Y.Wah.; Chu, J.Jang.Hann. 2020: Drug repurposing of pyrimidine analogs as potent antiviral compounds against human enterovirus A71 infection with potential clinical applications. Scientific Reports 10(1): 8159

Pashaei, Y. 2021: Drug repurposing of selective serotonin reuptake inhibitors: could these drugs help fight COVID-19 and save lives?. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 88: 163-172

Drayman, N.; Jones, K.A.; Azizi, S.-A.; Froggatt, H.M.; Tan, K.; Maltseva, N.I.; Chen, S.; Nicolaescu, V.; Dvorkin, S.; Furlong, K.; Kathayat, R.S.; Firpo, M.R.; Mastrodomenico, V.; Bruce, E.A.; Schmidt, M.M.; Jedrzejczak, R.; Muñoz-Alía, M.Á; Schuster, B.; Nair, V.; Botten, J.W.; Brooke, C.B.; Baker, S.C.; Mounce, B.C.; Heaton, N.S.; Dickinson, B.C.; Jaochimiak, A.; Randall, G.; Tay, S.ş 2020: Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro. Biorxiv: the Preprint Server for Biology 2020

Bakowski, M.A.; Beutler, N.; Wolff, K.C.; Kirkpatrick, M.G.; Chen, E.; Nguyen, T-Trinh.H.; Riva, L.; Shaabani, N.; Parren, M.; Ricketts, J.; Gupta, A.K.; Pan, K.; Kuo, P.; Fuller, M.; Garcia, E.; Teijaro, J.R.; Yang, L.; Sahoo, D.; Chi, V.; Huang, E.; Vargas, N.; Roberts, A.J.; Das, S.; Ghosh, P.; Woods, A.K.; Joseph, S.B.; Hull, M.V.; Schultz, P.G.; Burton, D.R.; Chatterjee, A.K.; McNamara, C.W.; Rogers, T.F. 2021: Drug repurposing screens identify chemical entities for the development of COVID-19 interventions. Nature Communications 12(1): 3309

Dittmar, M.; Lee, J.S.; Whig, K.; Segrist, E.; Li, M.; Kamalia, B.; Castellana, L.; Ayyanathan, K.; Cardenas-Diaz, F.L.; Morrisey, E.E.; Truitt, R.; Yang, W.; Jurado, K.; Samby, K.; Ramage, H.; Schultz, D.C.; Cherry, S. 2021: Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2. Cell Reports 35(1): 108959

Fletcher, E.J.R.; Kaminski, T.; Williams, G.; Duty, S. 2021: Drug repurposing strategies of relevance for Parkinson's disease. Pharmacology Research and Perspectives 9(4): E00841

Koulgi, S.; Jani, V.; Uppuladinne, M.; Sonavane, U.; Nath, A.Kumar.; Darbari, H.; Joshi, R. 2020: Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CL pro ). Journal of Biomolecular Structure and Dynamics 2020: 1-21

Zouboulis, C.C.; Nogueira da Costa, A. 2021: Drug repurposing through drug-gene interaction profiles for hidradenitis suppurativa/acne inversa treatment. Journal of the European Academy of Dermatology and Venereology: Jeadv 35(4): E251-E254

Kingsmore, K.M.; Grammer, A.C.; Lipsky, P.E. 2020: Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases. Nature Reviews. Rheumatology 16(1): 32-52

Mahdian, S.; Ebrahim-Habibi, A.; Zarrabi, M. 2020: Drug repurposing using computational methods to identify therapeutic options for COVID-19. Journal of Diabetes and Metabolic Disorders 19(2): 691-699

Zeng, X.; She, P.; Zhou, L.; Li, S.; Hussain, Z.; Chen, L.; Wu, Y. 2021: Drug repurposing: Antimicrobial and antibiofilm effects of penfluridol against Enterococcus faecalis. Microbiologyopen 10(1): E1148

Crunkhorn, S. 2018: Drug repurposing: Heart failure drug effective in medulloblastoma. Nature Reviews. Drug Discovery 17(12): 864

Sonaye, H.V.; Sheikh, R.Y.; Doifode, C.A. 2021: Drug repurposing: Iron in the fire for older drugs. Biomedicine and PharmacoTherapy 141: 111638

Begley, C.G.; Ashton, M.; Baell, J.; Bettess, M.; Brown, M.P.; Carter, B.; Charman, W.N.; Davis, C.; Fisher, S.; Frazer, I.; Gautam, A.; Jennings, M.P.; Kearney, P.; Keeffe, E.; Kelly, D.; Lopez, A.F.; McGuckin, M.; Parker, M.W.; Rayner, C.; Roberts, B.; Rush, J.S.; Sullivan, M. 2021: Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers. Science Translational Medicine 13(612): Eabd 5524

Pertusati, F.; Pileggi, E.; Richards, J.; Wootton, M.; Van Leemputte, T.; Persoons, L.; De Coster, D.; Villanueva, X.; Daelemans, D.; Steenackers, H.; McGuigan, C.; Serpi, M. 2020: Drug repurposing: phosphate prodrugs of anticancer and antiviral FDA-approved nucleosides as novel antimicrobials. Journal of Antimicrobial ChemoTherapy 75(10): 2864-2878

Pushpakom, S.; Iorio, F.; Eyers, P.A.; Escott, K.Jane.; Hopper, S.; Wells, A.; Doig, A.; Guilliams, T.; Latimer, J.; McNamee, C.; Norris, A.; Sanseau, P.; Cavalla, D.; Pirmohamed, M. 2019: Drug repurposing: progress, challenges and recommendations. Nature Reviews. Drug Discovery 18(1): 41-58

Nam, G.; Suh, J.-M.; Yi, Y.; Lim, M.H. 2021: Drug repurposing: small molecules against Cu(II)-amyloid-β and free radicals. Journal of Inorganic Biochemistry 224: 111592

Sleire, L.; Skeie, B.S.; Netland, I.A.; Førde, H.E.; Dodoo, E.; Selheim, F.; Leiss, L.; Heggdal, J.I.; Pedersen, P-H.; Wang, J.; Enger, P.Ø. 2015: Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion. Oncogene 34(49): 5951-5959

Insel, T.R.; Sahakian, B.J. 2012: Drug research: a plan for mental illness. Nature 483(7389): 269

Kubinyi, H. 2003: Drug research: myths, hype and reality. Nature Reviews. Drug Discovery 2(8): 665-668

Schwab, M.E.; Buchli, A.D. 2012: Drug research: plug the real brain drain. Nature 483(7389): 267-268

Pilcher, H.R. 2003: Drug research: the ups and downs of lithium. Nature 425(6954): 118-120

Gewin, V. 2002: Drug researcher quits controversial cat study. Nature 417(6891): 778

Harrison, C. 2020: Drug researchers pursue new lines of attack against COVID-19. Nature Biotechnology 38(6): 659-662

Hazarika, M.; Prajna, N.V.; Senthilkumari, S. 2021: Drug reservoir function of voriconazole impregnated human amniotic membrane: An in vitro study. Indian Journal of Ophthalmology 69(5): 1068-1072

Sliutz, G.; Karlseder, J.; Tempfer, C.; Orel, L.; Holzer, G.; Simon, M.M. 1996: Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: implication of quercetin as sensitiser in chemotherapy. British Journal of Cancer 74(2): 172-177

Hay, J.; Kirkness, C.M.; Seal, D.V.; Wright, P. 1994: Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy. Eye 8: 555-563

Li, Y.; Wang, Z.; Ajani, J.A.; Song, S. 2021: Drug resistance and Cancer stem cells. Cell Communication and Signaling: Ccs 19(1): 19

Wang, X.; Zhang, H.; Chen, X. 2019: Drug resistance and combating drug resistance in cancer. Cancer Drug Resistance 2: 141-160

Diriba, G.; Tola, H.H.; Alemu, A.; Yenew, B.; Gamtesa, D.F.; Kebede, A. 2021: Drug resistance and its risk factors among extrapulmonary tuberculosis in Ethiopia: a systematic review and meta-analysis. Plos one 16(10): E0258295

Anderson, E.S.; Lewis, M.J. 1965: Drug resistance and its transfer in Salmonella typhimurium. Nature 206(984): 579-583

Chatterjee, B.R. 1982: Drug resistance and multi-drug therapy in leprosy. Leprosy in India 54(3): 402-411

Arbab, S.; Ullah, H.; Wei, X.; Wang, W.; Ahmad, S.U.; Zhang, J. 2021: Drug resistance and susceptibility testing of Gram negative bacterial isolates from healthy cattle with different β - Lactam resistance Phenotypes from Shandong province China. Brazilian Journal of Biology 83: E247061

Berman, J.; Krysan, D.J. 2020: Drug resistance and tolerance in fungi. Nature Reviews. Microbiology 18(6): 319-331

Wang, Y.; Zhao, S.; Han, L.; Guo, X.; Chen, M.; Ni, Y.; Zhang, Y.; Cui, Z.; He, P. 2014: Drug resistance and virulence of uropathogenic Escherichia coli from Shanghai, China. Journal of Antibiotics 67(12): 799-805

Galmarini, C.M.; Kamath, K.; Vanier-Viornery, A.; Hervieu, V.; Peiller, E.; Falette, N.; Puisieux, A.; Ann Jordan, M.; Dumontet, C. 2003: Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics. British Journal of Cancer 88(11): 1793-1799

Radzio-Basu, J.; Council, O.; Cong, M-Er.; Ruone, S.; Newton, A.; Wei, X.; Mitchell, J.; Ellis, S.; Petropoulos, C.J.; Huang, W.; Spreen, W.; Heneine, W.; García-Lerma, J.Gerardo. 2019: Drug resistance emergence in macaques administered cabotegravir long-acting for pre-exposure prophylaxis during acute SHIV infection. Nature Communications 10(1): 2005

Nowacka, M.; Sterzynska, K.; Andrzejewska, M.; Nowicki, M.; Januchowski, R. 2021: Drug resistance evaluation in novel 3D in vitro model. Biomedicine and PharmacoTherapy 138: 111536

Mitsuhashi, S. 1968: Drug resistance factor-R. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 13(7): 643

Filipits, M.; Stranzl, T.; Pohl, G.; Heinzl, H.; Jäger, U.; Geissler, K.; Fonatsch, C.; Haas, O.A.; Lechner, K.; Pirker, R. 2000: Drug resistance factors in acute myeloid leukemia: a comparative analysis. Leukemia 14(1): 68-76

Zhao, J.; Zhang, H.; Lei, T.; Liu, J.; Zhang, S.; Wu, N.; Sun, B.; Wang, M. 2020: Drug resistance gene expression and chemotherapy sensitivity detection in Chinese women with different molecular subtypes of breast cancer. Cancer Biology and Medicine 17(4): 1014-1025

Liu, Q.; Yang, D.; Qiu, B.; Martinez, L.; Ji, Y.; Song, H.; Li, Z.; Wang, J. 2021: Drug resistance gene mutations and treatment outcomes in MDR-TB: a prospective study in Eastern China. Plos Neglected Tropical Diseases 15(1): E0009068

Beghin, J.-C.; Ruelle, J.; Goubau, P.; Van der Linden, D. 2020: Drug resistance in HIV-infected children living in rural South Africa: Implications of an antiretroviral therapy initiated during the first year of life. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 129: 104547

Jain 2000: Drug resistance in Helicobacter pylori infection. Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 19(Suppl 1): S38-S39

Johnson, R.; Streicher, E.M.; Louw, G.E.; Warren, R.M.; van Helden, P.D.; Victor, T.C. 2006: Drug resistance in Mycobacterium tuberculosis. Current Issues in Molecular Biology 8(2): 97-111

Haldar, K.; Bhattacharjee, S.; Safeukui, I. 2018: Drug resistance in Plasmodium. Nature Reviews. Microbiology 16(3): 156-170

Radha, S.; Murugesan, M.; Rupali, P. 2020: Drug resistance in Salmonella Typhi: implications for South Asia and travel. Current Opinion in Infectious Diseases 33(5): 347-354

Löscher, W.; Potschka, H. 2005: Drug resistance in brain diseases and the role of drug efflux transporters. Nature Reviews. Neuroscience 6(8): 591-602

Yagüe, E.; Raguz, S. 2005: Drug resistance in cancer. British Journal of Cancer 93(9): 973-976

Haider, T.; Pandey, V.; Banjare, N.; Gupta, P.N.; Soni, V. 2020: Drug resistance in cancer: mechanisms and tackling strategies. Pharmacological Reports: Pr 72(5): 1125-1151

Luo, M.; Yang, X.; Chen, H.-N.; Nice, E.C.; Huang, C. 2021: Drug resistance in colorectal cancer: An epigenetic overview. Biochimica et Biophysica Acta. Reviews on Cancer 1876(2): 188623

Barney, J.B.; Chandrashekarappa, D.G.; Soncini, S.R.; Schmidt, M.C. 2021: Drug resistance in diploid yeast is acquired through dominant alleles, haploinsufficiency, gene duplication and aneuploidy. Plos Genetics 17(9): E1009800

Czuczwar, P.; Kaczmarczyk, K.; Wierzchowska-Cioch, E.; Łuszczki, J.J.; Czuczwar, Sław.J. 2009: Drug resistance in epilepsy. Przeglad Lekarski 66(11): 963-966

Fairlamb, A.H.; Gow, N.A.R.; Matthews, K.R.; Waters, A.P. 2016: Drug resistance in eukaryotic microorganisms. Nature Microbiology 1(7): 16092

Ghosh, S. 1980: Drug resistance in leprosy. Indian Journal of Dermatology 25(3): 1-4

Matsuoka, M. 2010: Drug resistance in leprosy. Japanese Journal of Infectious Diseases 63(1): 1-7

Shanker, M.; Willcutts, D.; Roth, J.A.; Ramesh, R. 2010: Drug resistance in lung cancer. Lung Cancer 1: 23-36

Wery, M.; Coosemans, M. 1980: Drug resistance in malaria. Annales de la Societe Belge de Medecine Tropicale 60(2): 137-162

Hallinan, T.C. 1959: Drug resistance in malaria. West Indian Medical Journal 8: 132-134

Seruga, B.; Ocana, A.; Tannock, I.F. 2011: Drug resistance in metastatic castration-resistant prostate cancer. Nature Reviews. Clinical Oncology 8(1): 12-23

Sonneveld, P. 1999: Drug resistance in multiple myeloma. Pathologie-Biologie 47(2): 182-187

Pilarski, L.M.; Yatscoff, R.W.; Murphy, G.F.; Belch, A.R. 1998: Drug resistance in multiple myeloma: cyclosporin A analogues and their metabolites as potential chemosensitizers. Leukemia 12(4): 505-509

Weisberg, E.; Sattler, M.; Ray, A.; Griffin, J.D. 2010: Drug resistance in mutant FLT3-positive AML. Oncogene 29(37): 5120-5134